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Despite many women quitting smoking during pregnancy, the majority will return to 
smoking by 12 months postpartum. Smoking postpartum carries substantial risks of 
morbidity and mortality for both mother and baby. Breastfeeding is a protective factor 
against some of the risks associated with smoking. However, mothers who smoke are 
less likely to intend to breastfeed, initiate breastfeeding at birth, or continue 
breastfeeding, than non-smoking mothers. Current explanations for this association 
include a possible physiological mechanism, a coincidental association due to shared 
demographics, or a fear of harm.  
E-cigarettes are an increasingly popular alternative to smoking, helping to prevent 
relapse in those trying to quit, and Public Health England, in an evidenced based 
review, estimate cite them to be at least 95% safer than smoking. While research has 
explored e-cigarette use during pregnancy, thus far, no study has considered how e-
cigarettes may be being used in the postpartum period. Crucially, research has not 
explored if and how e-cigarettes are used by breastfeeding mothers. As e-cigarettes 
are likely to be far safer than cigarettes, with far fewer toxicants, they may be an 
appropriate alternative to smoking in the postpartum period. To explore possible future 
interventions using e-cigarettes to reduce postpartum smoking and increase the 
likelihood and duration of breastfeeding, research must first explore the acceptability 
and current use of e-cigarettes in relation to breastfeeding. 
This thesis includes three studies.  The first study aimed to explore whether an 
association between smoking and breastfeeding currently existed within a sample of 
UK mothers, independent of demographic factors. This study used data from the 
Pregnancy Lifestyle Survey, which recruited 750 current and recent ex-smokers, e-
cigarette users and dual users (both smoking and e-cigarette users) who self-completed 
questionnaires in early pregnancy, late pregnancy and at 3 months postpartum. In late 
pregnancy, 63.5% of women intended to breastfeed, 46.35% initiated breastfeeding, 
and 17.68% of women were breastfeeding at 3 months. Older mothers were more likely 
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to initiate breastfeeding at birth (p = 0.02), and mothers with higher levels of education 
were more likely to intend to breastfeed (p<0.001), initiate breastfeeding (p<0.001) and 
be breastfeeding at three months (p=0.01). Ex-smokers were more likely to intend to 
breastfeed (p<0.01), initiate breastfeeding (p=0.04) and be breastfeeding at three 
months (p<0.01) than smoking/vaping mothers. When adjusted for age and education, 
smokers were less likely to breastfeed at birth (OR 0.48, 95% CI: .26 - .75), and at three 
months postpartum (OR .19, 95% CI: .09 - .37), compared to ex-smokers. Vapers were 
similarly less likely to initiate and intend to breastfeed, but this was not significant.  A 
negative association between smoking and breastfeeding exists in the UK, irrespective 
of demographics. Interventions should consider the association is at least, in part, due 
to factors other than demographics. Due to only a small sample of vapers recruited, 
further research should explore the use of e-cigarettes and attitudes to vaping as a 
breastfeeding mother in more detail. 
The second study used infodemographic methods to explore the use of e-cigarettes 
postpartum, and opinions towards e-cigarette use when breastfeeding. This study used 
data obtained from online parenting forums. The study identified four themes using a 
template approach to thematic analysis; use; perceived risk; social support; and 
evidence. Women were using e-cigarettes to prevent returning to smoking postpartum, 
many having started using them during pregnancy to quit smoking. In regards to 
breastfeeding, women varied on their opinions as to the acceptability of e-cigarettes. 
However, overall, women were generally positive about their use. Women viewed the 
risks of using e-cigarettes using direct comparisons to the risks of smoking; using e-
cigarettes was seen as a positive behaviour to avoid smoking. Social support was an 
important part of the discussion; some women felt judged for using e-cigarettes, which 
was primarily related to the use of nicotine. Some women thought that the use of 
nicotine was evidence of bad mothering and a morality issue as well as a safety issue. 
A key finding was the sources of evidence women used and were looking for. Some 
women had accessed peer-reviewed scientific sources but had misinterpreted the 
results of the studies they quoted. Some women used non-scientific sources such as 
blogs and media articles to form both positive and negative opinions on vaping. Many 
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women felt there was not enough research on the long term use of e-cigarettes; this 
made them fearful that serious harm would be linked to e-cigarettes use in the future. 
One thing that united women who were both positive and negative about e-cigarette 
use were the shared opinion there wasn't enough advice and support for mothers who 
vaped and wanted to breastfeed. More advice and support needs to be available as 
part of usual care for women who do vape, to enable them to make informed decisions 
about breastfeeding their infants. 
The third study used an online survey to explore further the themes identified in the 
second study. This study recruited 149 women who either smoked, vaped, or smoked 
and vaped and had an infant aged 18 months or younger using social media 
advertisements and links on parenting forums. The survey asked women about their 
experiences and opinions on smoking/vaping breastfeeding using open-ended 
questions that were thematically analysed. The survey also included Likert scales 
following PPI feedback. Three main themes were identified: smoking, vaping and 
breastfeeding behaviours; barriers and facilitators for breastfeeding as a smoking or 
vaping mother; and barriers and facilitators for using e-cigarettes (and not smoking) 
postpartum.  
Women employed a series of behaviours to reduce perceived harm to their infant from 
breastfeeding as a smoker or vaper. For vaping mothers, this involved using only low 
or zero nicotine. Smoking and vaping mothers discussed maintaining a smoke-free 
home, ensuring the maintenance of proper hygiene, and timing feeds around their 
smoking/vaping behaviours. Vaping mothers reported being less cautious about vaping 
around their infants. Dual-use mothers reported vaping in the day and only smoking 
when they had either expressed enough milk they wouldn't need to feed their infant or 
when they had their partner home to care for the infant. Barriers and facilitators were 
not fixed and invariable. They included the mothers' beliefs on what was acceptable, 
the perceived safety of breastfeeding as a smoker/vaper, and access to social support. 
Barriers to breastfeeding as a smoker were often due to women's beliefs it was 
unacceptable and unsafe for them to breastfeed; this barrier was sometimes overcome 
by switching to vaping. However, a lack of support and advice from health care 
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professionals about vaping and breastfeeding was a barrier. Barriers to using e-
cigarettes included previous use resulting in adverse events (such as a cough, or not 
successfully quitting smoking) and a lack of consistent (if any) advice from health care 
professionals. Facilitators included wanting to improve health, pregnancy, good social 
support, saving money and not having the smells associated with smoking. 
Overall, women view e-cigarettes as acceptable for use when breastfeeding. 
Interventions should consider the use of e-cigarettes to prevent women from returning 
to smoking postpartum and improve confidence in breastfeeding. To support and 
encourage women to switch to vaping, training for health care professionals on the 
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In study one, data analysed was from the Pregnancy Lifestyle Survey cohort. Cancer 
Research UK funded the original study, the Chief Investigator (CI) was Dr Sue Cooper 
from the University of Nottingham. The survey design and implementation involved co-
investigators from the University of Nottingham, the University of London, the University 
of East Anglia, and the University of Stirling. For the first and second follow up surveys, 
I contributed questions relating to breastfeeding. In follow-up one, women were asked 
about their intentions to breastfeed. For follow-up two, one question asking about 
feeding intentions and three questions relating to breastfeeding behaviours were asked 
with pre-set answers to select from. A final question asked participants to rate how 
strongly they agreed or disagreed with a statement relating to a health belief. PPI insight 
was sought independently of the original study. The wording of additional questions on 
health beliefs changed in response to PPI feedback due to ambiguity. With this in mind, 
the initial wording of ‘Mothers should not smoke tobacco cigarettes/ e-cigarettes and 
breastfeed’ changed to ‘mothers should not breastfeed if they smoke tobacco 
cigarettes/use an e-cigarette’. At the time of this study, this was the first time women 
have been directly asked about the use of e-cigarettes in relation to breastfeeding. All 
findings presented in study one are the result of my own work, with input from 
supervisors (particularly Dr Sarah Lewis). 
Studies 2 and 3 were designed by me, including all protocols and ethics applications 
with support from supervisors. Data collection was managed by me, as was initial 
coding. A second coder was used to reduce bias. The survey and all questions were 
designed by me, although six Likert scales were added following PPI input. An 
independent company managed the advertisement for the study on social media – 
SMRS – but advert design and data collection were implemented and monitored by me, 
including liaising with parenting website moderators. Initial sorting and coding of the 
data was my own work, with support from a second coder to reduce bias. The results 
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1. Chapter 1: Background 
 
1.1 Smoking: overview 
The smoke from cigarettes contains many chemicals that are harmful to both the 
smoker and those exposed to smoke via passive smoking. Minimal amounts of smoke 
exposure are needed to present a risk of harm [1, 2]. Tobacco smoke from cigarettes 
is a “concentrated aerosol of liquid particles suspended in an atmosphere consisting 
mainly of nitrogen, oxygen, carbon monoxide and carbon dioxide” [3]. When assessing 
the health implications of cigarette smoke, we must understand the chemical 
composition, the concentration of these chemicals, and the size of particles and charge 
[4]. The constituent particles in cigarette smoke are multi-compositional; they are 
compounds created via the pyrolysis, distillation and combustion of tobacco [4]. 
Tobacco-related constituents are discussed in detail in 1.4.1.  
 
1.1.1 Health consequences of smoking 
The health concerns associated with smoking are well documented since Doll & Hill first 
published a paper in 1950 [5] highlighting the link between smoking and carcinoma of 
the lung. Smoking remains one of the biggest, yet preventable, causes of cancer [6]. 
Smoking alone is responsible for an estimated 5-6 million deaths a year globally [7] – 
in the UK, roughly 77,000 deaths are expected per annum, and around 484,000 
hospitalisations are likely to occur due to smoking-related health consequences [8].  
Even with low-intensity smoking (< 10 cigarettes a day), the risk of all-cause mortality 
is elevated [9]. Particularly for women, the disease risk from smoking has a rate ratio 
(RR) of 1.77 (CI 1.40-2.24) for low-level smoking and a RR of 1.95 (CI 1.70-2.24) for 
higher-level smoking (≥20 cigarettes per day) [10]. Cigarette smoke can also inhibit the 
immune response [11, 12], increase the acute risk of respiratory infection [13] and 
chronic lung conditions [14]. The risk of cardiovascular/coronary disease also increases 
with smoking [15-17], particularly for women who may be more vulnerable to the effects 
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of tobacco smoking. Female smokers have a relative risk ratio of 1.25 (CI 1.12-1.39) of 
developing coronary heart disease compared to male smokers [18].  Smoking is also 
linked to an increased risk of several cancers [19]. A systematic review and meta-
analysis reported the increased risk from smoking for lung cancer (RR = 8.96, CI 6.73-
12.11), laryngeal cancer (RR = 6.98, CI 3.14-15.52), pharyngeal cancer (RR = 6.76, CI 
2.86-15.98) cancer of the upper digestive tract (RR = 3.57 CI 2.63-4.84) and oral 
cancers (RR = 3.43, CI 2.37-4.94) [20].The risk of developing breast cancer is also 
elevated for women who smoke (HR = 1.24, CI 1.07-1.42) [21]. Smoking can also be a 
cause/contributing factor to infertility in women [22] and impotence in males [23]. 
Smoking does not just have consequences for the smoker but to those exposed to 
smoke via ‘passive smoking’ [24]. Passive smoking is the inhalation of ‘second-hand’ 
smoke by a person other than the smoker. Children and those with chronic respiratory 
illnesses are particularly susceptible to the risks of second-hand smoke [25]. Children 
of smokers have increased risks of childhood morbidity and mortality [26]; this is 
described in more detail in 1.1.3.2.  
1.1.2 Smoking in pregnancy 
Smoking during pregnancy remains one of the single most significant preventable 
causes of foetal and infant morbidity [27]. Globally, smoking during pregnancy 
prevalence is around 1.7% (95% CI 0.0-4.5) and 8.1% (CI 4.0 – 12.2) in European 
countries though this varies significantly by country [28]. In the UK, around 10.6% of 
mothers in the UK are still smoking at the point of delivery. This varies from area to 
area, with rates as high as 27.8% in Blackpool and as low as 1.6% in Wokingham  [29]. 
Smoking during pregnancy is associated with miscarriage, ectopic pregnancy, low birth 
weight, premature birth, stillbirth, and intrauterine growth retardation [30-33]. Infants of 
mothers who smoked during pregnancy are also at higher risk of sudden infant death 
syndrome as well as subsequent developmental and health-related consequences [32].  
Smoking during pregnancy is highest amongst younger mothers who have lower 
educational attainment, lower levels of social support and come from lower 
socioeconomic backgrounds [34, 35]. For some women, the stresses related to 
3 
 
pregnancy and the broader context of their lives (such as socioeconomic 
disadvantages) are barriers to quitting smoking during pregnancy. Relationships may 
also be a barrier or facilitator for quitting smoking during pregnancy. Having a partner 
who smokes can reduce a woman’s chances of successfully being smoke-free 
throughout her pregnancy, whereas having a supportive partner can improve a 
woman’s chances of quitting smoking successfully. Relationships with healthcare 
professionals are also a key facilitator; women who receive smoking cessation 
counselling and feel supported, rather than judged, have a better chance of remaining 
smoke-free [36]. 
National Institute for Health and Care Excellence (NICE) guidance recommends a 
referral pathway for midwives to identify and support pregnant smokers. This involves 
discussions with women regarding their smoking status, carbon monoxide (CO) testing, 
and referring those in need of support to stop smoking services [37]. Women who 
smoke in pregnancy, and fail to quit with behavioural support alone, are recommended 
to use Nicotine Replacement Therapy (NRT) such as patches or lozenges, but to avoid 
other pharmaceuticals such as varenicline or bupropion while pregnant [38]. More 
recently groups such as the smoking in pregnancy challenge group, alongside bodies 
such as the Royal College of Midwives (RCM), has supported the use of electronic 





Figure 1.1 NICE referral pathway 
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1.1.3 Smoking postpartum 
1.1.3.1 Epidemiology of smoking postpartum 
Postpartum relapse refers to women who stopped smoking immediately before or 
during pregnancy, resuming smoking within one year of giving birth [40, 41]. Qualitative 
research on smoking in pregnancy identifies concern for the baby’s health and the 
desire to be a responsible mother as the primary motivators for the decision to quit and 
maintain abstinence [42].  
The percentage of women who quit smoking during pregnancy is not well reported. 
However, a recent cohort study identified around 43% of women smoking at least three 
months before pregnancy have quit smoking by 26 weeks gestation; this figure drops 
slightly to 41% at 34-36 weeks gestation [43]. Although many mothers spontaneously 
quit during early pregnancy and wish to remain abstinent [44], around 44% will resume 
smoking within six months of giving birth [45, 46], and approximately 75% will return to 
smoking within 12 months [47]. A recent systematic review suggests that by six months 
postpartum the proportion of women returning to smoking is 43% (CI = 16-72%) from 
pooled data of studies that did not biochemically-verify smoking status, and 74% (CI = 
64-82%) for pooled studies that did biochemically-verify smoking status [48]. 
 
1.1.3.2 Health effects of smoking postpartum 
Smoking relapse postpartum exposes the infant to potential morbidity and mortality. 
Young children are more susceptible than adults to the harms of passive smoking, 
particularly as their respiratory system is still immunologically immature [49]. A meta-
analysis examining the risk of lower respiratory tract infections in infants found the odds 
ratio (OR) for an infant developing a lower respiratory tract infection was 1.58 (CI 1.45-
1.73) if the mother smoked postnatally. The same review found any household smoking 
increased the risk of the infant developing bronchiolitis (OR 2.51, CI 1.96-3.21) [50]. A 
further meta-analysis found an increased risk of wheezing (OR = 1.70, CI 1.24-2.35) 
and asthma (OR = 1.85, CI 1.35-2.53) in infants ≤2 years whose mothers smoked [51]. 
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As well as respiratory health effects, a meta-analysis identified that maternal smoking 
postnatally was associated with an increased risk of sudden infant death syndrome (OR 
= 1.97, CI 1.77-2.19) [52]. Other meta-analyses have concluded that maternal smoking 
increases the risk of middle-ear infections (OR 1.62, CI 1.33-1.97) [53], and invasive 
meningococcal disease (OR = 2.26, CI 1.54-3.31) [54].  Parental smoking is also a 
predictor of adolescent smoking; a meta-analysis identified that any parental smoking 
significantly increased the risk of the child smoking (OR 1.72, CI 1.59-1.86), this is 
particularly significant if the mother smoked (OR 2.19, CI 1.73-2.79) [55]. 
Parents who smoke may be given tips by health care professionals or can find advice 
online, on ways to reduce the risk to their child from tobacco smoke exposure. These 
include only smoking outside of the house, removing outer-layer clothing immediately 
after smoking, washing hands before picking up their baby and avoiding smoking close 
to the time they feed or pick up their infant as smoke continues linger for 2-3 hours after 
smoking [56]. Although all parents are advised to avoid bed-sharing, due to the 
increased risk of Sudden Infant Death Syndrome (SIDS), smoking parents are 
especially encouraged to never bed share/co-sleep with their infants [57]. Smoking 
mothers are also advised to breastfeed as breastmilk can offer some protective factors 
for the infant from the harm of cigarettes [58, 59]. 
 
1.1.3.3 Why women return to smoking postpartum 
Factors associated with a higher risk of relapse are similar to those associated with 
smoking in pregnancy. A recent systematic review found that the most significant 
predictors for postpartum relapse were; being less well-educated, younger, living with 
a household member who smoked, being multiparous, experiencing higher levels of 
stress, depression or anxiety, not breastfeeding, only intending to quit throughout 
pregnancy, and having low confidence about remaining abstinent [60]. This review 
encompassed 39 studies; the quality of these studies overall was insufficient for any 
particular factor to allow for a meta-analysis, however, the majority of the studies were 
graded as high quality. 
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A thematic synthesis of qualitative studies exploring postpartum return to smoking 
identified factors affecting relapse and barriers and facilitators to relapse prevention 
around five key themes; beliefs, social influences, motivation, physiological factors, and 
identity [61]. In this review, which included 16 studies (reporting the views of 1031 
women), barriers and facilitators are context-dependent. They have the capacity to help 
or hinder remaining smoke-free during the postpartum period. For example, the 
motivation for quitting smoking may have been dependent on pregnancy (protecting the 
unborn baby from harm). For some women that motivation is no longer present once 
the baby is born, whereas others are motivated to remain smoke-free to avoid second-
hand smoke exposure to the infant. The authors noted the themes of most importance 
were often misinformed beliefs [61], such as smoking as a way of mediating stress. This 
review also highlighted how pivotal the transition to motherhood is for smoking 
cessation; stress and lack of sleep resulting from new-born behaviour was a barrier to 
remaining smoke-free, although for some women the mothering role was a protective 
factor against relapse. This transitional theme was related to identity, where some 
women felt smoking was integral to their ‘old life’ before motherhood [61].  
Similarly, an earlier review [36] found social relationships reinforced identity; for some 
women, their immediate social circle had an expectation the mother would quit smoking 
during pregnancy but resume smoking postpartum. This review [36] also highlighted 
how barriers and facilitators for remaining smoke-free were not fixed and invariant.  
Both reviews [36, 61] highlighted social influences and relationships as being important 
barriers and facilitators to smoking cessation in the postpartum period. For example, 
women whose partners smoke or are generally unsupportive of their quit attempts are 
more likely to report returning to smoking in the postpartum period. In contrast, good 
support and health care professionals who are supportive and non-judgemental can 
help mothers to remain smoke-free. Both reviews offer an insight into what may help or 
hinder women’s attempts to remain smoke-free postpartum. However, it should be 
noted the later review [61] only included American/Canadian studies, which may not 
apply to the UK due to differences in health care systems. 
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Ethnographic research also suggests that smoking cessation is linked to both gender 
and class [62]. For example, historically gender roles place the health of women as a 
lower priority [62]. This research also suggests that ambivalence towards social mobility 
was directly related to ambivalence towards smoking cessation. In working class 
communities there are inequalities in the dissemination of health literature and unequal 
opportunities for smoking cessation, this leads to smoking as a social norm [63, 64]. 
Therefore smoking is more acceptable and, as a consequence, more prominent during 
pregnancy amongst working-class communities [65]. This may explain why lower 
educational attainment and SES are associated with smoking in the postpartum period. 
  
1.1.3.4 Relapse prevention interventions 
Relapse prevention refers to interventions that aim to reduce the risk of now-abstinent 
smokers returning to smoking.  
Behavioural interventions 
Behavioural interventions have focused on counselling, education and self-help 
materials. One systematic review of behaviour change techniques to prevent return to 
smoking postpartum identified 32 trials, six of which reported long-term effectiveness 
[66]. The review highlighted that the most beneficial interventions include problem-
solving, information about health consequences, information about social and 
environmental consequences, social support, reducing negative emotions, and 
instructions on how to perform a behaviour. Although long term effectiveness of some 
behavioural interventions were identified in this review [66], another systematic review 
published the same year did not find evidence to support the efficacy of behavioural 
interventions in pregnancy (RR= 1.05, CI 0.99-1.11), or postpartum (RR= 1.02, CI 0.94-
1.09) [67]. This systematic review considered relapse prevention techniques amongst 
the general population but included a sub-analysis of 8 pregnancy, and 15 follow-up 
postpartum studies that were all behavioural interventions [67].  
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The behavioural interventions reported in this review [67] ([68-73]) included face to face 
counselling throughout pregnancy and postpartum with additional materials [68, 69] and 
a follow-up video about the benefits of remaining smoke-free [69]. The addition of 
leaflets and materials wasn’t sufficient to reduce relapse rates [68]. There was some 
success with using a video prompt, although this effect decreased over time [69]. One 
study using motivational interviewing showed no effect in reducing relapse [70]. The 
final postpartum intervention in this review included both face to face and telephone 
counselling [71], but again there was no observed difference between the treatment 
and control group. Within this review, 15 studies followed up in the postpartum period; 
these had no significant effectiveness at reducing postpartum relapse (RR 1.02, CI 
0.94-1.09).  
Self-help materials are somewhat effective in reducing the risk of returning to smoking 
postpartum. Brandon et al. [72] used the ‘forever free’ booklet; an in-depth booklet, 
including educational information about tobacco dependence plus cognitive and 
behavioural strategies to manage cravings. The books were given throughout 
pregnancy and postpartum. Participants were randomised into two groups; treatment 
group who received the ‘forever free’ booklet and a control group who received usual 
care. Participants were then followed up at 1, 8 and 12 months postpartum and paid for 
their participation. The treatment group were significantly less likely to return to smoking 
at eight months postpartum compared to the control group (OR = 1.27, CI 1.04-1.56); 
however, no significant differences were observed at 1 and 12 months postpartum. 
Household income acted as a moderator for this effect; for households with an annual 
income of less than $30,000 the treatment group was significantly less likely to return 
to smoking at eight months (OR = 1.48, CI 1.09-2.00, p= 0.012) and at 12 months (OR= 
1.58, CI 1.17-2.14, p <0.01). No significant differences were observed for household 
incomes more than $30,000 per annum. As women from lower socioeconomic 
backgrounds are more likely to return to smoking postpartum [41, 46], the results of this 
intervention are promising. However, there were no a priori predictions regarding a 
moderating variable meaning this post hoc test requires replication. It should also be 
noted that of the 594 women involved in this study, biochemical verification of self-
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reported smoking status was only performed on 22 local women as the study was 
conducted via mail. Previous research has suggested that biochemical results are 
inconsistent with self-reported behaviour in up to 26% of cases [74]. This study was 
also under representative of racial and ethnic minority women, who are more likely to 
smoke in the postpartum period [41, 46].  
One study recruited an ethnically diverse sample of women with a household income 
of less than $30,000 per annum [73]. This study used Motivation and Problem Solving 
(MAPS); a holistic approach to aiding and maintaining behaviour change based on 
motivational interviewing and social cognitive relapse prevention theories. In this trial 
251 women were randomized into either MAPS or usual care groups. They attended 
assessment visits at 30-33 weeks pregnant, eight weeks postpartum, and 26 weeks 
postpartum and were compensated for their time with gift cards and small items such 
as nappies. All participants were given self-help materials, with the MAPS group 
receiving additional telephone counselling. When adjusted for age, race, education and 
partner’s smoking status, the treatment was somewhat effective at reducing the risk of 
relapse (OR = 1.60, CI 1.00-2.58), although this only just reached statistical significance 
and decreased over time. In this study, smoking status was biochemically validated at 
8 and 26 weeks postpartum; however, continuous abstinence was self-reported. 
Financial Incentives 
Four studies identified used financial incentives to remain smoke-free in the postpartum 
period [75-78]. Two studies were combined with other approaches to preventing 
relapse; self-help materials [75], and social support [77]. All studies used incentives 
through pregnancy and followed on with incentives postpartum. 
Only one of the studies had a control group for comparison, Heil [78] found that offering 
vouchers based upon biochemically verified abstinence significantly increased the 
likelihood of smoking abstinence from pregnancy, to 12 weeks postpartum (24% 
abstinent compared to 3% of the control group, p= 0.006).  
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The use of financial incentives postpartum combined with self-help materials, has 
shown effectiveness for reducing relapse rates up to 12 months postpartum [75], 
compared to care as usual. As part of a quasi-experimental study, women were given 
self-help materials and counselling monthly and asked to complete a CO breath test at 
each visit; if the test were negative, the women would receive the incentive to remain 
smoke-free. This study found voucher incentives were most effective when combined 
specialist cessation counselling and extended postpartum visits, compared with less 
intense cessation counselling and usual visits (OR = 4.60, CI 2.80-7.57).   
Previous research has combined financial incentives ($50 a month for biochemically 
verified quits) with social support [77]. This study found that the treatment group, which 
included a self-appointed peer support person who would also receive the same 
financial incentives for validated quits, were more likely to remain abstinent from 
smoking at two months postpartum (p<0.001). Higgins et al. [76] added to this by 
offering a contingent voucher for biochemically verified smoking abstinence, and a non-
contingent voucher regardless of smoking status.  This study examined whether the 
effects of an incentive-based intervention would persist beyond the two months 
postpartum found by Donatelle et al. [77]. It was observed that the contingent based 
voucher conditions were still statistically effective (p<0.0001) at reducing relapse rates 
at 24 weeks postpartum. 
Apart from the Heil study [78], there are no control groups within financial incentive 
studies. In Gadomski et al. [75] and Donatelle et al. [77], all conditions resulted in higher 
levels of postpartum abstinence than the usual levels of abstinence postpartum 
observed. In contrast, Higgins et al. [76] observed similar levels of abstinence to that of 
usual care in the non-contingent voucher group. There is a need for randomised control 
trials with control groups of usual care to fully asses the effectiveness of incentive-based 
studies. As incentive-based studies are often combined with self-help materials and 
counselling, it is difficult to asses the true impact of the incentive versus the combined 
intervention style. Overall there are significant limitations to these findings. As such, 
they should be viewed with a degree of caution. 
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Health care professional led 
The systematic review mentioned above [67] also included a health care led 
intervention [79]. In a randomised trial, health care professionals involved in the usual 
care of pregnant women were given training on how to tailor smoking cessation 
counselling to women based on their current stage of behaviour change [79]. There was 
significantly less risk of returning to smoking (biochemically validated) within 1 month 
postpartum (OR = 3.01, p = 0.04); by 3 months postpartum, there was still a small effect, 
but this was not significant (OR = 1.91, p = 0.65). The initial results observed during the 
first month postpartum are promising. However, previous research shows that the 
majority tend to relapse after 1 month [40]. The power of this study is reduced in 
comparison to individualised randomisation due to controlling for the clustering of 
women in the health centers. It does, however, suggest interventions that are 
successful during pregnancy do not persist over time in the postpartum period. It’s also 
worth noting that this study did not report the confidence intervals relating to the odds 
ratios; this makes the full effectiveness challenging to ascertain.  
Further research using health care professionals, educated midwives on how to deliver 
smoking cessation advice. Midwives distributed self-help materials for women, 
including a video on the benefits of remaining smoke-free [80]. Compared to a control 
group (who received treatment as usual) women were significantly more likely to 
achieve continuous abstinence from smoking at 6 weeks postpartum (n=286, OR = 
6.25, CI 1.16-33.61), however, due to logistical issues smoking status was self-
reported. Originally urine samples were collected to verify smoking status, but due to a 
problem with transportation, the majority of samples were lost, so smoking status was 
not biochemically verified for the majority of participants. At 6 weeks postpartum, only 
7 urine samples were tested, this may have led to self-report biases, and these results 
should be viewed with caution. Previous research has shown that midwifery-led 
interventions are acceptable and well adhered to, although again, reduction in 




The use of other pharmaceuticals has not been widely studied with postpartum women. 
Nicotine replacement therapy (NRT) is a method used to quit smoking that may consist 
of lozenges, transdermal patches or inhalation products. Of the two studies identified 
that considered NRT in the postpartum period, it was found to be unsuccessful at 
maintaining cessation [82, 83]. To date, studies concerning NRT and postpartum 
cessation exist only as extensions to pregnancy studies.  
While there is no pharmaceutical evidence for postpartum relapse, a systematic review 
of relapse prevention techniques amongst the general population, that included 81 
studies (69,094 participants) with randomised abstainers, showed extended 
pharmaceutical use could be effective at preventing relapse [67]. This was particularly 
evident for varenicline (RR= 1.23, CI 1.08-1.41) and rimonabant, an anti-obesity drug 
now withdrawn due to serious psychiatric side-effects, (RR= 1.29, CI 1.08-1.55). There 
was some evidence for the effectiveness of extending NRT with unaided abstainers 
(RR= 1.24, CI 1.04-1.47), but this was inconsistent with NRT for hospital inpatients 
(RR= 1.23, CI 0.94-1.60) and assisted abstainers (RR= 1.04, CI 0.77-1.40) [67]. NRT 
combined with bupropion was also not significantly successful in reducing relapse (RR= 
1.18, CI 0.75-1.87), nor was bupropion on its own (RR= 1.15, CI 0.98-1.36).  
Although not tested in a postpartum population, a meta-analysis found there was no 
substantial evidence to suggest one pharmaceutical drug, bupropion, is harmful to take 
during pregnancy [84], and thus may be safe for postpartum women. Bupropion is an 
anti-depressant that is licensed for smoking cessation use in the United Kingdom since 
2000. It works as a smoking cessation aid by inhibiting dopamine reuptake [85] and has 
proven to be effective in many trials, helping around 20% of smokers to quit [86-88]. 
However, a review of relapse prevention techniques amongst the general population 
did not find evidence of bupropion’s effectiveness at preventing relapse (RR= 1.15, CI 
0.98-1.36), even if combined with NRT (RR= 1.18, CI 0.75-1.87) [67].  
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Although the use of pharmaceuticals is an effective method of quitting smoking [67, 89], 
pharmaceuticals are primarily used to quit smoking, rather than prevent relapse.  
Follow-on interventions 
Most postpartum relapse prevention interventions are follow on interventions from 
pregnancy interventions. Some interventions have shown potential for reducing 
smoking in pregnancy using cognitive behavioural therapy (CBT), social support, 
counselling and self-help materials, but have shown no effectiveness in the postpartum 
period [90-98]. In a randomised controlled pilot study, pregnant smokers were asked to 
select an ‘intervention supporter’ (a female friend or relative to help them quit smoking 
and sustain cessation) [99]. In the intervention group, the supporter was to receive 
monthly contact to aid with counselling and support of the mother. Although the study 
showed an overall trend for biochemically validated abstinence at 3 months postpartum, 
this was not significant. Due to randomisation, the intervention group included a 
significantly higher proportion of multiparous and ethnic minority mothers compared to 
the control groups. Both demographics are associated with higher levels of smoking 
during pregnancy and higher levels of relapse [41, 46]. Fifty-two percent of the 
‘supporters’ were also smokers, which may have impacted the results.   
Interventions to prevent women from relapsing to smoking postpartum have included 
behavioural, cognitive, social, and incentive-based study designs. Overall there is still 
no intervention that successfully prevents women relapsing postpartum and sustaining 
that abstinence. Although incentive-based study designs do show more positive results 
for maintained abstinence, there are serious methodological flaws to take into account.   
 
1.1.4 Summary 
Smoking postpartum remains a public health concern, with a significant proportion of 
mothers continuing to smoke, or returning to smoking within the first 6 months 
postpartum. This poses serious health risks for both mother and child. Although 
interventions exist, they have not shown consistent success in reducing postpartum 
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smoking. Evidence suggests that self-help and financial incentives do show some 
effectiveness in reducing the risk of postpartum relapse. However, effectiveness is often 
not sustained long term, and there are issues such as relying on self-reported smoking 
status. Several risk factors of postpartum return to smoking exist, including whether a 
mother plans to breastfeed, and whether she initiates breastfeeding.  
 
1.2 Breastfeeding: overview 
Breastfeeding is the natural process of feeding an infant via lactation. Breastmilk may 
be given to the infant directly from the breast or expressed and fed via a bottle. In 
research, breastfeeding is divided into “never breastfed” (baby has only received 
formula milk from birth) or “ever breastfed.” Ever breastfed can relate to exclusive 
breastfeeding (just breastmilk without supplementary formula milk or solid foods), 
combination feeding (with supplementary foods/formula), or early cessation of 
breastfeeding (breastfed at birth but switched to formula milk.)  
 
1.2.1 Health consequences of breastfeeding 
Profound health benefits for both mother and baby are associated with any 
breastfeeding, although greater benefits are seen in infants who are breastfed 
exclusively and for a longer duration of time. Breastfeeding is known to reduce the risk 
of Sudden Infant Death Syndrome (SIDS). In a meta-analysis involving 18 studies the 
summary odds ratio (SOR) of SIDS for infants who received any amount of breastmilk 
for any duration was 0.40 (CI 0.44-0.69), and for breastfeeding for 2 months or longer 
the SOR was 0.38 (CI 0.27-0.54), compared to infants who had never been breastfed. 
When considering only infants who were exclusively breastfed for any duration, the 
SOR was 0.27 (CI 0.24-0.31) [100].  
Breastfeeding is also known to protect against gastrointestinal illnesses [101], a 
breastfed baby is less likely to develop Crohns disease (OR=0.45, CI 0.26-0.79) or 
ulcerative colitis (OR= 0.56, CI 0.38-0.81) [102]. Breastfeeding is also a protective factor 
against the development of asthma (OR 0.78, CI 0.74-0.84) and wheezing illnesses 
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(OR 0.81, CI 0.76-0.87) [103]. A meta-analysis found that babies exclusively breastfed 
for 4 months or more were less likely to be admitted to hospital with any respiratory 
illnesses (OR 0.28, CI 0.14-0.54) [104]. Breastfeeding for 6 months or longer is also 
associated with a 20% lower risk of developing childhood leukaemia (OR= 0.80, CI 
0.72-0.90) [105]. Research suggests breastfeeding is a protective factor against other 
childhood cancers, although the quality of this research is low and causality cannot be 
assumed [106].  
Overall, infants aged 6-11 months who were not breastfed have a risk ratio (RR) of 1.76 
(CI 1.28-2.41), and those aged 12-23 months have a RR of 1.97 (CI 1.45-2.67), for all-
cause mortality compared to infants who received any breastmilk. The risk ratio is 
higher in infants aged 0-5 months and increases the more breastfeeding is reduced. A 
predominantly breastfed baby (a breastfed baby supplemented with formula milk) has 
a RR of 1.48 (1.13-1.92), a partially breastfed baby (a baby who is formula fed but 
receives some breastmilk) has a RR of 2.84 (1.63-33.9), and a baby who receives no 
breastmilk has a RR of 14.4 (CI 6.13-33.9) of all-cause mortality when compared to 
exclusively breastfed infants [107].   
Breastfeeding also has health benefits for the mother; in a meta-analysis Chowdhury et 
al. calculated the relative risk of developing breast and ovarian cancer [108]. The results 
showed that ever breastfeeding was associated with a reduced risk of breast cancer 
(OR=0.78, CI 0.74-0.82) compared to never breastfed. This review found that the longer 
a mother breastfed, the more significant the reduction in risk. Mothers who breastfed 
for 6 months had an OR of 0.93 (CI 0.88-0.99), those who breastfed 6-12 months had 
an OR of 0.91 (CI 0.82-0.96) and those who breastfed >12 months had an OR of 0.74 
(CI 0.69-0.79) when compared to women who had never breastfed [108]. For ovarian 
cancer, the OR for women who had ever breastfed, compared to never breastfed, was 
0.70 (CI 0.64-0.77). As with breast cancer, the risk of developing ovarian cancer 
reduced the longer a woman breastfed for; for those who breastfed for <6 months the 
OR was 0.83 (CI 0.78-0.89, 6-12 months (OR 0.72, CI 0.66-0.78) and for >12 months 
(OR 0.63, CI 0.56-0.71) [108]. 
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Low breastfeeding rates in the UK may have led to increased incidence of illnesses with 
significant cost implications for the National Health Service (NHS) [109].  
 
1.2.3 Breastfeeding trends 
During the 20th century, breastfeeding became less common in high-income countries, 
and amongst wealthier and better-educated women in middle-income countries [110]. 
The introduction of formula milk, an artificial breastmilk substitute, led to a societal 
opinion that breastfeeding was for the poorer and less sophisticated in society. Formula 
milk was perceived as a modern and sophisticated way of feeding an infant [111]. This 
enabled women to work outside the home with more ease, and as breasts became 
more sexualised, formula feeding became the norm [112]. 
Not breastfeeding can have health consequences for both mother and baby; thus, the 
Innocenti Declaration was adopted as a global goal in 1990 [113]. The declaration 
stated that all women should be supported and enabled to exclusively breastfeed from 
birth to at least 4 months (adjusted to 6 months in 2016). It affirmed that infants should 
continue to breastfeed for up to 2 years old, supplementary to solid foods and water 
from 6 months. The UN Convention for the Rights of Children also introduced a legal 
obligation for countries to promote breastfeeding, adopt working practices to enable 
working women to breastfeed and to reduce marketing practices that promoted biased 
information designed to influence women to adopt formula feeding [114]. In 1991 the 
Baby-Friendly Hospital Initiative (BFHI) was also established to support, promote, and 
establish breastfeeding within hospitals [115]. The BFHI has had a significant effect 
globally [116-118] but has had limited success in the UK [117].  
The Infant Feeding Survey was (until 2010) conducted every 5 years to measure UK 
breastfeeding rates. The final Infant Feeding Survey showed that despite 81% of 
mothers initiating breastfeeding at birth, only 24% were still breastfeeding at 6 weeks 
postpartum, and by 6 months only 1% of UK infants are still breastfed. While the 2010 
report [119] showed a 12% increase in breastfeeding initiation since 2005, by 12 weeks 
postpartum, the UK has the lowest breastfeeding rates globally (17%) [120]. By a year 
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old, only 0.5% of UK mothers are still breastfeeding compared to 23% in Germany, 56% 
in South America and 99% in Senegal [120]. More recently, Public Health England has 
continued to collect breastfeeding statistics but only at 6-8 weeks postpartum. The latest 
annual report identified 46.2% of mothers are still breastfeeding at 6-8 weeks 
postpartum (CI 46.1%-46.3%); however, this does not differentiate between exclusive 
breastfeeding and any breastfeeding. It is also important to note that of the 145 local 
authorities involved in the data collection, only 72 are included in the 2018/2019 report 
due to validation issues [121]. 
The differences between breastfeeding rates within the UK and other countries can be 
explained by cultural differences. The cultural experiences of breastfeeding drastically 
vary. For example in some cultures withhold breastmilk for the first 48hrs of life due to 
the belief that colostrum, the initial milk produced immediately after birth is ‘dirty’. 
Despite this, women in these cultures are still committed to exclusive breastfeeding, for 
example in India 35% of infants had still not breastfed at 48hrs old, however by 1 month 
old 94% of infants were exclusively breastfed [122]. In some cultures, breastfeeding is 
expected, celebrated and supported; for example many countries still practice 
‘confinement’ after birth, that is a period of time in which the new mother is expected to 
remain home, usually in bed, with very few visitors as she acclimatises to motherhood 
and focuses on breastfeeding her infant [123].  
Within Western cultures breasts are often sexualised [112]; this can cause women to 
feel uncomfortable about feeding their infant outside of the house or in the company of 
others [124] [125] [126]. Research suggests that in the UK, breastfeeding is not seen 
as the social norm amongst women from lower SES areas. They report negative 
attitudes towards breastfeeding themselves and negative influences from friends and 
family about breastfeeding. Women also felt they had a lack of knowledge about 






1.2.4 Factors associated with breastfeeding 
Previous research concerning breastfeeding rates has identified sociodemographic 
factors as being significant predictors of breastfeeding [128]. Maternal age is associated 
with both the initiation [129] and duration [130] of breastfeeding, with younger mothers 
less likely to breastfeed. Women over the age of 25 are more likely to breastfeed, and 
women under 25 have a RR of 2.33 (CI 1.33-4.05) of early cessation of breastfeeding 
[131]. Another study conducted in Scotland identified that the OR of a mother 
breastfeeding significantly increases by 1.05 (CI 1.02-1.08) per year of age [132]. The 
same study found that previously breastfeeding increased the odds of breastfeeding by 
6.4 (CI 4.00-10.31) and living with a partner also increased the chances of a mother 
breastfeeding (OR= 1.92, CI 1.29-2.90) [132]. Marital status has been shown in 
previous work to be associated with breastfeeding, with single mothers less likely to 
breastfeed (RR= 1.46, CI 1.12-1.90) [130]. In a study focused on mothers from England 
and Wales, it was highlighted that lower socioeconomic status was associated with not 
breastfeeding, and breastfeeding for a shorter duration. They also identified lower 
educational attainment and lower household income, along with younger age, were 
associated with not breastfeeding and breastfeeding for shorter durations [133].  
Ethnicity is also associated with breastfeeding, with lower breastfeeding rates observed 
within ethnic and racial minority groups [134]. However, there is conflicting evidence as 
to whether belonging to an ethnic/racial minority increases or decreases the likelihood 
of breastfeeding. Some research shows that first-generation immigrants are more likely 
to breastfeed than those who are second-generation [135]. In the United Kingdom, 
Pakistani, Bangladeshi, black Caribbean, and black African mothers are more likely to 
initiate breastfeeding, and continue breastfeeding at 3 months, compared with white 
mothers [136]. 
Smoking status is one of the most significant predictors of breastfeeding; women who 
smoke are less likely to intend to breastfeed, to initiate breastfeeding and are more 
likely to breastfeed for a shorter duration when compared to non-smokers [137-139]. In 
a study of 2323 women, smoking was found to be the strongest predictor of not 
breastfeeding in comparison to other sociodemographic factors [140]. It is suggested 
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that breastfeeding rates could be improved if women reduced or quit smoking cigarettes 
[137]. 
1.2.5 Interventions to increase breastfeeding 
Interventions have focused on supporting women to initiate breastfeeding and maintain 
breastfeeding for as long as possible. When designing interventions to improve 
breastfeeding rates, there are three time points to consider; the intention to breastfeed 
during pregnancy, the initiation of breastfeeding at birth, and the continuation of 
breastfeeding after birth. 
The Innocenti Declaration and UNICEF have focused on intervening from a policy and 
structural perspective. A review by Fairbank et al., (2000) suggests that while health 
sector initiatives can be effective at promoting the initiation and continuation of 
breastfeeding, these effects are only really seen within rural or low-income areas. This 
review also highlighted that the effectiveness of health sector initiatives were 
inconsistent across studies [141]. Therefore, interventions may be more effective if 
focused on an individual level.  
One systematic review considering interventions to increase breastfeeding indicates 
that lay peer support combined with education and professional support was successful 
in improving the continuation of breastfeeding [142]. Lay peer support encourages other 
mothers who have breastfed or are trying to breastfeed to work with other mothers to 
support their breastfeeding journey. In this review, peer support was combined with 
professional advice from health care professionals and educational materials on the 
benefits of breastfeeding. Despite an improvement in the duration mothers’ breastfed 
for, this review found no evidence for the efficacy of peer support with the intentions to 
breastfeed, nor the initiation of breastfeeding at birth. It may be that mothers who are 
already motivated to breastfeed benefit from peer support to overcome any barriers 
they face after the initiation of breastfeeding. Fairbank et al., highlighted that peer 
support was effective for increasing breastfeeding initiation and duration, but only 
amongst low-income families [141].  
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In a UK specific review, while professional support has shown to be significantly 
effective for any breastfeeding (RR = 0.89, CI 0.81-0.97), this is not significant for 
increasing exclusive breastfeeding. Conversely, the same review found lay support to 
be significantly effective at reducing the cessation of any breastfeeding (RR= 0.66, CI 
0.49-0.89) but it was not significantly effective at increasing exclusive breastfeeding 
[143]. A UK specific review is useful for understanding the role professional support 
may have in increasing breastfeeding due to specifically low breastfeeding rates in the 
UK, and differences amongst global healthcare models.   
A further review and meta-analysis by Sinah et al. (2015) [144] looked at how the 
effectiveness of interventions may be influenced by the setting in which it is delivered. 
This review looked at the initiation, exclusivity and duration of breastfeeding. Overall, 
when pooled, interventions increased breastfeeding initiation (RR= 1.25, CI 1.19-1.32), 
exclusive breastfeeding (RR= 1.44, CI 1.38-1.51), any breastfeeding (RR= 1.38, CI 
1.28-1.50) and breastfeeding up to 23 months (RR= 1.61, CI 1.17-2.20). The review 
concluded that for all breastfeeding time points, interventions delivered concurrently in 
a combination of settings (hospital, home and community) were more effective than 
independent interventions delivered in a single setting. It should be highlighted, 
however, that there was a high degree of heterogeneity, even for subgroup analysis. 
Therefore it is difficult to determine whether the overall analysis of effects is due to the 
different intervention settings rather than the differences between the studies.  
Haroon et al. conducted a systematic review and meta-analysis to look at the 
effectiveness of promotional interventions for breastfeeding [145]. The review included 
63 randomised control trials and 47 quasi-experimental studies. The results indicated 
that educational interventions significantly increased exclusive breastfeeding rates at 
birth (RR= 1.43, CI 1.09-1.87), 1 month (RR = 1.30, 1.19-1.42) and between 1-5 months 
(RR= 1.90, CI 1.54-2.34). Educational interventions had no significant effect on 
predominant or partial breastfeeding. This review also found evidence that individual 
counselling was effective at reducing never breastfed (RR= 0.73, CI 0.55-0.96), and 
that group counselling was effective (RR= 0.57, CI 0.41-0.80), however, when 
combined there was no significant effectiveness [145]. Longitudinally, education, and 
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counselling were still effective at 6-12 months, increasing partial breastfeeding rates 
(RR= 1.19, CI 1.12-1.26) but not significant at increasing exclusive or predominant 
breastfeeding rates. This review evidenced the effectiveness of interventions early on; 
however, it showed limited success for breastfeeding beyond 6 months; this review 
concluded that overall, interventions were most effective for developing countries [145]. 
An editorial published in 2011 considered interventions conducted more recently; in the 
UK, none of the interventions tested in nine randomised controlled trials since 2000 
found any significant improvement for breastfeeding [146], whereas international 
studies suggest interventions have effectiveness above usual care [147]. The editorial 
suggested that there are often methodological weaknesses in UK based intervention 
studies and that interventions delivered are often reductionist and not understanding of 
how complex breastfeeding may be. The editorial calls for more individualised and 
tailored interventions for UK mothers [146]. 
 
1.2.4 Summary 
Breastfeeding is the healthiest infant feeding option for both mother and baby, with 
profound acute and long-term health benefits. Rates of breastfeeding declined globally 
in the 18th century, and despite recent global initiatives to increase breastfeeding having 
some effect, rates of breastfeeding in the UK remain low. While interventions have 
shown some success, they are often successful in improving ‘partial’ breastfeeding; 
these successes also have a minimal impact on the duration of breastfeeding. Various 
sociodemographic factors influence whether a woman breastfeeds or not. One factor 
related to whether a woman breastfeeds is her smoking status. Mothers who smoke are 
much less likely to initiate and continue breastfeeding.  
 
1.3 Smoking & Breastfeeding: overview 
Breastfeeding has been identified as a protective factor against returning to smoking 
postpartum, and research has identified that smoking may negatively impact whether a 
woman breastfeeds or not, and for what duration. Interventions to reduce smoking 
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postpartum are largely ineffective, and breastfeeding interventions have shown little if 
any, effect in the UK. As both smoking and not-breastfeeding can lead to serious health 
consequences for both mother and baby, combining support for both behaviours (rather 
than individually) may be more effective. This would depend on the strength of the 
association and more understanding of why this association exists. 
The initiation and continuation of breastfeeding are positively associated with smoking 
abstinence in postpartum women [41, 148]. Research suggests that the intention to 
breastfeed acts as a precipitating factor for reducing postpartum relapse [139]. 
Research indicates the intention to return to smoking is the strongest predictor of the 
intention not to breastfeed, as well as mothers who smoke being more likely to wean 
from the breast early (< 3 months postpartum) [137, 140].  
A meta-analysis in 2001 found that smoking mothers had an OR of 1.93 (CI 1.55-2.40) 
of not breastfeeding compared to non-smoking mothers [137]. After adjusting for 
maternal feeding intention, another meta-analysis identified that women who smoke 
during pregnancy have an OR of 2.5 (95% CI: 2.2-2.8) of not breastfeeding at 6 months 
compared to non-smoking mothers [139]. 
In a secondary analysis of data from a randomised controlled trial, women relapsing to 
smoking were more than twice as likely to stop breastfeeding (OR= 2.6, CI 1.5-4.7) than 
women who remained smoke-free, there was an even stronger association for women 
who relapsed to daily smoking (OR= 3.6, CI 2.1-6.4). Of the women who relapsed to 
smoking and stopped breastfeeding, 21.7% had stopped breastfeeding before relapse, 
28.9% stopped breastfeeding and relapsed within a 2-week window, but the remaining 
49.4% of women who relapsed stopped breastfeeding after they had resumed smoking 
[149]. Similar associations are found with women who smoke more than 10 cigarettes 
a day being more likely to stop breastfeeding by 10 weeks postpartum (RR= 2.32, CI 
1.13-3.95) [150].   
The reported association between breastfeeding and postpartum smoking status has 
led to the suggestion that including breastfeeding education may enhance current 
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smoking cessation interventions [151]. Research has shown that breastfeeding 
promotion can incentivise mothers to remain smoke-free [152].  
Within the literature, there is a strong case for an association between smoking and 
breastfeeding; however, most studies are observational [41, 139, 140, 149-152]. While 
observational studies are useful for collecting data that is naturalistic, it negates the 
ability to assume causality. While these studies highlight there is indeed a strong 
association between smoking and breastfeeding, they do not explore how or why this 
association exists. There are three proposed explanations for why an association exists. 
 
1.3.1 Proposed explanations 
Although there is no known causation for the relationship between smoking and 
breastfeeding, three primary schools of thought exist; physiological, sociodemographic, 
and fear of harm.  
 
1.3.1.1 Physiological mechanism 
Prolactin and oxytocin are hormones released from the pituitary gland that stimulates 
the production of milk in postpartum women. This theory suggests that nicotine may 
suppress the production of prolactin and oxytocin, which in turn lessens milk production, 
causing the infant to nurse more frequently, and if milk volume is sufficiently reduced, 
restrict growth and weight gain. If this theory is correct, it will account for why fewer 
women breastfeed if they smoke.  
Nicotine increases the release of dopamine, which in turn may inhibit the release of 
prolactin [153]; however, research has only been conducted with rodents and thus 
maybe not generalizable to humans. Some research examining the volume of 
breastmilk in humans did conclude smoking mothers produce lower quantities of milk 
than non-smoking mothers [154]. However, this research only involved 20 mothers and 
did not take into account the complex nature of milk production. For example, how 
regularly an infant feeds and how well they latch can determine how much milk the 
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mother produces. One study identified lower basal levels of prolactin in smoking 
mothers than in non-smoking mothers, but observed infant suckling induced acute 
increments in prolactin and oxytocin [155]. Some women do report insufficient milk as 
a reason for switching to formula feeding. However, research suggests that nicotine 
transfer may cause restlessness in an infant that may be perceived as hunger resulting 
from insufficient supply [156]. 
Although there is evidence that smokers have lower basal levels of prolactin, other 
studies have shown no relationship between plasma prolactin levels and the rate of milk 
synthesis; thus, the nicotine and milk production association is still uncertain [155, 157, 
158]. In a further review of the physiological mechanisms that may account for the 
smoking/breastfeeding association, it was concluded that studies that reported a 
negative impact on prolactin either relied on studies of mice or did not account for poor 
lactation practices [157].  
A review of epidemiological evidence considered the role of nicotine as a prolactin and 
oxytocin suppressant [138]. Six studies were included considering intentions to 
breastfeed, seven were included for breastfeeding initiation, and 10 studies were 
included for breastfeeding duration. The review concluded that smoking was 
consistently negatively associated with breastfeeding intentions, initiation and duration, 
even when confounding variables were accounted for; this finding was consistent 
across all study designs. Therefore a physiological effect was unlikely to explain this; 
as if the association were due to physiological effects, and we would anticipate no 
differences in the number of women intending to or initiating breastfeeding, we would 
only see differences in the duration of breastfeeding. Physiological effects cannot 
explain why smoking mothers are less likely to intend to breastfeed and why they are 
less likely to initiate breastfeeding at birth. 
Overall there is little consistent evidence that nicotine has any detrimental physiological 




1.3.1.2 Sociodemographic characteristics 
Sociodemographic variables are associated with both smoking status and the likelihood 
of breastfeeding. Breastfeeding intention, initiation, and duration are related to maternal 
age, deprivation, and educational levels; younger mothers, those from deprived areas 
and those with lower levels of education are less likely to breastfeed [159, 160]. These 
same factors are also associated with smoking during pregnancy and postpartum [34]. 
Therefore this explanation for the association between smoking and breastfeeding 
would suggest it is not the behaviours themselves but merely a coincidental association 
based on shared characteristics. 
To test this explanation, research has sought to examine the independent association 
of smoking and breastfeeding by adjusting for these factors. When these factors are 
adjusted for the association between smoking and breastfeeding exists independently 
[140] [139, 150]. In a study based using mothers from the UK, Donath et al., found 
women who smoked had an OR of 2.5 (CI 2.2-2.8) of not breastfeeding, but when 
adjusted for maternal age, education, socioeconomic status and breastfeeding intention 
the OR were reduced (OR = 1.5, CI 1.3-1.7) but still statistically significant [139], with 
smokers around 50% more likely to not breastfeed than non-smoking mothers. If a 
statistically significant association between smoking and breastfeeding persists even 
when sociodemographic characteristics are adjusted for, any association can be due to 
residual confounding by these and other associated factors. It’s also worth noting that 
the association is likely to be a combination of mechanisms, rather than a given factor. 
The association cannot be explained purely by shared demographics. 
 
1.3.1.3 Fear of harm 
Mother’s may consider smoking while breastfeeding to be detrimental to the infant’s 
health, and therefore either do not intend to breastfeed, initiate breastfeeding, stop 
breastfeeding earlier than non-smoking mothers [161]. In a longitudinal qualitative 
study, it was identified that women who smoked postpartum believed this affected both 
the quality and the quantity of their breastmilk; the authors noted around 95% of the 
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women in their study thought smoking had a negative effect on the quality of breastmilk 
[162]. This is highlighted in previous work, where mothers feared the composition of 
their milk was compromised due to smoking [163, 164]. Women felt that smoking 
caused their milk to contain toxic components, and was therefore not safe. They 
believed that the taste of their milk was altered resulting in the baby not feeding 
correctly, and that the presence of nicotine would mean their infant was addicted [162].  
This study also highlighted that women were concerned that the closeness necessitated 
by breastfeeding meant the infant wasn’t just exposed to toxins via milk, but also from 
lingering tobacco smoke on the mother. Misinformation given by health care 
professionals validated this belief; some participants were told if their infant wasn’t 
gaining enough weight, it was probably due to smoking depleting their milk supply. As 
well as misinformation, some women reported no health care professional had 
discussed smoking and breastfeeding with them, and due to the stigma they had felt 
unable to ask [162].  
The NHS [166] report the benefits of breastfeeding even when smoking; despite these 
recommendations, women are still uncertain of the safety of breastfeeding while 
smoking [150].   
 
1.3.2 Interventions for smoking and breastfeeding 
There have been very few interventions that specifically target both smoking and 
breastfeeding for behaviour change [167-169].  
In a randomised control trial, Philips et al. delivered an intervention combining support 
for both smoking cessation and breastfeeding within a Neonatal Intensive Care Unit 
(NICU)[169]. While both the control and intervention groups received encouragement 
to remain smoke-free and usual care breastfeeding support, the intervention group were 
also given more information on maternal-infant bonding and encouraged to frequently 
practice skin to skin holding (which promoted breastfeeding). Within the intervention 
group, 81% remained smoke-free, compared to 46% of the control group, and 86% 
were breastfeeding, compared to 21% of the control group by eight weeks postpartum 
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[169]. While this study showed that a combined intervention was effective, it was limited 
by its sample size; a priori power analysis estimated 128 mothers would be required for 
the study, yet only 54 women were recruited. This study also relied on self-reported 
smoking abstinence and CO monitoring once a week, which is not a reliable measure 
of smoking given CO would only be indicated if the mother had smoked within the last 
six hours. However, cotinine levels were checked at the end of the study (at eight weeks 
postpartum).  
A randomised control trial in the Netherlands combined smoking cessation advice with 
breastfeeding advice as part of the VoorZorg programme; this consisted of between 40 
and 60 home visits from specialised nurses throughout pregnancy and until two years 
postpartum [167]. This resulted in significantly lower rates of smoking during pregnancy 
and postpartum and well as significantly higher rates of breastfeeding when compared 
to usual care [167]. Although it should be noted this study relied on self-reported 
smoking abstinence rather than biochemical verification, this study also did not record 
whether women were exclusively or partially breastfeeding. There was also a high non-
response rate from women in the control group which may have added bias to this 
study. 
Another intervention reported by DiSantis et al. (2010) evaluated the effectiveness of a 
combined smoking and breastfeeding intervention against a smoking-only intervention. 
Although smoking was associated with a shorter duration of breastfeeding, the study 
found there were no differences in breastfeeding or smoking between the two 
intervention groups [168]. 
Although interventions combining both behaviours are minimal, there is evidence that 





1.3.2.1 Potential interventions 
The use of smoking cessation products among lactating women has not been 
extensively studied. The use of bupropion during the postnatal period has been 
reviewed in terms of transference to milk. Concentrations of the drug are higher in 
breast milk than in maternal plasma concentrations; however, accumulation does not 
occur in the infant [170]. One study concluded that bupropion should be considered to 
prevent postpartum smoking even if the mother is lactating [171]. However, we know 
from research concerning other drugs such as anti-depressants that the acceptability 
of taking medications is low amongst lactating women [172, 173]. Although one study 
found bupropion was deemed acceptable by lactating women as long as it was 
discussed with them during postnatal visits, however, this study did not look at the 
efficacy of bupropion use [174]. 
In a descriptive study looking at the attitudes, knowledge and practices of paediatricians 
in Pennsylvania, less than half of 296 physicians surveyed reported that breastfeeding 
was safe for smoking mothers [175]. In this study, physicians were asked five 
knowledge questions about smoking and breastfeeding. Only 21% of physicians were 
able to answer at least four correctly, and 27% answered none correctly. The lower the 
score on knowledge questions, the more likely a physician was to recommend formula 
feeding for smoking mothers [175]. The majority of the physicians involved in the study 
were also uncertain about whether it was safe to prescribe NRT or pharmaceuticals, 
such as bupropion, to lactating mothers [175]. Previous research also highlighted that 
physicians were less likely to recommend NRT to lactating mothers than pregnant 
women [176]. A recent review of the prevalence and risk of NRT during pregnancy and 
breastfeeding could not identify any studies concerning the use of NRT, or any potential 
health effects [177]. Research has found that using NRT does not influence the milk 
intake by a breastfed infant, and although high strength patches (21mg) show similar 
levels of nicotine in breastmilk to smoking 17 cigarettes a day. There is a significant 
reduction (p= <0.05) in nicotine present in breastmilk if medium dose (14-mg) or low 
dose (7-mg) patches are used [178]. Due to the absence of research in this area, the 
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only information available is in the form of narrative reviews. One such review 
considering myths around NRT use identified that NRT is likely to be far less harmful 
than smoking during breastfeeding as infants are not exposed to harmful cigarette 
smoke [179]. In a guide for health professionals on smoking cessation by the same 
author, it is recommended NRT should be offered to lactating mothers [180].   However, 
GlaxoSmithKline and Pfizer, pharmaceutical companies that produce NRT for 
consumer use, funded this review, which suggests a conflict of interest [179].  
Although financial incentives have been used for both smoking cessation and 
breastfeeding promotion, currently no study has utilised financial incentives for both 
behaviours concurrently. A mixed-methods review to inform a trial design named the 
Benefits of Incentives for Breastfeeding and Smoking cessation in pregnancy (BIBS) 
outlined that incentive-based interventions with tailored components show promise for 
both smoking cessation and breastfeeding. Still, acceptability from both providers and 
women was low [181]. The efficacy of combined incentives to support smoking 
abstinence and breastfeeding remains to be seen. 
A relatively new tool that some people have used for smoking cessation [182] is e-
cigarettes. These are devices that create a similar sensation to smoking [183, 184] but 
are less harmful than combustible tobacco [188]. With the potential for harm reduction, 
this is a potential aid for mothers who smoke to breastfeed that has not yet been 
explored. 
1.3.3 Summary 
There is strong evidence of a relationship between smoking and breastfeeding 
intentions, initiation and duration. There is no substantial evidence that there is a 
physiological effect of nicotine on prolactin that would explain the strength of this 
relationship.  There is evidence that women who smoke postpartum and women who 
do not breastfeed share similar demographics, although when these demographics are 
adjusted for it suggests there may be other mechanisms involved. The available 
literature supports the theory that the relationship between smoking and breastfeeding 
may be, at least in part, a psychological one, a fear of harm.  
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The fear of harm stems from a fear that toxic components of cigarette smoke will be 
passed to the infant via breastmilk. Women are told during pregnancy how harmful 
cigarette smoke can be to her unborn baby, and may use this information to inform 
breastfeeding choices. This is contradictory to advice form the NHS and APA who 
promote breastfeeding amongst smoking mothers to reduce the harm to the infant from 
smoking. What isn’t currently known is how smoking might be related to breastfeeding 
in the UK. Recent research concerning smoking and breastfeeding is primarily from 
Turkey or the USA. Research also compares just smokers and non-smokers, so we are 
unable to say whether any identified relationship is due to individual differences or the 
behaviours themselves. 
Interventions that promote change to both smoking and breastfeeding are minimal and 
limited by study design. Relapse to smoking postpartum persists in being a public health 
concern, which correlates with lower rates of breastfeeding, which is, in itself, a public 
health concern. A solution may be to offer an alternative method of nicotine delivery. 
An e-cigarette can create a similar experience to smoking but with reduced risk and 
may be an acceptable alternative.  
 
1.4 E-cigarettes: an overview 
An emerging product that may be useful for preventing relapse, and supporting 
cessation are e-cigarettes. E-cigarettes are Electronic Nicotine Delivery Systems 
(ENDS) [189]. E-cigarettes are handheld devices that produce an aerosolized mixture 
from a solution (e-liquid) typically containing concentrated nicotine, flavouring 
chemicals, and propylene glycol  [190]. E-cigarettes come in many forms (e-cigarettes, 
e-hookahs, vape tanks, etc.), but generally consist of a flow sensor, battery, solution 
storage area, and aerosol generator  [191]. The user draws a deep breath and inhales 
the vaporised liquid, an act known as ‘vaping’, creating a similar experience to smoking 
combustible tobacco. This may mean the user gains the bio-behavioural feedback they 
crave from cigarettes to appease their addiction [183]. Bio-behavioural feedback is 
particularly important for women. Research suggests women are less responsive to the 
interoceptive effects of nicotine [192, 193], and more sensitive to the sensorimotor 
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aspects of smoking [193, 194]. In an online survey Dawkins et al., (2013) found that 
women liked e-cigarettes because of the resemblance and similarity to a combustible 
cigarette and were more likely to agree they reduced cravings [195]. 
Nicotine is the principal psychoactive ingredient in e-liquids (although 0% nicotine ‘e-
juices’ are available); thus, e-liquids can be highly addictive and toxic if ingested [196]. 
Some research suggests that as well as nicotine, there may be exposure to toxicants, 
carcinogens, and heavy metals via e-cigarette vapour [196-198]. The popularity of e-
cigarettes has also caused disagreement within academics, and the public health 
community, as to whether they will serve as a tool to renormalize nicotine product use 
and act as a gateway to smoking combustible tobacco [199]. So far, most research 
suggests that this is not the case [187, 200, 201]. E-cigarettes are cited as being a 
useful quit aid for smokers looking to reduce or completely quit traditional cigarettes 
[187, 202-204]. Research concerning the safety of e-cigarettes is ever-growing, 
however evidence for long term safety is still minimal [205, 206], although Public Health 
England have reported that e-cigarettes are at least 95% safer than cigarettes [188]. 
 
1.4.1 Vapour versus smoke 
There are over 2,500 chemicals in a cigarette; upon combustion, these are transformed 
into over 7,000 chemicals, including more than 70 known carcinogens. The process of 
combustion is a chemical reaction whereby the reactant molecules (tobacco and 
oxygen) are mixed and rearranged, becoming product molecules and concurrently 
releasing heat. This results in the thermal decomposition of tobacco, the result of which 
is the production of smoke; a mixture of gases and suspended particles [207, 208].  
During combustion, the nitrogenous constituents of the tobacco leaf transform into 
tobacco-specific nitrosamines (TSNAs) [209]; the body metabolises these into 
carcinogenic compounds. High levels of formaldehyde are observed in cigarette smoke, 
particularly the first inhale, and trace metals are present [210].  
With e-cigarettes, there is no combustion; instead, a heating coil causes a liquid 
formulation (known as E-liquid or E-Juice) to vaporise, which the user then inhales 
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[191]. E-cigarette aerosol is generated when the e-liquid reaches between 100-250°C 
within the liquid chamber [189]. The aerosol generated is composed of liquid submicron 
particles of condensed vapour which consists of water, nicotine, flavourings, propylene 
glycol, glycerol and other chemicals [211, 212]. 
There is a growing body of evidence of empirical data examining the safety and 
composition of e-cigarette vapour.  Toxicity testing has evaluated the chemical nature 
of the vapour generated from e-cigarettes in comparison to combustible tobacco. 
Goniewicz et al. [213] generated vapours from 12 different brands of e-cigarettes, 
alongside the medicinal cessation product; a nicotine inhalator. Using a modified 
smoking machine, the researchers screened the resultant vapour for four groups of 
toxic or carcinogenic compounds: carbonyls, volatile organic compounds (VOCs), 
nitrosamines and heavy metals. Once extracted from the vapour, the selected toxicants 
were then analysed using chromatographic and spectroscopy methods. The 
researchers concluded there was evidence of some toxic substances existing in e-
cigarette vapour. However, the levels identified were up to 450 times lower than the 
levels of those toxicants found in cigarette smoke (Table 1.1). They were also, in many 
cases, comparable to the medicinal product of a nicotine inhalator. A total of 4 carbonyls 
were found in e-cigarette vapour, a finding consistent across almost all of the e-cigarette 
brands. Identification of tobacco-specific nitrosamines was less consistent across all e-
cigarette samples, with levels of NNN and NNK fluctuating in both presence and 
amount. Researchers also identified the presence of cadmium, nickel and lead in the 







Table 1.1 Goniewicz et al., 2014 
Toxic 
compound 
Conventional cigarette (µg in 
mainstream smoke)  
Electronic cigarette (µg per 15 
puffs) 
Formaldehyde 1.6–52 0.20–5.61 
Acetaldehyde 52–140 0.11–1.36 
Acrolein 2.4–62 0.07–4.19 
Toluene 8.3–70 0.02–0.63 
NNN 0.005–0.19 0.00008–0.00043 
NNK 0.012–0.11 0.00011–0.00283 
Cadmium 1.6-101 0.02–0.22 
Nickel 0.1-0.78 0.11–0.29 
Lead 3.9-32.9 0.02-0.57 
This study supports findings from other studies [214-217] that e-cigarettes represent 
significantly less exposure to toxic compounds that cigarettes. There are also 
methodological concerns to consider; this study analysed vapour generated using a 
smoking machine in laboratory conditions usually used for researching tobacco. 
Inhalation differs between e-cigarettes and tobacco cigarettes so to create vaping 
conditions reflecting actual usage, topography (‘puffing’ behaviour) was measured 
amongst 10 e-cigarette users. From this it was assumed ‘usual’ topography involved a 
user taking 15 puffs on an e-cigarette which corresponded to 1 cigarette; for this study 
10 series of 15 puffs were used to generate the vapour. The main limitation of this study 
is the use of a smoking machine that generates vapour in non-naturalistic conditions. 
This meant vapour generated might not reflect actual puff topography. Similar to issues 




A method of comparing the exposure to tobacco-related toxicants without artificially 
generating smoke is to compare biomarkers. Goniewicz et al. [218] conducted a 
population-based, longitudinal cohort study in the United States. This study used a 
cross-sectional analysis of biomarkers from exposure to tobacco-related toxicants in 
urine samples provided by 5105 adults who either smoked (n = 2411), vaped (n = 247), 
smoked and vaped (dual users) (n = 792) or never smoked or vaped (n = 1655). Fifty 
biomarkers were measured that fell into five classes of tobacco constituents: TSNA’s, 
heavy metals, polycyclic aromatic hydrocarbons (PAHs), and VOCs. The study found 
that in comparison to exclusive smokers, exclusive e-cigarette users had similar 
concentrations of almost all heavy metals (except for cadmium) and some VOCs 
(toluene, benzene, and carbon disulphide), but had 93% to 98% lower levels of TSNAs 
(p <0.001). Cadmium biomarkers were 30% less in exclusive e-cigarette users (p= 
0.02), and PAHs were 47% to 62% lower (p <0.001).  Exclusive e-cigarette users also 
had 59%-97% lower concentrations of VOCs biomarkers compared to exclusive 
smokers (p <0.001). Exclusive cigarette users also had 10% to 36% lower 
concentrations of several biomarkers than dual users [218]. The levels of biomarkers 










While this study [218] found evidence that conflicted with the earlier study  [186] in terms 
of concentrations of heavy metals, it should be noted that heavy metals have long half-
lives’ [219]. The similar levels of heavy metals observed between exclusive vapers and 
exclusive smokers in this study may be due to previous exposure from tobacco 
smoking, as 93% of exclusive e-cigarette users in this study had previously smoked 
tobacco. This study also did not assess which generation of e-cigarettes participants 
used, and previous research has shown that different generations of devices can deliver 
different levels of nicotine and toxicants [220]. This study may be a more accurate 
measure of how toxicant levels with shorter half-lives may differ between smokers and 
vapers. However, relying on urine analysis does pose a limit in establishing whether 
biomarkers are specifically related to smoking/vaping rather than the result of other 
environmental sources, such as pollution [219]. 
The findings [218] are similar to an earlier longitudinal study [197]. In this study, 20 
smokers (average 16 cigarettes per day) were recruited to switch to using an e-cigarette 
for two weeks. Urine samples were taken at baseline and tested for biomarkers of 13 
major carcinogens and toxicants in cigarette smoke. The biomarkers were then 
measured after two weeks of e-cigarette use. This allowed for a more ‘real world’ view 
of potentially toxic exposure from e-cigarettes. Although 55% of the participants 
reported smoking as well as using e-cigarettes, there was still a significant decline in all 
biomarkers except for nicotine metabolites.  Tobacco-specific nitrosamines, VOCs, and 
PAHs, were all significantly reduced, similar to previous research findings [186, 221]. 
The decline in biomarkers was decreased to similar quantities found in participants who 
quit smoking with no substitute e-cigarette [222].  
Another cross-sectional study also measured biomarkers of tobacco-related toxicants 
[216]. This study looked at biomarkers of TSNA’s and VOCs in the urine samples of 
exclusive smokers, former smokers who have used e-cigarettes exclusively for >6 
months, former smokers using NRT exclusively, dual smokers and e-cigarette users, 
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and dual smokers and NRT users. Each group had 36-37 participants. Those who were 
long term exclusive e-cigarette users and those who were long term exclusive NRT 
users had substantially lower levels of biomarkers (from urine and salivary samples) for 
TSNA’s and VOCs compared to those who used combustible tobacco. Exclusive e-
cigarette users had around a 97% lower level of TSNA’s than combustible tobacco, 
although significant reductions in TSNA’s were not observed in dual-use categories. 
Dual-use also didn’t have any significantly reduced levels of VOCs; however, exclusive 
e-cigarette users had the lowest levels of all the groups. This study is limited due to its 
cross-sectional design as we are unable to analyse a change in levels of carcinogens 
and toxicants over time, we cannot determine cause and effect. 
Despite methodological differences, these studies are relatively consistent. Any 
toxicants identified are consistently found to be at significantly lower levels than those 
found in tobacco products, apart from nearly all heavy metals in [218] which, as 
explained, maybe due to residual contamination from prior smoking. 
Compared with cigarette smoke, e-cigarette aerosol contains much less harmful 
components. Of those components identified, they are at much lower quantities than 
those found in cigarettes [186]. In a comparison study, cigarette smoke was found to 
have 1,500 times more potentially harmful/harmful constituents than e-cigarette vapour 
[223].  
 
1.4.1.1 Potential health consequences of using E-cigarettes 
There is evidence for improved health after switching from tobacco smoking to e-
cigarettes with the suggestion that an increase in e-cigarette use amongst current 
smokers could reduce the disease burden of smoking-related cancers [224].  
One of the primary, potentially harmful substances identified within e-cigarette vapour 
is formaldehyde, which can cause oxidative damage to DNA [225]. In animal research 
there is some evidence that exposure to e-vapour increases oxidative stress; when rats 
were exposed to e-vapour for four weeks increased levels of 8-hydroxy-
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2’deoxyguanosine (8-OHdG) which may be a biomarker for oxidative damage to DNA 
[226]. With in vitro studies, Thorne et al., [227] found that e-cigarette vapour was not 
mutagenic in contrast to cigarette smoke. Likewise, further in vitro research has found 
e-cigarette vapour generated using different flavoured liquids (with/without nicotine) 
does not have mutagenic, cytotoxic, genotoxic, or inflammatory effects [228].  
The risk of respiratory illnesses from e-cigarettes cannot entirely be ascertained due to 
the length of time they have been available for use. There is some concern over the 
constituents of vapour that have the capacity to cause harm to the respiratory system. 
Recently there were fears e-cigarettes could cause ‘popcorn lung’ (bronchiolitis 
obliterans). The risk stemmed from the flavouring diacetyl [229] which is now banned 
from e-liquids. Aside from diacetyl, there are substances within e-liquids that could 
cause respiratory issues, or exacerbate existing conditions. Liquids containing nicotine 
can impair cystic fibrosis transmembrane conductance regulator function due to the 
downregulation of the α7 nicotinic acetylcholine receptors [230]. This is a risk factor for 
developing chronic obstructive pulmonary disease (COPD) [231]. In vitro research 
using mice epithelial cells also identified effects associated with COPD when exposed 
to nicotine-containing e-liquid, but no effect was observed in nicotine-free e-liquid [232]. 
There is also the risk from other constituents of e-cigarette vapour – for example, 
ultrafine particulate matter (<100nm) can induce an inflammatory response [233]. 
Further In vivo studies on mice have shown that e-vapour may be associated with 
pulmonary abnormalities. However, when compared with tobacco smoke, the damage 
was far less [234].  Research has shown that switching from cigarettes to e-cigarettes 
does reduce the number of COPD exacerbations [235] and an improvement in smokers 
with asthma [236]. Overall there is no conclusive evidence that e-cigarettes cause 
respiratory disease in users, but there is some (limited) evidence of the potential to 
exacerbate pre-existing lung conditions. This must be viewed in the context of smoking, 
which is known to be a causal factor COPD [237] and is strongly associated with asthma 
prevalence and severity [238]. 
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Overall, despite inconsistency, specific components of e-vapour have the potential to 
induce mutagenesis; formaldehyde and acrolein are DNA-reactive, and there is 
evidence for oxidative stress. However, there is no conclusive evidence that e-
cigarettes pose a specific risk to health. It can be concluded that the risk from e-
cigarettes is higher than that of not vaping or smoking. Still, research shows that users 
of e-cigarettes are those who aim to quit or reduce smoking [239], therefore when 
considering the health consequences of e-cigarettes, we should view them in 
comparison with the relative risk from smoking combustible tobacco. 
 
 1.4.1.2 E-cigarettes: possible harm reduction tools? 
In line with PHE recommendations, E-cigarettes can be used as harm reduction tools. 
Harm reduction refers to minimising the negative health consequences of smoking with 
the use of e-cigarettes. While e-cigarettes cannot be defined as ‘safe,’ they are a way 
of diminishing the harmful effects of smoking, without eliminating the smoking behaviour 
(in this case the hand to mouth action, the inhalation of a substance and exhale, and 
the presence of nicotine in some cases). Harm reduction using e-cigarettes isn’t solely 
to reduce the impact of tobacco smoking on the smoker but to also prevent second and 
third-hand exposure to non-smokers. Currently, there is no long-term, epidemiological 
research that explores possible harm reduction from e-cigarettes, however, as there is 
no combustion, there is a lack of harmful toxins caused by pyrolysis.  
As well as a reduction in biomarkers of toxicants [197, 218], carbon monoxide (CO) 
levels are also observed to reduce significantly (around an 80% reduction) in those who 
switch from smoking to exclusive e-cigarette use [197, 221, 240]. Using self-report 
measures, smokers who switch exclusively to e-cigarettes also report better breathing, 
less coughing, less sore throats, improved sleep patterns, improved taste, and an 
improvement in general health and fitness [241, 242]. Clinically, evidence of enhanced 
respiratory function is inconsistent; some research has found that there is an increase 
in flow-mediated dilation [243], whereas other research has found no significant 
differences in spirometric indexes [242, 244]. However, improvements are observed, 
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just not to a significant degree [215]. There is evidence that those with existing 
respiratory illnesses experience a reduction in symptoms when switching to e-cigarettes 
[235, 236, 245]. There is more considerable evidence for increased cardiovascular 
health when switching to e-cigarettes from smoking. Acutely, smoking combustible 
tobacco elevates diastolic blood pressure and heart rate significantly more than using 
e-cigarettes, and switching exclusively to e-cigarettes significantly reduces blood 
pressure [215, 224, 245]. Arterial hypertension is also shown to significantly improve in 
those who switch from smoking to e-cigarettes [246]. Further research by Polosa et al. 
(2016b) has observed significant reductions in COPD exacerbations in smokers who 
switched to e-cigarettes [235]. 
Evidence also supports e-cigarettes being a harm-reductive approach to reducing 
second and third-hand smoke. While the homes of people who use e-cigarettes still 
show detectable levels of nicotine and particulates, these levels are 5.7 times lower 
than in the homes of smokers; the geometric mean (GM) of airborne nicotine were 
0.13μg/m3 in e-cigarette households and 0.74 μg/m3 in smoking households [247]. A 
systematic review by Hess et al., (2016) found that while passive vapour from e-
cigarettes has the potential to cause adverse effects in those exposed, it is significantly 
less harmful than those exposed to passive smoking due to quantities of biomarkers 
identified [248]. Although nicotine is found in the homes of e-cigarette users [249, 250], 
there is no evidence of exposure to CO or VOCs [249]. However, research examining 
passive exposure to e-cigarette vapour is currently limited. 
 
1.4.2 Smoking cessation 
Research is ongoing to assess not only the safety of e-cigarettes but also the efficacy 
of them as smoking cessation aids. The Smoking Toolkit Study [251] has collected data 
on electronic cigarette use since 2011. E-cigarette use in the UK has remained stable 
since 2013, and while the use of e-cigarettes amongst never smokers remains 
negligible, the use amongst long term ex-smokers has increased. The majority of 
people using e-cigarettes in the UK are dual users, although ex-smokers use an e-
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cigarette more frequently. Despite peaking in 2016, the proportion of smokers 
attempting to quit smoking with e-cigarettes has declined, which may be due in part to 
health and safety concerns reported in the media. 
In a 2014 Cochrane review, McRobbie, Bullen, Hartman-Boyce, and Hajek [252] 
reported promising results as to the efficacy of e-cigarettes as a tool to quit smoking. 
The review aimed to examine the efficacy of e-cigarettes in helping people to achieve 
long-term abstinence from smoking and to examine the efficacy of e-cigarettes in 
helping people who smoke to reduce cigarette consumption by at least 50%. The 
Cochrane review also looked for evidence of adverse effects from e-cigarette use. This 
review used various databases including the Cochrane Tobacco Addiction Groups 
Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL), 
MEDLINE, Embase and included records from 2004-2014. This review included 
randomized controlled trials in which current smokers were randomized to e-cigarette 
or a control group, and that also measured abstinence rates or changes in cigarette use 
at six months. The review also included cross‐over trials and cohort follow‐up studies 
that included at least one week of e-cigarette use for the assessment of adverse events. 
A total of 13 studies that measured abstinence continuously (with biochemically 
validated measures) and reductions in smoking dichotomously were included in to 
perform a meta-analysis. The results showed that those using e-cigarettes were more 
likely to remain abstinent from smoking at six months compared to those who used 
placebo products (RR=2.29, C 1.05-4.96). Although no significant differences in this 
review were recorded between those who used NRT vs those who used e-cigarettes, 
confidence intervals do show an important difference (RR=1.26, CI 0.68-2.34). No 
significant adverse events were associated with e-cigarettes, although throat irritation 
was reported in some cases. Overall the efficacy of e-cigarettes as a tool for quitting 
smoking, and reducing cigarette consumption is promising, especially with no evidence 
of significant adverse events.  
However, the authors did conclude that due to the small amount of data collected on 
what is still a relatively new product, these results are subject to minimal confidence 
rated ‘low’ by GRADE (Grading of Recommendations, Assessment, Development, and 
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Evaluations) standards [252]. A further review published in 2016 by Malas et al. [253] 
provided a qualitative synthesis on e-cigarette studies. The review concluded there was 
evidence of a positive relationship between smoking cessation and e-cigarette use. The 
review also supported the efficacy of e-cigarettes for reducing the desire to smoke and 
alleviating nicotine withdrawal symptoms. However, the GRADE standards were ‘very 
low’ to ‘low’ for cessation, and ‘low’ to moderate’ for reduced consumption due to limited 
availability of research. 
In 2019 Hajek et al. conducted an RCT testing the efficacy of e-cigarettes compared to 
NRT [254]. Unlike the earlier review, this RCT found that using an e-cigarette compared 
to NRT increased a person's chances of remaining smoke-free at one year (RR = 1.83, 
CI 1.30-2.58). They also found that at one year, 80% of the e-cigarette group were still 
using their device compared to just 9% of the NRT group who were still using NRT 
[254]. 
Other research has assessed self-reported smoking abstinence, and reduced cigarette 
consumption, amongst online populations. Abstinence at six months was reported by 
31% of respondents and significant reductions in cigarette consumption amongst 66.8% 
of respondents [255]. However, there are limitations to this study due to the cross-
sectional online study design and reliance on self-reported smoking status. Recent 
research has suggested that the daily use of e-cigarettes, compared to no use of e-
cigarettes, is associated with a 77% increase in odds of prolonged cigarette abstinence 
(up to 2 years) [256]. However, these statistics should be viewed with caution as daily 
cigarette users accounted for only 3.6% of the original sample, and smoking status was 
not verified. Other research has suggested that e-cigarettes are at least as effective at 
reducing smoking as NRT (although not significant, the proportion of abstinent smokers 
was higher amongst e-cigarette users than NRT) and has fewer reported adverse 
effects [257]. Although this study was an uncontrolled pilot study, e-cigarettes have also 
been shown to reduce cigarette consumption by more than 50% in smokers not 
intending to quit smoking [258]; this has been shown even with nicotine-free e-liquids 
[202]. However, the dropout rate for these studies was high, so results may not be an 
entirely accurate representation. E-cigarettes are also shown to reduce smoking 
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amongst populations where smoking cessation is often challenging to address [259]. 
Research also suggests that e-cigarettes may prevent a return to smoking after quitting 
[260]; this may be due to e-cigarettes reducing the desire to smoke and when containing 
nicotine, helping to manage nicotine withdrawal symptoms [261, 262]. 
1.4.3 Use in pregnancy 
Smoking in pregnancy harms foetal development and can lead to a myriad of problems, 
including morbidity and mortality, as discussed above. Due to the lower concentrations 
of toxins in e-cigarettes compared to tobacco smoke, e-cigarettes may be a harm 
reductive approach for women who are unable to, or unwilling to quit smoking. As well 
as the reduced toxins, there is no carbon monoxide when using an e-cigarette, which 
reduces the risk of harm to the developing foetus, a stance supported by the Royal 
College of Midwives [39]. The reduction in CO is an important factor to consider; 
exposure to CO during pregnancy causes hypoxia in the developing foetus which can 
lead to impaired brain development and intrauterine growth retardation (IUGR) [33]. 
Several chemicals within cigarette smoke are teratogenic – increasing the rate of 
miscarriage or congenital malformation [263]. 
Due to the relative novelty of e-cigarettes, research examining the potential effects on 
the developing foetus relies heavily on animal studies and the analysis of e-
liquid/vapour constituents [230]. The majority of this research has focused on the role 
of nicotine and the potential teratogenic effects; possible damage to the lungs via α7 
nicotinic receptors [264, 265], and brain development [266].  
Although evidence available on the safety of e-cigarettes during pregnancy is minimal, 
the evidence of harm from smoking is clear (1.1.2). Whilst the nicotine within e-liquids 
is not a benign substance, evidence form the SNAP trial suggests there are no adverse 
events associated with nicotine use (from nicotine patches) to the developing foetus 
[267]. Therefore e-cigarettes are an opportunity to remove the harm posed by tobacco-
related toxicants [230].  
The perception of e-cigarette safety differs among pregnant women [268-270]. A large 
proportion of pregnant women do accept there are risks associated with e-cigarette use 
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in pregnancy, but these risks are lower in comparison to smoking during pregnancy 
[271-274]. 
 
1.4.4 Postpartum use 
Research considering E-cigarette use in the postpartum period is currently limited. 
There is evidence that women are seeking information about e-cigarette use. However, 
they are also confused about the current evidence for e-cigarettes as a harm reductive 
tool, despite research suggesting this is so [186, 189, 197, 221, 235, 245, 275, 276]. A 
three-phase mixed methods study for designing an intervention to prevent a return to 
smoking in the postpartum period included qualitative data on the potential use of e-
cigarettes postpartum to reduce relapse [277]. Phase one, a systematic review, 
highlighted the need for postpartum interventions to consider the use of e-cigarette use 
in the postpartum period due to a small body of literature [66]. During phase two of the 
study, qualitative data was collected using interviews, focus groups, and online versions 
of the questionnaire. This phase of the study aimed to gather multiple viewpoints from 
a purposive sample of pregnant and postpartum women who had stopped smoking for 
or during pregnancy about the need for a relapse prevention intervention. This included 
why an intervention is needed, who should deliver it, when it should be offered, and 
what format it should take. This phase also asked specific questions about e-cigarettes. 
Amongst other findings, it was identified that women wanted objective information about 
infant feeding and staying smoke-free, and advice on additional support available, such 
as e-cigarettes. This phase determined that advice and information on e-cigarettes were 
somewhat mixed. While women reported they were very wary of using e-cigarettes, 
they did identify that e-cigarettes were likely to be much less harmful than smoking 
tobacco [277]. This was, in part, due to concerns that e-cigarettes were a way of 
‘continuing’ the addiction. There were also some concerns about the long term effects 
of e-cigarette use due to a lack of research. Women (and health care professionals) 
also highlighted the need for clear and precise information about using e-cigarettes, 
including which devices to use and advice of e-liquids. Crucially, both women and health 
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care professionals highlighted that information on breastfeeding and using e-cigarettes 
was thought to be completely unavailable [277]. 
Phase three of this study involved testing and retesting prototypes of the intervention 
[277]. Part of this was a box full of advice, information, and gifts. It was discussed that 
this box could contain a lapse prevention tool such as nicotine gum or e-cigarettes. 
While not every woman was receptive to using e-cigarettes as a prevention tool, 
participants did highlight they may be useful for women at risk of relapse to have access 
to alternatives they could turn to instead of cigarettes. Women did highlight that e-
cigarettes would need to be presented with very clear information, particularly due to 
confusion regarding nicotine use postpartum. It was expressed by some women that 
knowing which device and concentration of nicotine to use could be too complicated for 
some women and result in them returning to smoking. This study highlights the need 
for clear and concise information about e-cigarette use postpartum [277]. 
One qualitative study has sought to understand women’s perceptions of e-cigarette use 
postpartum [278]. This study found that overall, women were attracted to e-cigarettes 
due to claims they reduced harm. However, there was still a lot of uncertainty regarding 
potential health effects [278]. Some women were uncertain about the e-cigarettes due 
to the novelty of them. There was also evidence that for some women, e-cigarettes 
were often used in combination with cigarettes, and that using e-cigarettes exclusively 
did not always prevent relapse.  
While some research considers postpartum e-cigarette use, this is very limited; only 
three papers (two of which were part of the same studies) [66, 277, 278] discussed 
postpartum use of e-cigarettes. In the three-phase study [277] the review highlighted 
the need for postpartum relapse prevention interventions to consider e-cigarettes, and 
that the lack of clear and concise information regarding their use postpartum is an issue 
for women. This study did not specifically focus on e-cigarette use postpartum but 
highlighted the need for more evidence, advice, and support [277].  The Medicaid study 
[278] found similarly mixed views on e-cigarette use and provided information on how 
postpartum women are primarily using them as well as cigarettes. However, this study 
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had a small sample size and only reflected the views of women in the US in receipt of 
Medicaid. Thus it’s questionable how transferable this is to other women. Research 
considering postpartum e-cigarette use is in its infancy and more research is needed to 




E-cigarettes are still relatively new and lacking long term epidemiological data. We do, 
however, have consistent data that shows carcinogens and toxicants found in tobacco 
smoke are either absent from e-cigarette vapour or are identified at significantly lower 
levels. Those carcinogens and toxicants identified within e-cigarette vapour still have 
the potential mechanisms to cause damage to health, particularly the respiratory tract. 
Despite this, risks from e-cigarette use should be viewed in comparison to those from 
tobacco smoke, as research shows e-cigarettes are predominantly used by ex-
smokers, or smokers wishing to quit/reduce the number of cigarettes they smoke. E-
cigarettes are more effective than usual treatment for smoking cessation, although not 
much long term evidence exists for this efficacy persisting. Those who use e-cigarettes 
can regulate their nicotine levels in line with their nicotine needs from smoking which 
may explain why e-cigarettes have been successful for smoking cessation even in those 
smokers who were not looking to quit smoking. While pregnant mothers who cannot or 
chose not to quit smoking are advised to use e-cigarettes, not much research has 
examined postpartum use of e-cigarettes. Of the work that has considered e-cigarette 
use postpartum, confusion and seeking further information are prevalent themes. E-
cigarettes may be tools for reducing harm from tobacco smoking, but further research 
is needed to assess the acceptability of e-cigarettes postpartum. Currently, no data 




1.5 E-cigarettes and breastfeeding? 
Currently, there is no research considering e-cigarette use and breastfeeding. Women’s 
concerns regarding breastfeeding as a smoker (and the contamination of milk by 
tobacco-specific components) are not entirely unfounded. While it is safer for a smoking 
mother to smoke and breastfeed than smoke and formula feed, there is still exposure 
to harmful toxins that may transfer to the infant via breastmilk. This is due to the way 
breast milk is produced and secreted. It is important to understand the potential 
transference of smoke constituents to rationalise those concerns. Although toxicants 
identified in e-cigarettes are much lower than cigarettes (see 1.4.1), addressing how 
those toxicants may transfer into breastmilk, in comparison to cigarettes, may offer 
women the clear and concise information they want.   
Galoctopoesis is the maintenance of lactation, including the hormones that regulate 
milk production and the milk being removed from the breast. There are four major 
secretory processes to produce milk (Figure 1.3); secretion via fat globule, secretion 
related to concentration gradients, pinocytosis (the movement of small particles into a 
cell, and then suspended within the cell in small vesicles) and exocytosis of 






1.5.1 Transference from inhalation to breastmilk and potential health 
consequences 
Although relatively little is known about the movement of trace mineral and elements 
such as heavy metals into breastmilk, it is generally accepted that the most probable 
transportation of these elements is via binding to specific carrier proteins [281, 282]. 
The pharmacokinetics of nicotine-containing products into breastmilk depends mainly 
on the route of absorption, size of molecules, metabolic process, and distribution within 
tissues, lipid solubility, and excretion pathways [283]. Substances absorbed into the 
mother’s bloodstream or stored in her bones and fats can reach the nursing infant if 
they can pass directly into the breast during active lactation [282, 284]. 
Within cigarette smoke and e-cigarette vapour, there are potential contaminants of 
breastmilk. The most well-known chemical found in cigarettes and e-cigarettes is 
nicotine, which has been shown to pass directly into breastmilk [285]. In a study 
examining cotinine (the metabolite of nicotine) levels in the urine of infants, babies who 
Figure 1.3- Galopoesis 
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were breastfed by smokers had cotinine levels ten times that of bottle-fed infants of 
smoking mothers, suggesting that infant exposure to nicotine is via breastmilk and not 
environmental smoke [286].  Despite concerns regarding infant exposure to nicotine, 
there remains no conclusive evidence as to whether it is harmful to the infant, however, 
with a half-life of 90 minutes [287] women can reduce the risk of infant exposure by 
smoking directly after a feed [285].  
Some tobacco-related constituents are unlikely to pass into breastmilk due to molecular 
size; for example, formaldehyde [288] and acetaldehyde [289].  There is limited 
information on the likelihood of acrolein [290] or toluene transferring into breastmilk 
[291]; both have the potential to be transferred to milk, however, the quantities identified 
are minute.  
N-Nitrosonornicotine (NNN) is a group one carcinogenic present in tobacco products; 
around half of the NNN is released through burning the tobacco. Nicotine-derived 
Nitrosamine Ketone (NNK) is a pro-carcinogen (a substance that is not directly 
carcinogenic until it is metabolised); it relies on activation by enzymes or metabolic 
genes to exert its effects. Via an oxidative or reductive pathway, NNK becomes its 
metabolised carcinogenic form, NNAL (4-(methylnitrosamino)-1-(3-pyridyl)-1-
butanone)  [292]. Both NNN and NNK are transferred into the mother’s milk via smoke 
inhalation [291, 293]. Research into e-cigarette vapour has concluded NNN and NNK 
are either not present in vapour, or present in vastly reduced quantities (>97% less) 
compared to cigarettes [186, 197, 218].  
Heavy metals are also found in cigarette smoke; cadmium exposure is significantly 
increased in those who smoke [294, 295], and is known to transfer to breastmilk [296-
300]. As a cumulative toxin with a long half-life (6-38yrs) [301, 302], infants exposed via 
breastmilk may not experience the effects of cadmium until adulthood, although early 
life exposure via breastmilk is significantly associated with infant oxidative stress [303]. 
Cadmium exposure can cause gastrointestinal problems, reproductive and fertility 
issues, and DNA damage [302]. Cadmium also mimics oestrogen increasing the risk of 
osteoporosis and breast cancer in exposed females, as evidenced by ‘Itai-Itai’ disease 
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[304]. Cadmium has been identified in e-cigarette vapour, but again in vastly reduced 
quantities; with levels in tobacco smoke ranging from 1.6-101μg per cigarette, and 
levels in vapour of 0.02-0.22 per 15 puffs [186]. 
Lead is also known to transfer to breastmilk [305]. This is a concerning component of 
cigarettes for breastfeeding mothers as young children are particularly vulnerable to the 
toxic effects [306]. The concentration of lead transferred to breastmilk in smokers varies 
throughout the lactation processes, with the initial colostrum having a higher 
concentration of lead. Research has identified this ranges from 13.3 ng/mL to 3.01 
ng/mL throughout the feed [307].  There is already an increased exposure to the 
breastfeeding infant; during pregnancy and lactation as the increased turn over in bone 
releases stored lead into the blood  [308]. High exposure to lead in children can lead to 
profound and irreversible adverse health effects [309]. The World Health Organisation 
state that even blood lead concentrations as small as 5 µg/dL can result in long term 
mental and physical disabilities as a result [310]. Lower levels of exposure do not cause 
immediately apparent symptoms; however, as the levels of exposure increase, so do 
the spectrum of related injuries The accumulation of lead in children can adversely 
affect Intelligence Quotient (IQ) [311] and behaviour; such as reduced concentration 
and anti-social behavioural disorders [309]. Physiological symptoms may include 
anaemia [312], hypertension, renal impairment, immunotoxicity, and toxicity of the 
reproductive system [313]. The accumulation of lead in the child’s bones has a half-life 
that may span decades; therefore, the effects of childhood exposure may not be directly 
expressed until adulthood [314]. As with other heavy metals, lead has been identified 
within e-cigarette vapour (0.02-0.57μg per 15 puffs), but at vastly lower concentrations 
than cigarette smoke (3.9-32.9μg per cigarette) [186]. 
Tobacco-related toxicants that do transfer to breastmilk from smoking are found in 
minute quantities, however it is still safer for a mother to breastfeed if she smokes, than 
to not breastfeed. Those toxicants that are also found in e-cigarettes (apart from 
nicotine) are found in much lower quantities. Therefore breastfeeding mothers who use 
e-cigarettes can be assured that contamination of their milk due to these toxicants is 
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likely to be in extremely minute amounts (13.3 ng/mL- 0.16 ng/mL for heavy metals 
[307]) and unlikely to cause any health consequences for their child.    
As well as reducing fears of milk contamination that may be a barrier for breastfeeding 
to some women, e-cigarettes may also reduce exposure to toxicants in those infants 
who are breastfed by a smoking mother. 
1.5.2 Summary 
There is currently no research that exclusively considers e-cigarettes and 
breastfeeding. While e-cigarettes contain some toxicants that are capable of 
transferring into breastmilk, these are extremely minute quantities that are unlikely to 
pose any acute or long term harm. E-cigarettes should be considered for breastfeeding 
























2. Chapter 2: Rationale and research aims  
 
2.1 Rationale 
As discussed in Chapter 1, most women who quit smoking during pregnancy will return 
to smoking within 12 months postpartum. Smoking postpartum has clear health 
implications for both mother and child. Women who do smoke postpartum are less likely 
to breastfeed, which again has clear health implications for both. Thus far, few 
interventions aim to reduce relapse and increase breastfeeding. Of the small body of 
literature that exists, there is no proven effective, long term intervention that targets both 
behaviours in combination. Some women who return to smoking postpartum are 
concerned that toxicants in cigarette smoke may pass to the breastmilk and negatively 
affect their baby. Although some toxicants transfer to breastmilk, as they are only 
transferred in minute quantities, these are not known to pose any significant risk to the 
infants. However, some women are still reluctant to breastfeed. E-cigarettes deliver 
nicotine in a similar way to cigarettes and are used by smokers to quit or reduce their 
smoking, but have far fewer harmful toxicants than cigarettes. Using an e-cigarette 
could potentially further reduce any risk of transferred toxicants and be more acceptable 
to breastfeeding mothers. 
Although previous literature has identified a relationship between smoking and 
breastfeeding, there is no recent research that explores this relationship within UK 
mothers. It is also important to establish if a relationship exists, whether any relationship 
is the result of shared demographics/characteristics (such as age/education) or another 
mechanism. Crucially, there is currently a gap in the literature that explores the 
relationship between smoking and breastfeeding within women who currently smoke, 
and women who are recent ex-smokers. There is also a clear gap in the literature for 
understanding how the introduction of e-cigarettes over the past decade may have 
influenced or affected the number of women smoking and breastfeeding postpartum.  
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Currently, no published work has explored whether women are using e-cigarettes while 
breastfeeding. There is a need to understand whether women are using e-cigarettes 
postpartum, and what may motivate, or be a barrier to their use. As e-cigarettes are 
very novel products, there may be specific challenges that these women face. Given e-
cigarettes do not contain most of the toxicants present in cigarettes that may transfer to 
breastmilk, there may be differences, depending on their knowledge of e-cigarettes, in 
how women view their use during breastfeeding. 
There is also currently no literature that considers the barriers and motivators that may 
impact the decisions mothers who vape make regarding whether or not to breastfeed. 
Research has also not explored the experiences of vaping mothers postpartum and 
how this may affect how they feed their babies. There is a need to understand whether 
using e-cigarettes to protect against a lapse in smoking is acceptable to new mothers 
and how acceptable they are to use as a breastfeeding mother.  
Establishing the above issues would create the necessary background literature 
needed for developing possible future interventions using e-cigarettes, for reducing 
postpartum smoking and increasing the number of women breastfeeding in the UK.  
 
2.2 Philosophical foundations & mixed methods approach 
In health and social science research, there are two distinct research strategies; 
quantitative and qualitative [315, 316]. Both strategies are underpinned by different 
ontological and epistemological positions that exist on opposite ends of the spectrum 
[316]. A positivist philosophical approach is taken with quantitative research, rooted in 
the realist ontological perspective; the belief that reality is ontologically independent of 
human minds [317]. The positivist epistemology is based on objectivism; that facts exist 
objectively and are therefore discovered and not constructed, and the researcher is an 
independent observer [318]. Therefore there is an objective truth that exists and can be 
discovered. Positivism focuses on facts, causal relationships, and the falsification of 
hypotheses. This assumes that psychological and social phenomena can be studied 
using objective, scientific methods that result in context-free generalisations [317]. 
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Qualitative research, on the other hand, has a relativist ontological position and is 
rooted in social constructivism and interpretivism [318]. In this epistemological stance, 
it is believed that reality does not objectively exist but is constructed from a person’s 
interaction and shared social experiences, and thus, multiple-realities may exist [319]; 
therefore there is no ‘truth’, and indeed our understanding of what exists is constructed 
form our experience of natural phenomena  Rather than being concerned with the 
falsification of hypotheses, this approach is more concerned with gaining a deeper 
understanding of the human experiences related to the phenomena being investigated 
[320, 321].   Unlike positivism, this is underpinned by the epistemology of subjectivism. 
Rather than an objective observer, the researcher is an integrative part of the research 
[319, 320]. Therefore the understanding of the phenomenon studied is constructed 
based on interpretations of interactions between participant and researcher [316, 319, 
320].  
It may be argued that as these approaches come from such opposing philosophical 
positions, they are not compatible and should not be mixed [316]. However, research 
has recognised there are benefits to  incorporating a flexible and mixed approach, which 
can counteract the limitations of using a singular approach arising from the limitations 
of each methodology [322]. For example, whilst quantitative research does attempt to 
account for context and environment, it is often in a controlled and limited way. This can 
mean that the complexities of the environment within which the phenomena occur are 
not fully considered, nor are the underlying motives, perceptions, and experiences that 
may underpin or influence how the phenomena is lived [322]. While qualitative research 
allows in-depth exploration of experiences, perceptions, and motivations, this approach 
is susceptible to methodological flaws such as researcher bias, low reliability, and the 
inability to generalise findings [316, 322]. Whilst qualitative research does attempt to 
reduce these limitations, such as the use of reflexive accounts and second coding, 
limitations persist. For this thesis, a stance of critical realism will, therefore, be taken. 
Critical realism is positioned between the positivist and interpretivist paradigms; it 
accepts there are objective realities but also recognises that our knowledge of the world 
is relative to who we are and how we acquire our understandings [323, 324]. The 
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position of critical realism lends itself well to methodological triangulation in research, 
where the objective is to increase confidence in findings via confirmation of a research 
question using two or more independent measures [325].   
As described in the rationale, there is a need to explore any association between 
breastfeeding and smoking in the UK and the use of e-cigarettes postpartum. Collecting 
data in a quantitative format gives an overall, generalizable picture of the phenomenon. 
To then explore the opinions on breastfeeding in relation to e-cigarettes, and to further 
explore the experiences, barriers and facilitators for breastfeeding as a smoking mother, 
a qualitative approach is more appropriate. This is due to the need to explore the 
phenomenon in the context of the women’s lived experiences, which are constructed 
by societal expectations and shared knowledge. It is important to ensure the 
methodologies complement one another and that equal importance is afforded to each 
study, regardless of data collection and analytic methods. Therefore as outlined by 
Singh [326], in this thesis, the philosophy and methodology were considered in a holistic 
context that integrates the overall research [326]. 
 
2.3 Aims of research 
This thesis aims to explore how women use e-cigarettes during the postpartum period 
and how acceptable they are for breastfeeding mothers. This will involve exploring 
associations between smoking and breastfeeding in a sample of UK mothers. This 
thesis will aim to understand if, and how, e-cigarettes are currently being used during 
the postpartum period and how this may relate to breastfeeding. It will also consider 
what barriers or facilitators for switching to e-cigarettes are. It will be important to 
understand how women form their opinions on e-cigarettes and where they source 
evidence and advice. If women are using e-cigarettes, this thesis will also look at why 
they are using them, for example, are e-cigarettes being used as an alternative to 




 To understand whether there is a relationship between smoking and  
breastfeeding within a sample of smokers, ex-smokers, and vapers 
 To describe the characteristics of women who breastfeed, smoke and/or vape 
postpartum 
 To explore women’s current usage, understanding and opinions of e-cigarettes 
in relation to breastfeeding 
 To explore the barriers and motivators to breastfeeding as a smoking/vaping 
mother 
 To explore the motivators/barriers for using e-cigarettes, as an alternative to 
smoking, in the postpartum period 
 To explore the acceptability of using e-cigarettes as a breastfeeding mother  
 
2.4 Methods 
The methods used to meet the aims and objectives outlined in 2.3 are detailed below. 
These will form three separate studies as part of the PhD, and the findings from all three 
studies will then be collated to answer the overall question posed: are e-cigarettes an 
acceptable alternative to smoking for breastfeeding mothers? 
 
2.4.1 Study one: Determining the characteristics of women who smoke, 
vape and/or breastfeed: a quantitative analysis 
To determine if smoking and breastfeeding are negatively associated, irrespective of 
socio-demographics and characteristics, data from the Pregnancy Lifestyle Survey will 
be analysed. Three surveys (early pregnancy, late pregnancy, and postpartum) will 
collect quantitative data about basic demographic information, smoking/vaping status, 
breastfeeding status, and health beliefs/opinions on smoking and/or vaping as a 
breastfeeding mother. This study will recruit smokers, vapers, dual users and women 
who have quit smoking during, or just prior to, pregnancy. Chi-squared analysis will be 
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used to test for associations, and logistic regression analysis will be used to explore 
any independent associations between smoking and breastfeeding. Copies of the 
questionnaires are found in appendix 3.1, 3.2 and 3.3. This study is described in detail 
in Chapter 3. 
 
2.4.2 Study two: Is it safe to vape whilst breastfeeding? Postpartum 
women’s opinions on e-cigarettes, using online forum discussions: a 
qualitative analysis 
Online forum discussions from popular parenting websites will be analysed qualitatively 
to explore opinions, current use, knowledge, and sources of knowledge about e-
cigarettes in relation to breastfeeding. Google searches will be used to identify 
discussions around vaping and breastfeeding, which will then be analysed using a 
template approach to thematic analysis. A template approach will be used as the 
original discussions were not created for the purposes of this research. Thus a priori 
codes will help to focus the analysis on answering the research question. The a priori 
codes are ‘Using e-cigarettes postpartum’; ‘health beliefs (e-cigarettes and 
breastfeeding)’; ‘Opinions (on e-cigarettes)’; ‘Information (seeking and giving)’; 
‘Evidence (sources)’. These codes will be modified and expanded through an iterative 
process, and new codes added as and when they emerge. The full details of this study 
are described in Chapter 4. 
 
2.4.3 Study three: Smoking and Vaping postpartum – results from an 
online survey about experiences, beliefs and infant feeding choices 
Qualitative online surveys will be designed and distributed to explore the motivators and 
barriers to breastfeeding as a smoking and/or vaping mother, motivators, and barriers 
to vaping postpartum and assess the acceptability of using e-cigarettes as a 
breastfeeding mother. The survey will be distributed using Facebook adverts and 
adverts on online parenting forums, recruiting between 80-120 women who are aged 
18 years or above, who smoke and/or vape and have an infant aged 18 months or 
59 
 
younger. Responses will be analysed thematically; this study is described in detail in 
Chapter 5. 
 
2.5 Reflexive statement for qualitative chapters 
For qualitative research, the data is mediated through the researcher. Therefore the 
preconceived ideas and experiences of the researcher may introduce bias into the work. 
As per the consolidated criteria for reporting qualitative research (COREQ) guidelines 
[327], the personal characteristics of the researcher will be disclosed in this section, 
enabling the reader to understand the perspectives of the researcher while interpreting 
the results. As critical realism highlights the need to distinguish the subjectivity of the 
researcher, the beliefs and pre-existing biases of the researcher should be considered 
when interpreting the results [318, 328]. 
Characteristics of the researcher: I am a female mother of two children, aged 3 and 8 
at the time of study two (Chapter 4) and aged 4 and 9 at the time of study three (Chapter 
5). I have a BSc in Psychology, MSc in Health Psychology, and am nearing completion 
of a PhD conducted within the Smoking in Pregnancy Research Group at the University 
of Nottingham. The research group is situated within the UK, and the health authorities 
(Public Health England) stance on e-cigarettes is that using an e-cigarette is safer than 
smoking for people who are unable to quit unaided or quit using Nicotine Replacement 
Therapies and/or behavioural support. This stance could potentially influence the views 
of all the researchers on the team. I am an ex-smoker who, at the time of this research, 
is using an e-cigarette to remain smoke-free, as I had done for the previous three years. 
I grew up with one smoking household and one non-smoking household, in a high 
poverty area where smoking was normal behaviour. I began smoking at a young age, 
having been given cigarettes by an adult within my family. I struggled to quit smoking, 
except for when pregnant, although I returned to smoking at roughly nine months 
postpartum. At 21yrs old I was diagnosed with cancer of the bladder, I knew this type 
of cancer could possibly be linked to smoking, however even such an alarming health 
scare did not put me off enable me to quit. I breastfed both my children exclusively until 
6 months, and alongside supplementary food and drink until they self-weaned at around 
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3yrs. When my eldest child was six months, I volunteered as a breastfeeding peer 
support worker for a period of four years. In the area I grew up breastfeeding was not 
the norm, and I did struggle with breastfeeding initially, particularly with being able to 
breastfeed in public. 
With my own personal experiences, I was already aware of my reasons for returning to 
smoking postpartum. When my children reduced the amount of breastfeeds, they 
needed, going back to University/work and the associated stresses, and also that of 
being a young mother and wanting to maintain my identity within my friendship circle. 
In my working life, I have worked in two industries that relate to this thesis. The first was 
as a marketing manager and consultant. I wrote, under a pseudonym, for two parenting 
forums that are both used within Chapter 4. This meant I already had a good working 
knowledge and understanding of how these forums operate. I had to ensure that when 
writing up the research for Chapter 4, I wrote it in a way that non forum users could 
understand. This involved expanding on all abbreviations. The second industry was 
working in palliative care, working with end of life patients. As part of this work I saw 
people with illnesses directly related to smoking; seeing patients suffering from 
respiratory distress and still attempting to smoke whilst attached to oxygen tanks really 
piqued my interest in smoking cessation research. 
 At the start of this research, my beliefs were that breastfeeding was crucially important 
regardless of whether a mother smoked or vaped and that e-cigarettes were a safer 
form of nicotine delivery. Being aware of my experiences and beliefs I found I had to be 
conscious of transferring my own experiences and opinions on to the data analysis 
process. Throughout the process, I attempted to give equal weight to views opposing 
those of my own. In both qualitative studies, I used a second coder to offset any 
personal biases.  
The second coder for study two (Chapter 4) was Dr Katarzyna Campbell (KC) (PhD, 
MSc Health Psychology), a research fellow with the Smoking in Pregnancy Team at the 
University of Nottingham. KC has experience of qualitatively analysing forum data, and 
KC is a never smoker/vaper. For study three (Chapter 5) the second coder was Lucy 
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Phillips (LP) (MSc Health Psychology, BSc Psychology), LP is a research assistant with 
the Smoking in Pregnancy Team at the University of Nottingham with experience of 
qualitatively analysing data, who is a never smoker/vaper. Both second coders hold the 
belief that breastfeeding is best even if for a short amount of time, and believe 
smoking/vaping mothers should be encouraged to breastfeed but with adequate harm 








Chapter one has discussed the characteristics of women who breastfeed (1.2.4) and of 
women who smoke postpartum (1.1.3.3), but much of the recent literature on smoking 
in relation to breastfeeding concerns mothers in the USA [329] or Turkey [330]. What is 
not currently known are the characteristics of women who breastfeed, and those who 
smoke within the UK. To explore ways of reducing smoking postpartum, and increasing 
breastfeeding rates within the UK, we must first be able to describe the current situation, 
which includes the characteristics of women who smoke, breastfeed and/or vape. 
As discussed in chapter one, smoking is reportedly negatively associated with 
breastfeeding (1.3). There are shared demographics that may explain the association 
(1.3.1.2); however, there may be alternative explanations (1.3.1.1 and 1.3.1.3). 
Whether there is an association which is independent of confounding factors such as 
age and education is unknown for the current UK situation. Hence there is a need to 
explore this with a sample of UK mothers.  
As well as limited research on smoking and breastfeeding in the UK, there is currently 
no literature that considers the use of e-cigarettes. Research has begun to look at the 
use of e-cigarettes (or e-cig/vapes) during pregnancy [269, 278, 331-335], with some 
consideration for their use postpartum [270, 278]. However, the characteristics of 
mothers who use them and how this relates to breastfeeding behaviour is currently not 
known. Women's opinions toward using e-cigarettes when breastfeeding are also 
unknown. However, literature on women’s beliefs and opinions towards smoking as a 
breastfeeding mother does exist [162]. 
In previous literature, most studies have been cross-sectional, including never smokers 
and those who haven’t smoked for a long time [137, 139, 150]. Looking at longitudinal 
data on a group who have all smoked recently, just before or during pregnancy, 
provides the opportunity to look at predictors of their smoking behaviour in the 
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postpartum period, and is sufficiently large and recent to explore predictors of vaping 
as well. This data from pregnancy through to the postpartum period allows us to explore 
how this may relate to breastfeeding. Therefore this chapter will describe characteristics 
using a sample of smokers, recent ex-smokers and vapers in relation to breastfeeding, 




The overarching aim of this research is to be able to describe the characteristics of 
women who were part of the Pregnancy Lifestyle Survey cohort, from the birth of their 
infant to three months postpartum. Specifically, the aim was to: 
 To describe the demographics of women who are breastfeeding 
 To describe the demographics of women who smoke and/or vape 
 To understand the relationship between breastfeeding and smoking in this 
population  
 To test if this relationship is independent of demographic factors 
 To explore for the first time breastfeeding behaviours in women who vape  
 To describe the beliefs women have about smoking/vaping and breastfeeding  
 
 3.3 Methods 
3.3.1 Study design and recruitment 
This study was part of the ‘Pregnancy Lifestyle Survey: a multi-centre longitudinal 
cohort survey of smokers, recent ex-smokers and vapers during pregnancy and 
postpartum’ study. Women aged over 16 years old, who were 8-24 weeks pregnant, 
and attending National Health Service (NHS) hospital antenatal clinics between June 
and November 2017 were asked to complete a screening survey about their vaping and 
smoking status. Those who reported that they were recent ex-smokers (who had quit 
<3 months prior to pregnancy) or who currently smoked and/or vaped were invited to 
complete the full survey, plus two additional follow up questionnaires in late pregnancy 
and postpartum. This study looked at breastfeeding intentions and initiation, which were 
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measured in the two follow-up questionnaires. A £10 high street shopping voucher was 
offered to women for completing each survey (a total of £30 if all questionnaires were 
completed).  
Purposive non-probability sampling was used by selecting 17 hospital sites, with varying 
smoking in pregnancy rates, from across England and Scotland for recruitment. A 
research midwife/nurse systematically handed out a screening survey to all pregnant 
women attending various antenatal clinics (including specialist) at each site. Each 
hospital was asked to recruit approximately 44 women into the study. A unique identifier 
was given to women who completed the full survey after they gave contact details; these 
were cross-matched by a member of the research team to ensure each woman 
completed the survey only once.  
Of the 3360 mothers who were eligible to complete the initial screening survey, 1024 
were recent ex-smokers/current smokers and/or vaped. A total of 867 women 
completed the baseline questionnaire, 392 completed follow-up 1 (late pregnancy), and 
415 completed follow-up 2 (postpartum) – full details of recruitment numbers are shown 
in Figure 3.1Error! Reference source not found.. 
Follow-up questionnaires were sent by post at 34 weeks gestation, and three months 
postpartum; for women who provided an email address the survey made available 
online using JISC (formerly Bristol Online Survey Tools) and sent to them via a unique 
link. Participants were also sent an SMS as a prompt to enhance response rates. If a 
participant did not respond to the initial surveys sent out, a reminder was sent via post, 
text and/or email, and, if there was still no response, a member of the research team 
telephoned and offered the opportunity to answer all questions over the phone. Before 
sending out the follow-up surveys, hospital staff were contacted to check medical 
records for accurate delivery dates and to ensure questionnaires were not sent 





Figure 3.1: Consort diagram 
 





3.3.2 Ethics and funding 
This work is part of the Pregnancy Lifestyle Survey, a study funded by Cancer Research 
UK, Tobacco Advisory Group Project (Grant number C53479/A22733). Ethical approval 
was granted by the South West Frenchay Research Ethics Committee, and a patient 
public involvement panel was involved in the study design. Full details of the original 
study are in the protocol [336] and Research Registry database [274]. 
 
3.3.3 Survey content and measurements   
The first survey was divided into two parts: the screening survey and the full survey 
(baseline – appendix 3.1). The screening survey asked women about their gestation, 
age and whether they had previously completed the questionnaire. Women were then 
asked about their smoking (cigarette only)/vaping status; women were either current 
smokers, ex-smokers (stopped smoking more than three months prior to finding out 
they were pregnant) or recent ex-smokers (quit smoking less than three months prior 
to finding out they were pregnant. Women were also asked if they vaped (either used 
daily, or used occasionally), had never vaped (never heard of vapes, or heard of them 
but never tried) or were ex-vapers. 
The full survey asked questions about women’s views and experiences of e-cigarettes; 
this included future intentions about e-cigarette use and attitudes and acceptability of 
using e-cigarettes during pregnancy. Participants were also asked more detailed 
questions about their smoking behaviour, and demographic information was collected. 
In follow-up 1 (FU1 – appendix 3.2) and follow-up 2 (FU2 – Appendix 3.3: Pregnancy 
Lifestyle Survey Follow-Up two 3.3), women were asked about their vaping at the time 
of the questionnaire, at the time of delivery, and the first three months after their baby’s 
birth (FU2 only). The options were: not at all; only used once or twice; used occasionally, 
but less than weekly; used daily, but less than once a week; used every day. Women 
were then asked if anyone the woman knew felt they should use e-cigarettes either 
during pregnancy (FU1) or postpartum (FU2). Participants were asked about their 
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views, attitudes and acceptability of using e-cigarettes during pregnancy (FU1) or 
postpartum (FU2), and the safety of using them. This was measured using a 7 point 
Likert scale (ranging from strongly disagree to strongly agree).  
Some of the reasons people give for using e-cigarettes in pregnancy (FU1) or 
postpartum (FU2) were listed, and participants were asked to select one from the list 
as being the most important reason for using e-cigarettes, and then asked to select any 
of the other reasons they felt were important. The same format was used with some 
reasons people may give for not using an e-cigarette during pregnancy (FU1) or 
postpartum (FU2). Participants were also then asked about their intended use of e-
cigarettes in the future, and those who did use e-cigarettes were asked about their use, 
device type, e-liquid preferences, and reasons for use, satisfaction and comparison to 
e-cigarettes. 
The questionnaires then focused on feeding intentions, and feeding practices (FU2), 
the options were; breastfeed only (from breast or expressed milk via bottle); formula 
feed only; combine breastfeeding and formula feeding; unsure. In FU2, further 
questions were asked relating to feeding, including how old an infant was when they 
last received any breastmilk (if formula feeding at the time of the questionnaire). 
Attitudes and opinions towards using e-cigarettes as a breastfeeding mother were 
measured with a 7 point Likert scale (ranging from strongly disagree to strongly agree). 
Participants were then asked about their smoking status: not at all; occasionally, but 
not every day; every day, but cut down during pregnancy (FU1)/less than during 
pregnancy (FU2); every day, the same as before pregnancy (FU1)/same as pregnancy 
(FU2); every day, but more than before pregnancy (FU1)/ more than during pregnancy 
(FU2). In FU2 women were also asked about their smoking in the week prior to birth 
and for those who did smoke, how soon after birth did they have their first cigarette. 
Women were also asked about their future intentions to quit smoking, what support (if 
any) they would use to enable a quit attempt, and how many cigarettes they smoked. 
Demographic questions asked about ethnicity, educational attainment, and the age 






The primary outcome measures were; breastfeeding intentions and behaviour, and 
smoking/vaping status. Women were categorised as “never breastfed”: women who 
reported their infant never received any breastmilk, and “ever breastfed”: women 
reported the infant had received at least some breastmilk. At FU2, women who reported 
any breastfeeding were classified as ‘breastfeeding’ Smoking and vaping status were 
categorised as “Ex-smoker”: women who identified they were neither smoking nor 
vaping, “Smoker”: women who reported smoking (daily or occasionally) but were not 
currently using e-cigarettes, “Exclusive vapers”: who currently used an e-cigarette but 
did not currently smoke, and “Dual users”: who currently used an e-cigarette (daily or 
occasionally) and also smoked cigarettes (daily or occasionally).   
Maternal characteristics, smoking and vaping behaviour, breastfeeding (intention and 
initiation) were all analysed using descriptive statistics. Cross tabulations with Chi-
Square statistics were performed using Stata/SE 16 to explore any differences in 
breastfeeding intention and initiation by demographic characteristics (age, ethnicity and 
education), and by smoking/vaping status. Multivariate logistic regressions were 
performed to assess the associations between smoking and breastfeeding, 
independent of significant demographic confounders. P values were deemed significant 
if they were less than 0.05. 
 
3.4 Results  
3.4.1 Missing data 
At baseline (early pregnancy), a total of 750 women were included in the study; of those, 
62 were withdrawn from the study (outlined in Figure 3.1), leaving 688 participants. Of 
the 688, 392 returned follow-up 1, a loss of 43%. Littles Test of Missing Completely at 
Random (MCAR) [337] was performed; the results suggest the data is not MCAR 
(P<0.001). Individual tests examining missing variables showed that missing data were 
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associated with smoking status and educational levels at baseline; missing data at 
follow up 1 was more frequent amongst women who smoked at baseline, and women 
who held a GCSE level education. As missing data could not be assumed to be 
completely random, a listwise deletion method was used to manage missing variables 
[338]. 
In order to be included in the analysis, participants must have reported both their 
smoking and vaping status. For some breastfeeding variables, the total number of 
participants included differ due to whether data was reported for these variables; these 
are shown in Figure 3.2 and belowFigure 3.3. 




Figure 3.3 Follow-up 2 missing data 
 
 
3.4.1 Demographic characteristics of women who breastfed  
The demographic characteristics of the women at follow up 1 and 2 are presented in 
Table 3.1Error! Reference source not found.. Overall, at FU1 (34 weeks gestation), 
63.5% of women intended to breastfeed, with 46.35% of women initiating breastfeeding 
at birth, by three months postpartum (FU2), only 17.68% of women were still 
breastfeeding. Older mothers were more likely to commence breastfeeding at birth (p = 
0.02) and tended to be more likely to continue breastfeeding at three months (p = 
0.019). Breastfeeding was also highest amongst mothers with greater levels of 
education, intention to breastfeed (p<0.001), breastfeeding at birth (p<0.001), and 
breastfeeding at three months (p=0.019).  Due to small sample sizes within most 
ethnicity categories, ethnicity was not included in this analysis.  
In terms of smoking, vaping, and dual-use during pregnancy in relation to breastfeeding, 
ex-smokers were more likely to intend to breastfeed than smokers, vapers, and dual 
users (p<0.001). Ex-smokers were also more likely to initiate breastfeeding at birth 





Table 3.1 Baseline characteristics, and smoking status at FU1/FU2 according to breastfeeding 
behaviour 
1,2 
                                                          
1 Chi square tests for association between intention and initiation of breastfeeding, 
breastfeeding at 3 months, and demographics (at baseline) and smoking status (during 
pregnancy and postpartum) 
2 Percentages are given in rows 
 Follow up 1 Follow up 2 
Demographics 
N Intend to 
breastfeed (n (%)) 
N Breastfed 
at birth 
N Breastfed at 3 
months 
Age       
16-24 142 86 (60.0%) 120 44 (36.7%) 146 19 (13%) 
25-34 199 131 (65.8%) 169 87 (51.5%) 191 36 (18.8%) 










Missing 3   84   36   
P Value  0.602  0.024  0.178 
Education       
None 49 19(38.8%) 41 10(24.4%) 45 7(15.6%) 
GCSE 148 83(56.1%) 130 50(38.5%) 155 18(11.6%) 
A level 94 69(73.4%) 79 42(53.2%) 92 16(17.4%) 
Degree 92 73(79.3%) 77 51(66.2%) 82 23(28.1%) 
Other 4 2(50%) 3 1(33.3%) 4 0(0%) 




378 64  
(16.9%) 
Missing 5   85   37  
P Value  <0.001  <0.001  0.019 
Smoking Status       
Ex-smoker 145 111 (76.6%) 129 74 (57.4%) 88 33 (37.5%) 
Smoker 173 98 (56.6%) 133 48 (36.1%) 198 20 (10.1%) 
Vaper 17 10 (58.8%) 23 9 (39.1%) 32 8 (25.0%) 
Dual User 34 18 (52.9%) 37 20 (54.1%) 52 4 (7.7%) 






Missing 23  93  45  
P value  0.001  0.004  <0.001 
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3.4.2 Demographic characteristics according to smoking/vaping status 
The demographic characteristics, according to smoking/vaping status, are presented in 
Table 3.2Error! Reference source not found.. Although 39.3% of women in this cohort 
were ex-smokers/vapers during pregnancy, by three months postpartum, only 24.4% 
remained smoke/vape free. Age was not associated with smoking/vaping status. 
Mothers’ education was related to smoking status such that mothers with higher 
educational levels were more likely to be neither smoking nor vaping during pregnancy 
(p<.001) and at three months (p=.005).  
 
Table 3.2 Demographic characteristics according to smoking/vaping status 
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3 Percentages given in columns 










Smokers Vaper / 
dual 
users 
Age         




































Total 369 145 173 51 402 98 215 89 
Missing 23  13  
P Value 0.628 0.592 
Educati
on 
        


























































Total 366 144 171 51 401 98 212 91 
Missing 26  14  





  Smoking / vaping at follow up 1 Smoking / Vaping at follow up 2 
Demographic Total Ex-smoker Smokers Vaper Dual 
users 
Total Ex-smoker Smokers Vaper Dual 
users 
Age           








































Total 369 145 173 17 34 402 98 215 35 54 
Missing 23  13 
P Value  0.628      0.592 
Education           


































































Total 366 144 171 17 34 401 98 212 35 56 
Missing 26  14 
P Value  <0.001 0.005 
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3.4.3 Smoking, Vaping & Breastfeeding 
To test for the independent association between smoking/vaping status, and 
breastfeeding at birth, a logistic regression was performed to adjust for age and 
education. In the univariate logistic regression (Table 3.3) of the effect of smoking 
status on the outcome of breastfeeding at birth, those in the smoking category had a 
reduced odds of breastfeeding compared to those who were ex-smokers. Those who 
vaped also had reduced odds of breastfeeding, but this effect was not significant.  
Although adjusting for age and education does affect the strength of the association, 
Table 3.4 shows that women who smoke at birth have a 51% reduction in odds of 
breastfeeding at birth compared to ex-smokers (OR .480, 95% CI: .258-.890; P <0.001). 
Table 3.3 Unadjusted logistic regression for smoking status and breastfeeding at birth 
 








Z P Confidence 
Interval (95%) 
Smoking status 
     
1. Ex-smoking   - - - - - 
Smoking .425 .121 -2.98 0.002 .243 .745 
Vaping .547 .2325 -1.01 0.310 .170 1.754 







Z P Confidence 
Interval (95%) 
Smoking status 
     
1. Ex-smoking -  - - - - - 
Smoking .480 .151 -2.33 0.01 .258 .890 
Vaping .643 .416 -0.68 0.49 .181 2.287 
Dual Use .717 .347 -0.69 0.49 .277  
 
Educational level 
     
1. None - - - - - - 
GCSE 2.175 .949 1.78 0.075 .925 5.116 
A level 3.684 1.696 2.83 0.005 1.494 9.081 
Degree 5.029 2.358 3.44 0.001 2.006 12.608 
 
Age 
     
1. 16-24 - - - - - - 
25-34 2.228 .598 2.98 0.003 1.316 3.770 
35+ 2.538 1.025 2.31 0.021 1.150 5.599 
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As educational level was the only demographic to be significantly associated with 
breastfeeding and smoking status at three months postpartum, a logistic regression to 
check for an independent association between smoking and breastfeeding was 
performed adjusting for educational level. Smoking remains highly significant for the 
likelihood of breastfeeding at three months, even when adjusted for educational level 
(OR .190, 95% CI: .099-.367; P <0.001). 
Table 3.5 Unadjusted logistic regression for smoking status and breastfeeding at 3 months 
postpartum 




Std. Error Z P Confidence Interval 
(95%) 
Smoking status     
1. Ex-smoker - - - - - - 
Smoker .187 .060 -5.19 <0.000 .099 .352 
Vaper .556 .257 -1.27 .205 .224 1.38 
Dual user .139 .078 -3.49 .000 .046 .420 
 
Table 3.6 Smoking and breastfeeding status at 3 months, adjusted for education 




Std. Error Z P Confidence Interval 
(95%) 
Smoking status     
1. Ex-smoker - - - - - - 
Smoker .190 .063 -4.96 <0.000 .099 .367 
Vaper .568 .272 -1.18 0238 .222 1.45 
Dual user .157 .090 -3.24 .001 .051 .482 
 
Educational level      
1. None - - - - - - 
GCSE .563 .286 -1.13 0.258 .208 1.523 
A level .823 .428 -0.38 0.708 .296 2.283 






3.4.4 Health beliefs 
Health beliefs, according to smoking category and overall, are presented in Table 3.7. 
The following health belief statements were given to participants who were asked to 
state whether they disagreed, agreed or neither disagreed/agreed with the belief. The 
results suggest women believe vaping mothers should breastfeed more than they agree 
smoking mothers should, however mothers did not agree that using e-cigarettes when 
breastfeeding was safe. However responses, varied significantly by smoking status for 
beliefs on whether woman should breastfeed if she smokes (p<.001) or uses e-
cigarettes (p<.001). Smokers were also less likely to agree that e-cigarettes were safer 
for breastfeeding than smoking (p=.013). 
Table 3.7 Health beliefs by smoking status 
Belief / 
Smoking status at 3 months 
Total Disagree Neither 
 
Agree 
‘Mothers should not breastfeed if they smoke 
tobacco cigarettes’ 
348    
























P value     <0.001 









Mothers should not breastfeed if they use e-
cigarettes 
336    


























P value     .000 











Belief / Smoking status at 3 months Total Disagree Neither Agree 
Using e-cigarettes when breastfeeding is safe 
for the baby 
316    






















P value 4, 8.02    .091 









Using e-cigarettes when breastfeeding is as 
safe for the baby as nicotine patches 
324    
























P value     .329 
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If a mother breastfeeds, it is safer for the baby 
if she uses an e-cigarette than if she smokes 
tobacco cigarettes 
338    
























P value     .013 











3.5.1 Key findings 
Despite 63.9% of mothers intending to breastfeed, only 46.35% of women did initiate 
breastfeeding, and by three months postpartum, only 17.68% of mothers were still 
breastfeeding. Mothers who were older and/or had higher levels of education were more 
likely to initiate and continue breastfeeding. Age was not associated with smoking 
status; however, women with higher levels of education were more likely to remain 
smoke-free throughout pregnancy and the postpartum period. Those who did remain 
smoke-free were more likely to intend to, initiate, and continue to breastfeed compared 
to mothers who smoked and/or vaped. When taking in to account age and education, 
women who smoked and/or vaped were still less likely to intend to, initiate, or continue 
breastfeeding compared to those who remained smoke-free. 
Overall many women held the opinion that smoking mothers should not breastfeed, 
although half of the women who smoked/vaped disagreed with this. Conversely, the 
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majority of women held the opinion that vaping mothers should breastfeed, and smoking 
women were more likely to agree vaping mothers should breastfeed, than smoking 
mothers should breastfeed. Despite this, 83% of women, including 60% of vapers, felt 
using an e-cigarette as a breastfeeding mother was not safe for the baby, and 80% 
believed nicotine patches to be safer. Overall the majority of women disagreed that it 
was safer for the baby if the breastfeeding mother vaped instead of smoked, which was 
contradictory to the earlier opinions, which were much more favourable of vaping than 
smoking. When looking at the responses to this question by smoking status, this 
contradiction may be explained by a higher percentage of smokers (who were the 
largest of the three groups) disagreeing. This question did have the highest ‘unsure’ 
responses, with around 20% of women being uncertain. 
 
3.5.2 Strengths and limitations 
This survey was the first of its kind to ask new mothers about their views and opinions 
on e-cigarettes and breastfeeding, as well as providing information on views and 
opinions of smoking and breastfeeding. By recruiting women at antenatal appointments 
target population was reached, and prospective longitudinal design enabled the follow-
up of women at three separate time points. 
This data did rely on self-reported smoking status, which has been previously shown to 
be inaccurate [339]. However, the validity of self-reported smoking is suggested to be 
more reliable when anonymous surveys are used [340], which may improve the 
reliability of the data collected in this study. 
Unfortunately, only 44.8% of the full baseline sample returned FU 1. Little’s test for 
MCAR showed that missing data was not completely random and further analysis 
showed that missing data was more frequently those who were smokers, and those 
with a GCSE education, at baseline. This may add bias to the analysis; however, 
overall, smokers were still the largest category in FU1 and 2, and GCSE level education 
was still the most prominent category for education. This will have impacted the 
prevalence of breastfeeding and smoking in both follow-up surveys. However, the 
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primary purpose of this research is to look at associations between smoking and 
breastfeeding, and associations tend to be less affected than prevalence. 
Only a small proportion of the sample were exclusive vapers. This meant that for some 
of the analysis, dual users and exclusive vapers were grouped. There are likely to be 
differences between those women who exclusively vape and those who are dual users 
that could not be further explored within this data. However, it should be noted that 
currently, no literature exists that considers any vaping (exclusive or otherwise) in 
relation to breastfeeding and smoking. Still, the small sample sizes should be 
considered when interpreting the results. Small sample sizes may mean significant 
associations are missed. So the lack of a significant association between breastfeeding 
and vaping may be due to the small number of vapers, suggesting further research is 
needed. Despite the small sample size and unequal groups, this research is the first of 
its kind. It gives us novel data on e-cigarette use in the postpartum period, as well as a 
more recent data set of smoking and breastfeeding demographics. 
3.5.3 Relation to prior work 
The women in this study initiated breastfeeding at lower rates than most recent NHS 
Maternity statistics (2017-18); 46.5% initiated breastfeeding compared to a national 
average of 74% [341]. There is no recorded statistic for breastfeeding at three months 
within the NHS Maternity statistics. However, the final Infant Feeding Survey in 2010 
[119] has statistics for four months postpartum, where 42% of mothers are still 
breastfeeding, compared to 17.7% in this sample at three months. The lower 
breastfeeding rates in this sample are likely to be due to the higher proportion of 
smokers. In this study 64.82% of mothers reporting smoking within the last 30 days at 
baseline (between 8-24 weeks pregnant), whilst the NHS Maternity statistics report 
smoking status at booking in appointment only, they recorded 14.8% of mothers 
smoking. In this sample, 46.9% of mothers were smoking in late pregnancy, compared 
to a national average of 10.8% mothers smoking at the time of delivery (1.6% - 27.8% 
range) [29]. The statistics for smoking in this study were going to be higher than the 
national average due to purposefully recruiting a sample of women who either smoked, 
vaped, or had quit smoking immediately prior to, or during early pregnancy. 
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With this in mind, when looking at just the ex-smokers in relation to breastfeeding, the 
figures are closer to the national average; 61.1% of ex-smokers initiated breastfeeding 
(compared to 74% national average) and 37.5% were still breastfeeding at three months 
(compared to 42 % at four months national average). Although these percentages are 
lower, they are much closer to the national average if smoking mothers are excluded 
from the sample. For smoking mothers, just 40% initiated breastfeeding, and by three 
months post-partum, only 10.1% were still breastfeeding. Regardless of smoking 
status, fewer women initiated breastfeeding than intended to breastfeed [342, 343]. This 
study did not consider why this may be, however previous research has identified that 
women who experience traumatic deliveries or have caesarean section deliveries are 
less likely to initiate breastfeeding at birth. This is due to insufficient milk supply, or the 
mothers need for recovery.  
Previous studies have linked both age and education to smoking and breastfeeding 
status [47]. While our results show education is associated with smoking and 
breastfeeding status and age is associated with breastfeeding initiation, the logistic 
regression shows that when adjusting for these variables, the association between 
smoking status and breastfeeding is still significant. As this sample compares 
smokers/vapers/dual users to recent ex-smokers, conclusions can be drawn that are 
not afforded by other research that just compares non-smokers to smokers. This 
suggests that by changing the smoking/vaping behaviour, we may be able to increase 
breastfeeding intentions, initiation, and duration. There were no observable differences 
between smoking and vaping/dual-use mothers; however, this may be due to the small 
sample size of vapers in this study. There may be important differences between dual-
use mothers and smoking mothers that, due to the novelty of e-cigarette research, have 
not been explored. 
The belief that women should not breastfeed if they smoke is concerning; the NHS 
advises that women who smoke continue to breastfeed [58]. Breastfeeding can mitigate 
some of the risks to an infant who has a smoking parent [344-346], so despite the 
transference of smoke constituents into breastmilk, it is important that smoking mothers 
are not discouraged from breastfeeding. In this study participants were more likely to 
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agree that women who use an e-cigarette should breastfeed, than agree women who 
smoke should breastfeed, even amongst the smoking category. Prior studies have 
shown that overall smokers, non-users, dual-users and e-cigarette users perceived e-
cigarettes as safer for bystanders (due to passive exposure) than smoking [347] which 
may account for the greater support for vaping mother’s breastfeeding. Qualitative work 
has also shown that overall new mothers do perceive vaping to be safer around infants 
than cigarettes [270]. 
Despite the majority of mothers being more likely to agree that vaping mothers should 
breastfeed than smoking mothers, when asked if using an e-cigarette was safer for 
breastfeeding than smoking, the majority of women disagreed. This may be due to a 
larger number of smokers disagreeing with this statement, and as smokers were a 
larger group than ex-smokers and vapers/dual users, this may have skewed the results. 
When looking at these responses by smoking status, over half of vapers/dual users and 
half of the ex-smokers disagreed with this statement. In a narrative literature review of 
perceptions about e-cigarettes, the majority of studies suggested people perceived e-
cigarettes to be less harmful than cigarettes. However, more recent studies within the 
review showed this perception had changed somewhat to e-cigarettes being perceived 
as equally harmful [347]. Within this review [347], it was identified that current smokers 
and non-vapers were more likely to perceive e-cigarettes to be more harmful than 
cigarettes. However, it was identified that different flavours of e-liquids influenced the 
risk perception, which we did not ask participants about in our study. Research involving 
women who had recently given birth also identified harm perceptions as a potential 
concern for mothers using e-cigarettes, citing more research was needed [270]. 
Participants in this study did not perceive e-cigarettes to be as safe as NRT (Nicotine 
Replacement Therapy). Although not much information exists on perceptions between 
e-cigarettes and NRT, one qualitative study did identify women who had successfully 
quit smoking and did not vape. This study reported women favour NRT in case of 
relapse, rather than e-cigarettes. Women viewed e-cigarettes as potentially leading 
back to smoking. Women who had never vaped or were ex-vapers also felt that NRT 




This research shows that even when we account for certain demographic variables, 
smoking is strongly associated with whether a mother intends to breastfeed, initiates 
breastfeeding and for how long she continues to breastfeed. Overall, e-cigarettes are 
viewed more positively than cigarettes. However, we still don’t fully understand what 
motivates women to use an e-cigarette, and what perceptions they have about e-
cigarettes in relation to breastfeeding. Further research is needed to consider what may 
motivate some mothers to use a vape, and others not to. We must also explore the 
harm perceptions and health beliefs about e-cigarettes. Future research should 




4. Chapter 4: Is it safe to vape whilst breastfeeding? Postpartum 
women’s opinions on e-cigarettes, using online forum 
discussions: a qualitative analysis. 
 
4.1 Introduction 
As discussed in chapter 1, maternal smoking and low breastfeeding rates are both 
significant public health concerns relating to the post-partum period, with health 
implications for both the mother and her child [101, 348-354].  
Very little research thus far has examined the use of e-cigarettes amongst postpartum 
women; the research available has focused on the use of e-cigarettes in pregnancy. 
Therefore there is a need to understand the use of e-cigarettes in the postpartum period 
and how this may relate to breastfeeding. As seen in Chapter 3, women are using e-
cigarettes during the postpartum period. While the data in Chapter 3 would suggest 
women who do use e-cigarettes breastfeed at similar rates to those who smoke, the 
sample size limits the value of this information. What was worth noting was that the 
participant sample as a whole (including smoking, vaping and ex-smoking mothers) 
were more likely to agree vaping mothers should breastfeed, than smoking mothers. 
This highlighted the potential for using e-cigarettes to reduce postpartum smoking, 
which may in turn improve UK breastfeeding rates.  
For women not initiating breastfeeding (or stopping breastfeeding) due to fears that 
smoking may contaminate breastmilk, and the concern about passive smoking due to 
the proximity of breastfeeding, the belief that e-cigarettes are safer provides an 
alternative solution. As women are more likely to agree vaping mothers should 
breastfeed, the promotion of e-cigarettes for women who cannot, or do not, want to 
remain nicotine-free seems a sensible solution.  
Due to the pressure on new mothers to appear as ‘good mothers’ [355-357], there may 
be a lack of representation of mothers who engage in behaviours that fall outside of this 
expected norm. This, along with the relative novelty of e-cig research in the postpartum 
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period, calls for an exploratory research design that reduces the influence of social 
desirability. With this in mind, an infodemic approach was used. 
Infodemiology refers to a method of conducting health-related research using the 
medium of the internet [358]; it is used for health surveillance, promotion, and the 
tracking of health campaigns. With the increasing availability of the internet, 
infodemiology is a modern way of collecting data. Infodemiology is particularly useful 
for reaching ‘hard to reach populations’ [358]. When collecting data using new mothers, 
particularly when it relates to subjects that carry a burden of stigma (breastfeeding and 
smoking postpartum), an infodemic approach can access greater populations with 
fewer biases [358]. The use of infodemic methods is also advantageous when studying 
subjects that are relatively novel, such as e-cigarettes.  
 
4.2 Aims 
The overarching aim of this study was to explore the views of women present within 
online parenting forums on e-cigarette use during the post-partum period, specifically 
in relation to breastfeeding. 
Specifically, this study aimed to: 
 
 Explore beliefs about the use of e-cigarettes during the postpartum period  
 Explore beliefs about the use of e-cigarettes by breastfeeding mothers 
 Understand how, and where, women are getting the information to form these 
beliefs about e-cigarettes use 









4.3.1 Data Collection 
As discussed, an infodemic approach was utilised for this research. Infodemiology 
allows for exploratory research of novel health related topics, and is particularly 
advantageous for stigmatised behaviours amongst ‘hard to reach’ populations [358]. 
Practically, infodemic research also allows for a wider range of opinions to be included 
in research; in this study parenting forums were used to provide opinions of many 
women across the UK [358]. Qualitative analysis of discussions on online parenting 
forums has been previously used to explore a range of context-specific behaviours, 
attitudes and beliefs [359, 360]; including the use of e-cigarettes (e-cigarettes) during 
pregnancy [269]. Plus, with the novelty of researching e-cigarette use in relation to 
breastfeeding, the lack of literature provides no framework for the design or 
implementation of other qualitative methods. This research involved collecting data 
publically posted to online parenting forums. 
Inclusion criteria:  
Due to varying guidelines between countries on e-cig use, only UK based forums were 
used. The eligibility for the inclusion of a thread (a continuous discussion on a forum) in 
the final analysis was: 
 It was posted to a forum which is open to public use, without the need to sign 
up/log in to read posts – for ethical purposes 
 It was posted to parenting forums not affiliated with vaping or tobacco 
companies – to reduce bias 
 It contained a minimum of four unique contributors to the discussion – to ensure 
maximum transferability 
 Discussions that included the mention of e-cigarette use/vaping and 
breastfeeding – in order to meet the aims of the research 
Search strategy for data collection:  
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The keywords for e-cigarettes (Table 4.1) were combined using operator “AND” with 
keywords for breastfeeding, and searched using the search operator; a Google-based 
command to filter results; “site:sampleforum.co.uk” via Google search engine.  
The use of search operators, or search parameter, involves a string of 
characters/phrases designed to narrow the focus of an online search. This was the most 
effective and thorough way to ensure relevant discussions were obtained, while ignoring 
forums owned by specific groups who may have competing interests, such as e-cig 
manufactures or tobacco companies. These sites were identified by screening of the 
URL name and home page. 
Table 4.1 Keywords 














A total of 597 google results were returned using the above search terms; searches 
were then adapted to exclude ‘pregnancy’ and ‘TTC (trying to conceive)’ in line with the 
aims of the research. The threads used in the analysis were then transferred into 
NVivo11. 
In the analysis, abbreviations within quotes were expanded in squared brackets, and 
the data source is identified by T (thread), and the numbered data set. 
 
4.3.2 Ethical considerations  
There are distinct ethical considerations when utilising forum data for research 
purposes, the main concern being the inability to gain informed individual consent. 
However, this was not deemed necessary as the data were publically posted on a large 
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forum [361-364]. The British Psychological Society (BPS) The BPS has published 
guidelines on internet-mediated research. This can be separated into four distinct sets 
of principles [365]; Respect for the Autonomy, Privacy and Dignity of Individuals and 
Communities, Scientific Integrity, Social Responsibility, and Maximising Benefits and 
Minimising Harm.  
To maintain respect for participant’s autonomy, privacy, and dignity (and that of the 
virtual community as a whole), only forums with a large number of members were used. 
This is because comments on large public forums are less identifiable than those on 
smaller, private online communities [366] (for this research, a large forum was defined 
as forums with over 1,000 members). Furthermore, all contributing users were randomly 
assigned a new name to protect their identity. Names of people, places, and institutions 
were removed from quotes, and quotations were corrected for spelling and kept brief to 
reduce the possibility of them being traced back to the original poster. 
Maintaining a high degree of scientific integrity is vital when using forum data; the risk 
of researcher bias is one to be considered. For example, as the data has been created 
as part of a discussion not intended for research, the final results must reflect an 
analysis of the discussions, not merely the interpretation of the researcher and the pre-
existing biases they may hold as a result of their research interests. To acknowledge 
this, a reflective journal was kept during data collection, the formation of a priori codes, 
and the construction of the coding template. A second coder was also used to 
independently analyse a portion of the data to reduce the risk of biases. The validity of 
the data remains an ongoing issue for any research utilising forum data; the ability to 
know for certain if the real person behind the online avatar is indeed a breastfeeding 
mother who smokes is not afforded to this type of research. Specific measures can be 
employed to reduce this risk; for example, in this study, data from any forums 
associated with e-cigarette or tobacco companies were not used, and all data collected 
was screened. Despite this apparent limitation, the benefits of using an infodemic 
approach for this research were deemed to far outweigh the limitations. 
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When considering social responsibility, it is important to consider whether the research 
procedures and dissemination of the research may disrupt or harm the virtual 
community as a group; i.e. a loss of anonymity. To minimise this, only data from 
publically accessible forums, where users are made aware during the initial sign up 
process that all posts are open to public access, were used [367]. Also, as the two 
parenting forums used in this research have been used in prior research [269], and both 
virtual communities have a newsletter and magazine for which comments and 
discussions may be published, the risk of harm to the virtual community was deemed 
to be minimal. Finally, with the health implications of smoking postpartum and low 
breastfeeding rates being a threat to the long and short term health of both mother and 
baby, the benefits of this research can outweigh the minimal risk of harm. 
Ethical approval was obtained from the University of Nottingham Medical School 
Research Ethics Committee.  
 
4.3.3 Analysis 
Template analysis (a template approach to thematic analysis) was used to analyse the 
data, following the guidelines outlined by King [368, 369]. There are six stages to 
performing a template analysis; Familiarisation with the data – reading through the 
transcripts (or a subset of transcripts for larger studies); Preliminary coding with (if 
applicable) a priori codes; Initial coding template design; Application of the initial 
template to the data, allowing for modifications as and when they arise; Continued 
modification of the template through iteration; and Application of the final template to 
the full data set. When analysing large online support group datasets, template analysis 
is useful for comparing the perspectives of different contributors. 
The use of a priori codes permits the analysis of the textual data that had been produced 
for ‘a different purpose in a different context' [369]. The use of a priori codes can be 
used when there is the assumption that certain aspects of a research question should 
be focused on; for this research the data collected was not generated to specifically 
explore the research question, therefor, the a priori codes were used to focus the 
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analysis on addressing the needs of the research aims. The a priori codes in this study 
were: Using e-cigarettes postpartum, health beliefs (e-cigarettes and breastfeeding), 
Opinions (on e-cigarettes), Information (seeking and giving), and Evidence (sources). 
It is important to note that a priori codes are tentative and may be removed or redefined 
through iteration of the coding template. In line with the guidelines this initial template 
of a priori codes was used to code each transcript, with codes being continually modified 
or expanded, by Emily Johnston (EJ). After the last transcript was coded, a subset of 
transcripts was then coded by Dr Katarzyna Campbell (KC), one of the PhD supervisors 
with experience in qualitative analysis of online forum data, any disagreements were 
resolved via discussion allowing for final modifications and amendments until the coding 
and themes were finalised, a final version of the template was then used to re-code all 
transcripts (Table 4.2), and a mind map was also created to show integrative 





Table 4.2 Final coding template 
1st level 2nd level 
Evidence The sharing of evidence from various 
sources to support the argument for the use 
of E-cigarettes or the dis-use of them for 
breastfeeding mothers. 
Anecdotal Evidence is presented from personal opinions, or through the sharing of non-
scientific articles. May include online sources which are not government certified 
authorities on health, or media stories 
Professional Evidence is presented from scientific sources or from health professionals. It may 
be that the health professional quotes do not support the scientific knowledge, but 
will still be reflected here as an authority on health. Online sources such as NHS 
based sites will be included here, as well as academic citations. 
Lack of evidence  Asserting that conclusions cannot be drawn due to the lack of relevant evidence. 
This may include accepting recent evidence, but wanting long term evidence, or not 
accepting enough evidence to make an informed choice. 
Social Support Includes areas of support such as online 
groups, messages of support and the 
sharing of personal experiences of both 
smoking, quitting, remaining smoke free 
and relapse 
Advice: seeking and giving Asking for advice and recommendations as well as giving advice and 
recommendations. Unlike the evidence category this is based on personal opinion, 
experience or recommendation from others. 
Validation to use or not use The behaviours and opinions of others validate a woman’s choice to vape and 
breastfeed or choice not to. May cause divisions in the posters. 
Judgement May be of self or of others – includes feelings of shame, embarrassment or concerns 
about the ability to be a good mother. May also include comments designed to 
shame mothers who vape or project own parenting ideals on to others regarding 
vaping and breastfeeding. 
Breast Milk & 
transference 
Discussions of the impact of smoking, 
vaping and NRT on breastmilk in terms of 
composition and what enters milk 
Nicotine & infant health May include health effects of nicotine on infants, or the presence of nicotine in milk. 
Reducing the risk Mediating any perceived risks of breastfeeding a vaping by modifying vaping 
behaviour 
Vaping & breastfeeding Vs 
Smoking & breastfeeding 
Comparing the two behaviours either as a way of justifying the use of one or arguing 
the safety of one. 
Risk to health Discussing the concept of ‘risk’ involved in 
using ENDS as a new mother. Discussions 
of the safety of e-cigarettes and potential 
health implications of use. 
A justified risk Balancing up the perceived pro’s & cons of vaping and breastfeeding, or justifying 
the use of an e-cig in a way to still adhere to ‘good mother’ roles. 
Infant health Discussions on possible positive or negative health implications of vaping as a 
breastfeeding mother on the infant. 
Mothers health Includes health effects for the mother- positive and negative, as well as discussions 
around addiction 
Mediate the risk Modifying behaviour or taking action to mediate any perceived risks that are non-
specific to breastfeeding 
Use Exploring how women are using e-
cigarettes and what the motivations are for 
use 
Relapse prevention E-cigarettes as a tool for reducing the risk of relapse to smoking 
Quitting As a tool to quit smoking 
Motivation for use Context-specific triggers for use and the concept of identity and choice 





Of the eight parenting forums identified, two met the inclusion criteria. 
Following the search method outlined, a total of 95 google results (discussion threads) 
were screened for inclusion; 39 were duplicate results and 46 did not meet the inclusion 
criteria, leaving a total of 10 results to be analysed (Table 4.3).  
Table 4.3 Threads (T) for analysis 
Thread 
number 
Opening post title Website Sub-group 
heading 
Comments 
T1 Vaping whilst Breastfeeding? Babycentre Vapers Lounge 13 
T2 Ecigarette and breastfeeding 
:( 
Babycentre June 2016 Birth 
Club 
6 
T3 Smoking while 
breastfeeding? 
Babycentre September 2015 
Birth Club 
19 
T4 Does anyone vape? Babycentre October 2015 Birth 
Club 
10 
T5 Today I am.. Babycentre February 2015 
Birth Club 
48 
T6 (AIBU?) To smoke an 
electronic cigarette whilst 
breastfeeding? 




T7 (AIBU) To use the vape? For 
friend? 




T8 (AIBU) To use electronic 
cigarettes even though I'm 
BF? 




T9 (AIBU) To ask DH to stop 
vaping? 




T10 (AIBU) To not give up 
smoking just yet? 





Four main themes were identified within the transcripts: use, perceived risk, social 
support, and evidence.  
 
Use (preventing relapse, quitting smoking & motivation for use): 
Women were using e-cigarettes postpartum in a variety of ways and for a variety of 
purposes. Some reported using them to prevent relapse; describing cravings that 
93 
 
returned postpartum that were normally associated with specific triggers such as the 
demands of motherhood, mental health issues or relationship problems. Motivations for 
use were a separate subtheme, as motivations applied to those who had relapsed to 
smoking postpartum as well as those who had not relapsed (thus far), with women 
identifying this as a better alternative to smoking. Despite many women reporting going 
“cold turkey” throughout pregnancy, cravings were still experienced post birth which 
some women found could be alleviated by e-cigarette use: 
‘Before pregnancy I used to smoke roll ups but quit when I found out I was pregnant! 
But after giving birth I started craving badly so decided that rather than smoking again 
I would try e-cig.’ Cressida, T2 
Some women had used an e-cigarette to quit during pregnancy and continued use of 
an e-cigarette postpartum prevented them from returning to smoking. Others, however, 
did not manage to achieve abstinence during pregnancy or had already relapsed to 
smoking postpartum, whilst some had planned to return to smoking postpartum as they 
enjoyed smoking. The following quote highlights the experience of one woman who had 
already identified that she enjoyed smoking and didn’t want to lose that experience, but 
found an e-cigarette to be a suitable alternative: 
‘I didn't want to quit, I liked smoking. Bought an e-cig and did 24hrs on it and thought 
well I can't go back to smoking now. That was 9 months ago and I haven't smoked at 
all’ Sakina, T10 
As identified above, women were able to identify what motivated them to seek out an 
alternative method of nicotine delivery. These were mainly related to the context specific 
issues attributed to new motherhood, such as lack of sleep, stress, loss of identity and 
relationship difficulties, as discussed below: 
‘She is going through a massively stressful time right now and struggling to cope. She 
borrowed her mum's vape and loved it, felt totally better and less stressed straight 
away.’ Leah, T5 
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Perceived risk and strategies to mitigate risk (behavioural strategies, psychological 
strategies, physiological effects & environmental risks)  
Although women were using e-cigarettes postpartum, they still had concerns regarding 
risk. However, this was mitigated by comparing to the perceived risks of vaping with the 
known risks of smoking: 
‘They are not unregulated, we know what's in them and they are at least 95% safer than 
tobacco.’ Talitha, T6 
Sometimes these were compared favourably and used to make assumptions on e-
cigarette safety, such as the guidance on smoking and breastfeeding being used to 
argue the safety of vaping and breastfeeding: 
‘They say it's better for a smoker to smoke and breastfeed than not to breastfeed at all, 
so I should think the same applies to e-cigarettes.’ Delilah, T4 
However, there were also unfavourable comparisons, such as the health detriments of 
smoking being projected to vaping: 
‘I'm not an anxious or risk averse person, really. It's just the link between smoking and 
SIDS is so strong. What if you do continue to breathe out something for hours after 
vaping? If in twenty years they turn round and say vaping and co-sleeping causes x, 
and our baby had x?’ Acacia, T7 
Many of these comparisons were related to the nicotine content, for example the 
following forum user was advised it was OK for her husband to vape as he is not 
breastfeeding: 
‘The most harmful thing in e cigarettes is the nicotine. Unless your DH [dear husband] 
plans on doing the breastfeeding, it isnt going to harm your baby.’ Daffodil, T7 
There were also perceived risks associated with the physiological effect of vaping on 
breastmilk, with discussions on what was likely to transfer to the infant via breastmilk if 
the mother vapes. There were comments about ‘unknown’ substances that may be 
harmful if transferred to an infant, however the most commonly discussed concerns 
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were about nicotine, and the perceived health risks associated with passing nicotine to 
the baby. However, there were comments about ‘unknown’ substances that may be 
harmful if transferred to an infant. This concern was often mixed with judgement, the 
emphasis being that a good mother would not smoke or vape, for example: 
‘You're basically asking, "AIBU [Am I Being Unreasonable] to feed my baby small 
amounts of nicotine"? What do you think OP [opening poster]?’ Tirzah, T6 
Mothers were also informed their infant would develop an addiction to nicotine, in that 
the infant would ‘feel like they want a fag’ and would suffer ‘withdrawal’ from nicotine 
when breastfeeding ceased. 
The concept of risk came with a variety of strategies to manage perceived risks. 
Behavioural strategies involved altering behaviours to reduce exposure to vapour for 
infants; these included only vaping outdoors or in a separate room, choosing low 
nicotine juice, or timing vaping around the infant’s feeds to allow the maximum time to 
pass between vaping and the infant receiving inhaled components via breastmilk: 
‘I would recommend trying to time a vape after a feed rather than before so that you get 
the biggest gap possible between ingesting nicotine and then feeding the baby. That 
gives it the most chance to disperse from the milk.’ Jemima, T6 
Psychological strategies were also used; this involved justifying any perceived risk in a 
way that presented their choice to vape in a more favourable light, such as explaining 
that without vaping they would be stressed, which was worse for their baby. They also 
justified the perceived risks of vaping by comparing it to more accepted health 
behaviours, such as drinking coffee, as illustrated in the following quote: 
‘Nicotine is in the same drug classification as caffeine so its only as bad as anyone that 
drinks coffee and breastfeeds.’ Helena, T2 
As well as specific risks to infants via the breast milk, there were wider concerns for 
risks from the environmental exposure to vapour. This was mainly founded on the basis 
of the harm from passive smoking; women were concerned about the exposure to 
second hand vapour based on the known harm from second hand smoke: 
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‘It's just not in my instincts to puff on a weird manmade contraption, full of unknown 
manmade synthetic substance, in close proximity to a new born baby. My instinct says 
that little one should get as natural untarnished breathing air as I can realistically 
provide.’ Dahlia, T7 
 
Social support (informational, emotional & instrumental) 
While discussing risk on the forums, women were also seeking and giving support to 
one another about vaping. Social support was varied in nature. In many ways, the forum 
users offered positive social support to women who were vaping or considering an e-
cigarette. There was informational support, such as giving advice on which products to 
use or how best to use an e-cigarette. Informational support was often guided by the 
woman’s own experience of vaping, and included positive messages to support women, 
especially those, who were trying to quit smoking: 
‘Come over to the stop smoking section and we'll help you find one that works. Actually, 
come over anyway, you'll get lots of support and no judgement, whatever method you 
are using’ Jael, T4 
Emotional support came from supportive comments about posters’ own and others, 
experiences of quitting smoking and the health benefits they experienced. Sometimes 
it came from reassurance a woman would not be judged for vaping. The following forum 
user discussed her partner’s experience of vaping and how she viewed it positively: 
‘I would much rather see him vape than smoke and he no longer wheezes when lying 
down, he is much fitter and it's the first time he has gone longer than a week without 
smoking. I think he is coming onto three years now.’ Bryony, T7 
However, not all posts were positive and supportive; there were instances of harsh 
judgement of vaping mothers, or indeed a mother’s harsh judgement of herself. There 
were accusations of not putting their infant’s needs before their own and the insinuation 




‘Why would anyone condone it? Very strange. She is teaching her son an unhealthy 
way of coping with normal life stress.’ Tabitha, T6 
The varying forms of support often led to a polarised divide amongst forum users with 
strong views amongst both those pro-vaping and anti-vaping. 
Instrumental support was also identified, which included directing women to the best 
places to buy products or other forums to use for more information. This was also 
evident from those opposed to smoking who would direct women to alternative 
products/behaviours to remain smoke-free; including traditional NRT use, self-help 
materials or indeed more comical ways of both parents remaining smoke-free: 
‘Reward him with... I dunno. Doughnuts or something. I'd suggest BJs [oral sex] but 
then I remember how pregnant you are.’ Xanthe, T7 
 
Evidence (professional, non-professional, anecdotal, lack of evidence & 
mistrust/uncertainty)  
This theme showed that women accessed a wide variety of sources of information to 
inform their arguments and opinions, and then interpreted and communicating their 
understanding of this evidence on forums (sometimes inaccurately). 
Professional evidence came from academic articles or via professional websites such 
as the National Health Service (NHS) and Public Health England (PHE). This was often 
misinterpreted, particularly from those who were opposed to vaping. One example was 
an article available on the NHS website about ‘popcorn lung’ 4, this was cited several 
times across transcripts, incorrectly, as evidence of e-cigarettes being harmful. A further 
example is the following poster, who hyper-linked a paper by Farsalinos & Polosa 
(2014): 
                                                          
4 ‘Popcorn Lung’ or Bronchiolitis obliterans is a rare fibrosing form of chronic obstructive lung disease 
that follows a severe insult to the lower respiratory tract 370. McEwen, A. and H. McRobbie, 




‘If you want decent info on the risks and benefits of vaping this5 is a good place to start. 
You can access the whole paper for free if you create an account’ Jael, T4 
The most frequently quoted evidence was from non-professional sources;  this included 
media articles such as blog posts and newspaper articles, but also linked to social 
media profiles and discussions. There were also examples of non-empirical sites, such 
as Wikipedia, being cited as sources of evidence against vaping, this was met with 
ridicule by some pro-vape forum users. The non-professional evidence was mostly 
quoted by those opposed to vaping, whereas those who were pro and anti-vaping 
equally shared professional evidence. 
Anecdotal evidence was also shared by both pro and anti-vapers and appeared to be 
the most substantial form of evidence accepted by women. The women were often more 
responsive to the experiences and stories from other forum users than they were to 
other forms of evidence available, and these forms of evidence often appeared to be 
more persuasive: 
 ‘Anecdotally I can tell you that when my ExH [Ex-husband] vaped, our cats fled from 
the vapour and I hated the idea of him vaping inside near the cats. I'd be even more 
concerned about a baby.’ Grace, T4 
‘I do, I feel so much better too, no coughs or colds. I am positive that e cigs are much 
much less dangerous than cigarettes and think maybe you're being a bit over anxious.’ 
Jonquil, T7 
As well as sharing, quoting and interpreting evidence, there was also a general 
discussion on the lack of evidence available about the safety of e-cigarettes. This was 
most often attributed to a lack of empirical evidence of the long term effects of vaping. 
Women were anxious to read information that related specifically to their situation, and 
talked about lack of evidence on vaping and breastfeeding, or vaping around young 
children. 




‘Everyone says that these things "must be better than real cigarettes..." ok, based on 
what evidence? Long term studies? The ones that haven't been done, you mean???’ 
Joy, T6 
This lack of evidence specific to new mothers was also displayed in the final subtheme 
of mistrust and uncertainty. In the following quote, a forum user highlights the use of 
thalidomide in pregnancy, and how this was perceived as safe: 
‘95% safer, Not 100% safe then? Not that long ago the NHS also said Thalidomide was 
safe. Look how that ended.’ Camelia, T7 
This is evidence of women looking for evidence that relates to their specific 
circumstances; the comparison of a professional recommendation that resulted in infant 
harm. But it wasn’t just mistrust at the science itself, but also the institutions that make 
the recommendations: 
‘And PHE [Public Health England] have been criticised for their supportive stance on e-
cigarettes. They are very keen to get tobacco smoking down so I can see why they 
would be supportive.’ Joy, T6 
 
4.5 Discussion and conclusions  
 
4.5.1 Key findings 
This research is the first to describe how women are accessing information about e-
cigarette use during the postpartum period. It is also the first evidence of women 
proactively using e-cigarettes to prevent relapse to cigarette smoking and aid smoking 
cessation, particularly as breastfeeding mothers. Women have concerns regarding 
potential risks of using an e-cig and utilise online forums to discuss these risks with 
other women. This type of forum provides both positive and negative social support. 
The themes show that women are accessing information on e-cigarette safety and their 
use via multiple sources; both lay and professional. However, this information is not 
necessarily being interpreted correctly, or is met with a degree of mistrust and 
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uncertainty. There are conflicting opinions on the use of e-cigarettes while 
breastfeeding. This is mainly due to health concerns regarding what may be transferred 
from e-cigarette to breastmilk, as well as concerns second-hand vapour exposure. 
 
4.5.2 Strengths and limitations 
Online support groups provide specific benefits of virtual group membership compared 
to physical group membership. They are accessible 24-hours a day, 7-days a week, are 
free to join and participate in, lack geographical barriers and offer anonymity [371-375]. 
The public availability of online discussions provides rich data that is formed as part of 
an everyday discussion. With the anonymity that posting online affords a person, forum 
data is free from many of the social and research biases that may present in other 
qualitative methods such as interviews and focus groups. Online forum also offers a 
safe place to discuss sensitive topics or topics in which a person feels they may be 
judged [376] and has been used for discussions regarding smoking [377]. Accessing 
data from a virtual community offers the opportunity to analyse naturalistic data on a 
stigmatised issue without being influenced by research agenda; we are able to 
understand from an everyday perspective what women really think about e-cigarette 
use, what experiences they report and what particular issues that surround this are 
important to them.  
The use of online support groups or ‘forums’ can also have potentially empowering 
effects on those who use them, providing health information, information sharing, and 
input for individuals to make health-based decisions [371]. The use of parenting forums 
is a valuable source of data on what women think about health-related risks and 
decision making [378-381].  
There are limitations as to the use of online forum data; the very nature of this research 
forgoes the possibility of following up individual users or seeking clarification on the 
meaning of their words which increases the risk of bias during coding. It is also 
impossible to establish the validity of posts – i.e. to be completely confident that a user 
who identifies as a breastfeeding mother is in fact, a breastfeeding mother. The 
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transferability of these themes to the general postpartum population is limited due to a) 
the exclusive participation of forum users and b) all transcripts coming from only two 
parenting forums. There is also no way to establish the authenticity of the users on the 
forum entirely or whether they have connections within the e-cigarette or tobacco 
industry. We are also unable to follow up participants for clarification, longitudinal data 
or further research. 
On the other hand, the use of online data has several strengths; discussions are free 
from the response bias that may be present within interviews, forum data provides a 
discourse that has been written to express and debate opinion for discussion, not for 
research. The use of forum data provides in-depth qualitative data; in other research, 
the use of a discussion analysis tool found that online interactions involving conflicting 
viewpoints promoted more discussion and critical thinking [382].  
There should also be considerations for the dates of the threads included in this 
research, for example, some threads identified were produced in 2015. Given the 
popularity of e-cigarettes has increased in recent years [256] , and research has 
advanced, there may be opinions within these discussions that are outdated to the 
participants themselves. This research is novel in both subject matter and approach. 
Therefore, this research should be treated as an exploratory qualitative piece for which 
further research can be built upon. Thus far, this is the only piece of work that considers 
the motivators, barriers, and opinions of breastfeeding mothers using e-cigarettes 
postpartum.  
 
4.5.3 Relation to prior work 
This work has improved our understanding of how and why women use e-cigarettes in 
the postpartum. For the first time, we can understand and explore what evidence 
women are accessing to inform themselves about e-cigarettes and how this information 
is then interpreted. It also provides the first evidence of women perceiving their use of 
e-cigarettes postpartum to be preventative of smoking relapse. We are also able to 
understand better the concerns women have around the impact of e-cigarettes on infant 
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health. In particular, the misbelief that nicotine is the most harmful substance 
transferred to infants via a smoking mother’s milk is sometimes an obstacle to the use 
of e-cigarettes postpartum. 
Previous research has highlighted that some women perceive smoking to affect the 
quality of their breastmilk in a way which is detrimental to their infant’s health [150, 162], 
despite the previous decade of recommendations from professional health bodies 
encouraging women who do smoke, to continue breastfeeding [166]. This current 
research helps us better understand the fears women have about e-cigarette use, most 
notably in relation to the perceived lack of consistent, evidence-based information about 
e-cigarette safety and the effects of nicotine transferring through breastmilk. By 
addressing these concerns, we could improve the acceptability of using a vape 
alternative for women who are breastfeeding and smoke, while minimising harm to the 
mother and infant and reducing her fears regarding her child’s exposure to vape 
constituents via breastmilk. 
Prior work using forum data considered e-cigarette use during pregnancy [269], with 
three distinct themes explaining how forum users debated the use of e-cigarettes while 
pregnant: quitting (nicotine) cold turkey is unsafe; vaping is the lesser of two evils; and 
vaping is not worth the risk, concluding that women perceive their addiction to cigarettes 
as more than just nicotine addiction and that the behavioural aspects of smoking are 
also important, hence the potential for e-cigarettes. In this research, there were 
similarities in postpartum views. Vaping being the lesser of two evils, was present within 
the evidence and perceived risk themes. The justification for using e-cigarettes was due 
to the relative safety of e-cigarettes compared to smoking. This was a motivating factor 
for using e-cigarettes; the concept of reducing harm for both mother and baby by using 
an e-cigarette instead of smoking. It also found within the perceived risk theme that 
some women viewed e-cigarettes as not worth the risk, for example in transcript 7 one 
woman asked ‘If in twenty years they turn round and say vaping and co-sleeping causes 
x, and our baby had x?’.  This fear isn’t completely unfounded, for example historically 
tobacco smoking was touted as a safe, even ‘healthy’ behaviour. For example, in 
response to concerns about detrimental effects of smoking in the 1930’s- early 1950’s 
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tobacco companies began financing reports form physicians on the health benefits of 
smoking [383].   
 As with the pregnancy forum discussions, postpartum forum discussions in our studies 
showed women displayed mixed views on e-cig safety. The majority of users accepted 
that e-cigarettes were ‘probably’ safer than cigarettes. However, there was skepticism 
and mistrust of the evidence for this, which acted as a barrier to using e-cigarettes. 
Health bodies such as PHE and the NHS were classed as biased due to their targets 
of reducing cigarette smoking, and comparisons were made regarding previous health 
recommendations that have since transpired to be detrimental. Women are accessing 
scientific journals to learn more about e-cigarettes; however, this is often mistranslated. 
News media stories are often shared amongst online groups if a headline is unusually 
provocative. Even when these stories were discredited, users felt that these fears must 
be based on something.  Lack of evidence, or mistrust of the current evidence, appears 
to be a barrier for the use of e-cigarettes as a harm reduction tool during the postpartum 
period; this often gives rise to a thought process of ‘better the devil you know.’ This 
scepticism is not confined to e-cigarettes; previous research identifies some women 
believe nicotine replacement therapy patches to be harmful and smoking as preferable 
to these [384]. Evidence was cited from a variety of sources. Women who were opposed 
to vaping often cited media articles or unregulated sites, such as Wikipedia. This was 
often met with sarcasm and ridicule by those in favour of vaping. Likewise, those who 
cited scientific articles were often ridiculed for being ‘too trusting’ of large organisations, 
such as PHE, who some women felt were untrustworthy. Overall, personal anecdotes 
were exempt from this type of conflict. 
Uncertainty regarding e-cigarette safety was a further barrier to use and often led to 
women discussing the concept of ‘risk,’ either in terms of comparison to smoking or in 
justifying the perceived risk. This individual assessment of risk is not unique to e-
cigarette use and is attributed to a ‘knowledge deficit’ between professionals and the 
lay public [385]. The risk assessment formed by laypeople is complex and situationally 
influenced, and reflects their values [386], particularly relevant when considering the 
morality of motherhood and the negative attitudes some women hold towards vaping 
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while breastfeeding. For example, the negative attitude to government-backed advice 
on risk is assumed to be due to perceived exclusion from science-led and political 
decision-making [387]. With this in mind, involving women in discussions about e-
cigarette use and safety within usual postnatal visits could help them make an informed 
choice on e-cigarette use. 
This knowledge deficit could explain the reliance on unverified evidence from social 
media, news publications, or web content found within this study; these are written to 
inform a general population but are also written to be read with ease. This may explain 
why women are engaging more with this type of evidence. There is also a reliance on 
others for information; while women are seeking support and advice from health care 
professionals, they are also seeking advice from other mothers. It is unsurprising that 
new mothers would seek information that is easy to access and easy to read, but also 
the use of online forums provides anonymity. Therefore, despite judgment from other 
mums, the ability to remain anonymous while receiving or giving information offers 
some form of protection of self [388], the mother can still have perceived control over 
how those around her view her morally and ethically.  
The concept of risk is a subjective one. While there was much discussion of risk, apart 
from discussions on nicotine, this risk was not defined. There were suggestions of harm 
drawn from media conclusions, but the risk was often discussed as a general term. 
Other lifestyle behaviours such as alcohol and caffeine consumption were commonly 
used to justify this ‘risk’ concept; the idea that if these behaviours were acceptable for 
mothers, then vaping was also acceptable.  
The risk of nicotine exposure to the baby was one of the defined examples of risk. There 
were false attributions that nicotine caused SIDS. Women also expressed concerns 
about infants becoming addicted to nicotine, and therefore, being forced to experience 
withdrawal once breastfeeding ceased. There were also concerns that the use of e-
cigarettes to manage the mother’s mental health needs (such as stress) would lead to 
children who grew up exposed to unhealthy coping mechanisms. The exposure of 
infants to nicotine was also the subject of judgment; some women would argue that a 
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mother asking if it was OK to vape, was asking if it was OK to feed her baby nicotine. 
The nicotine becomes a deliberate exposure rather than a by-product of the breastmilk.  
This concern regarding nicotine acts as a barrier to the use of e-cigarettes postpartum. 
Harmful effects from nicotine are not fully understood but are likely to be minimal 
compared to the effect of other compounds, although it is accepted as an extremely 
addictive substance [389]. There are far more worrying compounds within cigarette 
smoke, which research suggests are either not present in e-cigarettes, or present at 
significantly lower levels [186]. There is still limited empirical data on the safety and 
composition of e-cigarette vapour. However, there have been some promising toxicity 
testing which has evaluated the chemical nature of the vapour generated from e-
cigarettes. [186] Despite the identification of specific toxicants within e-cigarette vapour, 
these levels are <1% of the levels present in cigarette smoke. E-cigarettes, therefore, 
has potential as a harm reduction tool, as confirmed by the PHE report [188]. 
This research closely relates to the ‘good mother’ social construct [355], as shown with 
the justification of perceived risk, or the moralised stances against the use of any 
nicotine-containing products as a breastfeeding mother. The role of mother is one that 
is subject to historical and cultural experiences; social networks provide a framework 
within which to make sense of their experiences and responsibility that are culturally 
defined [390]. The use of an online forum varies slightly from this; bringing together 
women from various socioeconomic backgrounds, age, experiences and cultures to 
discuss breastfeeding. Therefore, the social constructions of a ‘good mother’ are more 
explicit, particularly for infant feeding [391]. A ‘good mother’ is synonymous with 
breastfeeding, without cultural or environmental context [355]. The justification of risk 
here is similar to mothers who justify smoking by claiming that it is for their baby’s sake 
[392], i.e., the explanation that the baby should have a mother who isn’t stressed or is 
more alert. 
In terms of what motivated women to begin using e-cigarettes, women reported using 
them to either prevent relapse to smoking or to quit smoking after having already 
relapsed. Relapse (or perceived likelihood of relapse) was often triggered by the 
106 
 
demands of motherhood, perceived stress or the feeling of needing some ‘me’ time, 
similar to previous research on postpartum relapse [61]. Interestingly, some women are 
choosing an e-cigarette in response to what has previously been identified as reasons 
why women relapse to smoking traditional cigarettes; smoking for relief and nostalgia 
for their former self [393]. Although evidence is limited, it is suggestive that women who 
use e-cigarettes during pregnancy are still likely to relapse to cigarette smoking, with 
one qualitative study partly attributing this to a lack of professional consensus within 
healthcare on the safety of e-cigarettes [278]. Lack of consistent and transparent 
information from professional health sources is a significant barrier to e-cig use 
postpartum, an issue to be addressed given the success some women report using e-
cigarettes to prevent smoking relapse. 
 
4.5.4 Conclusions and implications 
In conclusion, this study has shown women hold a mixture of views on the acceptability 
of vaping as a mother. Still, some women are using (or are interested in using) e-
cigarettes in the postpartum period. They are seeking, and need, more reliable 
information to facilitate their use, especially when breastfeeding.  The implications of 
this are that women are seeking to use less harmful alternatives to smoking, but are not 
able to access the information they require. Therefore there is a need for further 
research that explores the experiences of vaping and breastfeeding mothers in greater 
detail, to understand what motivates mothers to switch to vaping, and what may be a 
barrier to switching from cigarettes to vaping. As this research relied on forum data, an 
extension of this would be to directly ask women who do smoke/vape about what beliefs 
they hold about their smoking and vaping status, and what support or advice may have 
influenced these beliefs. With the evidence of judgment found within this work, it would 





5. Chapter 5: Smoking and Vaping postpartum – results from an 




From the previous research in Chapters 4 [394] and 3, it was identified that some 
women who breastfeed are also using e-cigarettes. Chapter 4 also identified there was 
a lot of confusion and misunderstandings amongst women about e-cigarettes, with 
some women opting to smoke cigarettes as they didn’t feel they knew enough about e-
cigarettes to use them. There was also evidence of judgement from non-smoking 
women about breastfeeding mothers who smoke or vape. While this study allowed us 
to gain some understanding of mothers’ experiences of and views on vaping while 
breastfeeding and the challenges they might face, forum discussion analysis has 
several limitations. For example, the research was limited to the observation of existing 
conversations between members, this prevents being able to ask questions, clarify or 
explore specific themes in more depth. Therefore, to further our understanding of e-
cigarette use, along with motivators and barriers to breastfeeding from the perspective 
of smoking/vaping mothers, an online survey was designed. 
To understand the potential role of e-cigarettes in supporting mothers to initiate and 
continue breastfeeding, and to not return to smoking, we need to understand how 
perceptions of e-cigarettes compare with smoking in regards to impact on 
breastfeeding. We also need to understand what motivates one woman to choose an 
e-cigarette but another to continue smoking. We must also understand how women who 




This research aimed to explore the experiences and beliefs about smoking or vaping 
while breastfeeding, from the perspective of new mothers who smoke or vape.  
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 What are the mother’s experiences of being a smoker and/or a vaper 
postpartum? 
 What views and beliefs do mothers who smoke and/or vape have about 
smoking and breastfeeding, and about vaping and breastfeeding? 
 What support and information on breastfeeding do mothers who smoke and/or 
vape receive, and what support and information would they like to receive? 




All data collected were anonymised, and participants were not asked to provide any 
identifiable data. To help ensure privacy, participants were assigned a volunteer study 
identification number, upon analysis, women were randomly assigned names. 
Participants were advised that all research data and records would be stored for a 
minimum of 7 years after publication or public release of the work of the research. 
Participants gave informed consent by checking a box confirming they had read all the 
study information and were happy to proceed.  
Ethical approval was given by the UoN Medical School Research Ethics Committee. 
 
5.3.2 Study design 
This cross-sectional study was an online questionnaire with open-ended questions was 
conducted throughout May and June 2019.  
Understanding the time constraints many new mothers feel, and the stigma that may 
be attached to smoking, vaping and whether or not a mother breastfeeds, it was decided 
an online survey would be the best method of data collection. The demands of 
motherhood may be a barrier to participating in research. Sleep/feeding schedules, 
sickness, and maternal/parental leave ending have been shown to reduce the 
recruitment and retention of new mothers in research [395]. Smoking/vaping 
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postpartum is also a sensitive topic, with women reporting feelings of shame and 
judgement [392, 393], which may hinder recruitment. Online recruitment and 
participation is a convenient and confidential method of conducting research [396] 
which may increase the recruitment of new mothers to our study. By reducing 
participant burden and giving participants a more secure sense of confidentiality, we 
may reduce the risk of recruitment bias in our research [397]. Jisc (formerly Bristol 
Online Surveys) online survey platform was used to design and host the survey.  
 
5.3.3 Recruitment: 
Parenting forums (UK only) 
A google search for online parenting support groups was conducted using a 
combination of the search terms “parenting” “new mother” “motherhood” (and related 
search terms) and “online support group” “online forum”, “online community”, “message 
board”. A ‘moderators’ information sheet (appendix 5.1) was designed, giving 
moderators of groups brief information on the study and requesting permission to recruit 
via their forums. An ‘invite’ was also designed (appendix 5.2Error! Reference source 
not found.) to be posted into groups (with permission). This included brief information 
on the study and a link to the online survey. The following process was used. 
Process: 
 Contacted the ‘gatekeeper’ (i.e. website moderators and owners) first 
 If permission was given, the forum was searched to understand if it consisted 
of one community forum or several groups within a forum 
 Contacted administrators of groups (or community page) within the website for 
permission to post in individual groups 
 If permission was given, posted the ‘invitation’ message  to the group 
 If allowed, the invitation message was kept visible in the group using ‘Bump’ (a 
common way of maintaining visible posts within a forum by commenting ‘bump’ 
on a post)  
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 If permission wasn’t given to post in groups, the moderators were thanked for 
their time 
Posts began on the parenting websites on May 15th 2019 and were ‘bumped’ weekly as 
per the guidance received by group administrators. Posts were not ‘bumped’ after 13th 
June 2019 as the recruitment numbers were met. 
Facebook groups (UK specific) 
Search terms such as “breastfeeding”, “formula feeding”  “parenting” “new mother” and 
“motherhood” were used to search Facebook for relevant groups. Parenting forums 
identified in the google search above were also searched for within Facebook, as it is 
common for forum users to move away from the forum and create Facebook groups for 
select others from the shared forum.   
Process:  
 Contacted the group administrator for permission to post (Appendix 5.1:  
Moderators message) 
 If permission was given, the researcher introduced  themselves to the group 
first and outlined the research 
 Posted an invitation to take part in research (appending Invite) 
 ‘Bump’ post once daily if permitted, or repost at intervals allowed by the 
administrators 
Posts were made on the 15th May 2019, and a further post was allowed on June 5th 
2019. Links to the survey were shared by the ‘Mums & mums to be: research on 
smoking & quitting during & after pregnancy’ Facebook group, run by the Smoking in 
Pregnancy group at the University of Nottingham, on 3rd June 2019 and received 16 
shares. 
Facebook advert (UK specific) 
A Facebook advert ran for a period of one month (17th  May to 17th June 2019). The 
advert was targeting women aged 18-47 who lived in the UK.  
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The advert (Figure 5.1) showed a picture of a new-born infant with the title ‘Smoking & 
Vaping postpartum’ with the headline ‘research exploring what it’s like to be a smoking 
or vaping mother – share your experiences.’  
 
A brief description of the research was also included, specifying that the research was 
interested in women with infants aged <18months. The advert was managed by SMRS, 
a digital marketing company, on a ‘pay per click’ basis with a budget of £500. The advert 
was delivered using algorithms to target potential participants at times of the day when 
they were most likely to be viewed, in line with the company’s knowledge and 
experience of running advertisements for the recruitment of mothers to research.  
 
5.3.4 Participants 
The target population for this study was mothers of infants aged under 18 months who 
exclusively smoked, exclusively vaped, or both smoked and vaped (dual users). As the 
regulations and popularity of e-cigarettes vary depending on country, only UK based 
forums and groups were included in this study.  
Figure 5.1 Facebook advert 
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The nature of this type of study and method of recruitment meant that while we could 
influence the type of participant recruited to the study through specific inclusion criteria, 
other aspects were more difficult to control for. For example, while it would be ideal to 
achieve a ratio of 50/50 recruitment smokers/vapers, there was an awareness that this 
might not be possible. The prevalence of smoking is much higher than the prevalence 
of vaping; thus, higher recruitment of smokers (than vapers) was anticipated. Using Jisc 
online surveys enabled the adaption of the screening questionnaire at a later part of the 
recruitment process in the event we struggled to recruit enough vapers; however, this 
was not necessary as our sample was relatively evenly split. Determining a sample size 
a priori for qualitative research is inherently problematic with no agreed framework 
[398]. To determine probable sample size, studies using similar recruitment methods 
were reviewed [399, 400]; these studies managed to achieve the quantity and quality 
of data suitable for qualitative analysis, such as thematic analysis, with around 100 
participants. We, therefore, aimed to achieve similar numbers of 80-120 respondents, 
with the option to re-open the survey if data saturation was not achieved.  
 
5.3.4.1 Inclusion / exclusion criteria 
Before completing the questionnaire, women were asked a series of screening 
questions to ensure they met the inclusion criteria of the study: 
Inclusion criteria: 
Mother with an infant aged 0-18 months 
Current smoker or vaper  
UK resident 
Aged ≥18yrs 





Works/has worked for a tobacco or vape related industry or 
Had immediate family who works for a tobacco or vape related industry 
 
5.3.5 Questionnaire design 
The survey began with a participant information sheet, and then a consent form with 
information on how to withdraw from the study. Women were then asked to either 
consent or not consent to take part. Women who did not consent were thanked for their 
time and proceeded no further with the survey (appendix 5.3). A screening survey was 
used to ensure women met the criteria for the study (appendix 5.4). Those who didn’t 
meet the inclusion criteria were thanked for their time and unable to proceed with the 
study. Demographic information, such as age, parity, infant age, and marital status, was 
collected. Women were asked whether they smoked, vaped, or smoked and vaped; 
data were also collected on whether women had smoked/vaped during pregnancy. 
Women who didn’t smoke/vape throughout pregnancy were asked when they first had 
a cigarette/vape postpartum. Information was collected on breastfeeding status; women 
were asked about their current breastfeeding status, and those no longer breastfeeding 
were asked how old their infant was when they last received any breastmilk. 
Open-ended questions were asked about opinions on smoking and breastfeeding, and 
vaping and breastfeeding. Women were asked about any advice they had received 
(from health care professionals, friends or family) about breastfeeding as a smoker or 
vaper. Other open-ended questions asked about any experiences they had of vaping; 
for those who vaped (or had previously vaped) what had led them to try vaping, and 
those who smoked, and hadn’t vaped were asked what would make them more likely 
to try a vape. Women were also asked what they felt would have helped them to 
breastfeed initially and for a longer duration. 
This questionnaire was piloted with ten patient and public involvement (PPI) 
representatives, and with 10 participants. PPI feedback highlighted that some questions 
were difficult to understand, so the wording was amended. An additional six questions 
(three smoking, three vaping) with Likert scales were added to the questionnaire as a 
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result of PPI feedback. A full copy of the questionnaire is available in appendix 5.5.  The 
questionnaire length was acceptable to PPI and took roughly 10 minutes to complete. 
When piloted with participants, the responses collected were relevant and met the aims 
of the study, so no further amendments were made to the questionnaire, and as per the 
ethics approval these ten responses were included in the overall analysis 
 
5.3.2 Data Analysis 
Descriptive tables of participant characteristics were generated, and box plots of 
responses to Likert scales were produced. The boxplot was created to show how views 
on acceptability and safety may differ between smoking and vaping. 
Qualitative data were analysed using reflexive thematic analysis (TA), following the six-
phase process outlined by Braun & Clarke  [401]. In the reflexive TA approach, themes 
are defined as a pattern of shared meaning underpinned by a central concept or idea. 
While the six phases are sequential, TA is also a recursive process meaning these 
phases are not rules to follow rigidly. The six-phases in a reflexive thematic analysis 
are a series of conceptual tools that are designed to guide the analysis in a way that 
facilitates a thorough examination, understanding and engagement with the data.  
1. Familiarisation with the data: The survey responses were read, and re-read until the 
researcher was familiar with the content.  
2. Coding: Brief codes were attached to features of the data that may be relevant to the 
aims of this research. The entire dataset was coded within NVivo. 
3. Generating initial themes: Codes and the respective collated data were examined to 
establish any significant patterns that could potentially be themes. Coded data was 
collated for each emerging theme.  
4. Reviewing themes: The themes identified in phase 3 were then checked against the 
dataset to ensure they answered the research aims and were prevalent across data 
sets. During this phase, some themes were merged, some themes were split, and 
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subthemes began to emerge. Themes that were not prevalent or relevant to the 
research questions were discarded.  
5: Defining and naming themes: A detailed analysis of each theme was developed that 
considered the particular focuses of individual themes, this evolved into a short 
narrative of each theme and each theme was given a name.  
6. Writing up: The themes were written, including extracts from the data set, to tell the 
narrative of the data.  
After phase five, a second coder (LP) was given a selection of transcripts to ensure 
coding was rigorous. As surveys are answered in different degrees of detail by different 
participants, responses were categorised into three groups prior to analysis; this 
ensured that for second coding, LP would have a selection of responses to code. These 
were grouped into category C (where a participant has answered primarily using 
minimal words and detail, usually less than one sentence), category B (where a 
participant has responded to the open-ended question with some detail, answers are 
primarily less than three sentences) and category A (where a participant has answered 
open-ended questions with detailed responses, primarily using more than three 
sentences). This categorisation did not affect the analysis overall, but it did allow the 
second coder to have a selection of data sets that were representative of the whole 
data set. The second coder was given six category C transcripts, six category B 
transcripts and, five category A transcripts. The overall number of transcripts by 
category were; 53 category C, 62 category B, and 38 category A. After coding half of 
the transcripts, a meeting was held between EJ and LP to discuss any issues within the 
coding that may have become apparent. At this stage, there were some 
misunderstandings about how two sub-themes differed from one another. After looking 
at the content and narrative of each sub-theme, it was decided that they were two 
distinct sub-themes, and a more detailed analysis of the sub-themes was written. After 
all coding was completed by LP, a further coding meeting was held during which any 





5.4.1 Characteristics of participants 
The Facebook advert was seen 39,988 times, reaching 11,688 unique profiles. A total 
of 531 users clicked the advert, and so viewed the information sheet and consent 
pages. We are unable to say how many participants were recruited as a direct result of 
the Facebook advert, and how many came from online parenting forums. The majority 
of respondents completed the survey in the evening (between 20:00-23:00). The survey 
took, on average, 11 minutes and 23 seconds to complete. 
A total of 168 participants responded to the survey, 14 did not meet the inclusion criteria, 
and one person did not consent to continue taking part, leaving a sample of 153 
participants who completed the survey. Upon analysis, 4 participants had selected that 
they neither vaped, nor smoked and so were excluded from the analysis. A total of 149 
women were included in the analysis. The characteristics of the participants are shown 
in Table 5.1. 
Table 5.1 Characteristics of participants 
Characteristics N=149 
Median age of mother (IQR) 28.0yrs (6.0) 







Number of children 1 57 (33.3) 
2 43 (28.9) 
3 32 (21.5) 
4+ 17 (11.4) 
Marital status Living with 
partner 
122 (81.9) 
Not living with 
partner 
9 (6.0) 
Single 18 (12.1) 
Partner’s smoking status Smokes 48 (36.6) 
Vapes 29 (22.1) 








5.4.1.1 Smoking, vaping and breastfeeding status 
Smoking, vaping, and dual-use categories were evenly represented, the majority of 
women in this study had continued to either smoke, vape, or both throughout pregnancy 
(Table 5.2). The majority of women were not breastfeeding at the time of this survey; 
as we recruited women with babies from birth to 18 months, we asked mothers who 
were not breastfeeding at the time of this survey what age their infant last received any 
breastmilk. Just under half of our sample reported their infant had never received any 
breastmilk. Of those who had been breastfed at birth, the majority had stopped 
breastfeeding at <1 month (Table 5.3Error! Reference source not found.).  
Table 5.2 Smoking/vaping status 
 




Smoke/vape status (n (%)) Pregnancy Postpartum 
Smoke 46 (27.5) 67 (45.0) 
Dual 39 (26.1) 44 (29.5) 
Vape 35 (23.5) 38 (25.5) 
Didn’t smoke/vape 34(22.9) 0 (0) 
Total 149 149 












































Likert scales were added to the survey in response to PPI input, and this study was 
qualitative, so no a priori power analysis or sample size calculations were performed, 
these results should be viewed with caution. Women were asked whether they agreed 
or disagreed with three statements based on smoking and the same three statements 
about vaping; the results of these are shown in Figure 5.2, with the results for smoking 
and vaping presented side by side for each statement. Overall women were often 
unsure or disagreed that breastfeeding as a smoker was safe or socially acceptable. 
With vaping, women appeared to be unsure or in agreement that vaping as a 
breastfeeding mother was safe and socially acceptable. Women were primarily in 
agreement that mothers should be encouraged to breastfeed if they smoke or vape, 
although more women were likely to disagree with this statement for smoking mothers 
than disagree with this for vaping mothers. As outlined earlier, a quantitative analysis 
was not planned for this research; these findings indicate that further quantitative work 
is needed, but does provide some context for how women may view vaping and 
breastfeeding, and smoking and breastfeeding, differently. 
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5.4.3 Qualitative findings 
Three main themes, with eight subthemes, were identified (Table 5.4):  
Table 5.4 Table of themes 
 
5.4.3.1 Smoking & Vaping behaviours postpartum 
Women described how they smoked/vaped as breastfeeding mothers. This included 
ways to reduce harm to the infant posed by smoking/vaping, but also how they altered 
their smoking/vaping to fit around their infant’s needs. Dual-use mothers (women who 
both smoked and vaped) also discussed how they alternated between smoking and 
vaping to suit their baby’s needs.  
Reducing harm  
Women discussed various techniques and behaviours they employed to reduce the risk 
to their infant from smoking and vaping. This included maintaining a smoke/vape free 
home, washing hands after smoking/vaping and for smoking specifically, removing an 
outer layer of clothing after smoking: 
‘I use an old dressing gown to go outside and smoke then take it off when I come inside 
so the smoke isn’t sticking to my skin’ Meg (Dual user) 
 
Themes Subthemes 
Smoking, vaping & breastfeeding 
behaviours postpartum 
Reducing harm 
Barriers and facilitators for breastfeeding 




Barriers and facilitators for switching to 








Both women who smoked and vaped expressed concerns about the effects of nicotine 
passed on to the infant via the breast milk and described techniques they employed to 
minimise the risks. For example, some women timed their smoking/vaping around their 
baby’s feeds to minimise the amount of nicotine their baby received: 
‘Smoke straight after a feed and avoid contact for as long as possible. I was told 3 hours 
is how long the nicotine stays in my milk. So I express milk and just do my best.’ Eugenie 
(Smoker) 
For vapers, reducing the nicotine level in their e-liquid was also seen as a harm 
reductive behaviour, with the ideal being to vape liquids without any nicotine: 
‘I vape 0mg nicotine so I can be sure that no harmful chemicals would pass over to the 
baby.’ Constance (Vaper) 
Women who were dual users often viewed vaping as a way of reducing harm. They 
discussed how they would alternate between smoking and vaping around their 
children’s needs. For some women, this was occasional; they would usually vape 
unless they were feeling particularly stressed, or were out socialising with friends/having 
an alcoholic drink: 
‘I vape during the week and when regularly breastfeeding. I tend to have a cigarette if I 
have an alcoholic drink or at a weekend when I give my baby expressed milk.’ Meena 
(Dual user) 
For other women alternating between smoking and vaping was a daily occurrence, 
vaping was often used during the day, and smoking would generally be used in the 
evenings when the mother felt assured she would not need to breastfeed until morning. 
A few mothers reported they would struggle without their first cigarettes in the morning, 
so would smoke when they woke up, and then vape until their partner returned to help 
with the infant. Women also reported vaping until they had enough expressed 
breastmilk; they would then use it as an opportunity to smoke, knowing the infant had 
expressed milk that they felt wasn’t contaminated by smoking. Many women had a set 
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routine for when they smoked and when they vaped, however, women would deviate 
from this schedule if they were stressed: 
‘I generally vape during the day and will sometimes smoke a couple of cigarettes in the 
evening once my partner returns from work and assists with the baby. Occasionally I 
will smoke one cigarette in the day if I am feeling stressed or if it is offered by a friend 
but never around my children’ Sara (Dual user) 
 
5.4.3.2 Barriers & facilitators to breastfeeding as a smoking/vaping 
mother 
Acceptability, safety and social influences were all themes that could either be barriers 
to breastfeeding, or facilitators. Overall mothers tended to disclose more barriers to 
breastfeeding than vaping mothers. 
Acceptability of breastfeeding as a smoking or vaping mother 
The perceived unacceptability of breastfeeding as a smoking/vaping mother was a 
barrier to breastfeeding. The perceived unacceptability of breastfeeding as a smoking 
mother was particularly a barrier; women spoke about the ‘smell’ of cigarettes and how 
that would transfer to the baby and how it was ‘selfish’ to smoke and breastfeed. The 
perceived unacceptability of breastfeeding while being a smoker was prevalent 
amongst women who didn’t smoke, and women who smoked but didn’t breastfeed, and 
was often rooted in their beliefs of what a mother ‘should’ and ‘shouldn’t’ do; 
‘It's wrong in every way  ... a mother shouldn't be putting anything into her body that she 
wouldn't want her child to have simple’ Hermione (Vaper) 
 
Some women found breastfeeding while vaping to be also unacceptable, although this 
was less commonly expressed than the unacceptability of breastfeeding while smoking. 





‘Same as before... the mother's decision, not the babies therefore mothers shouldn't do 
it [vaping] whilst pregnant/ breastfeeding.’ Elphaba (Vaper) 
 
On the contrary, perceived acceptability of breastfeeding as a smoking mother could 
act as a facilitator; for some women breastfeeding as a smoker was seen as acceptable 
as it was a way of protecting the baby from the risks of smoking: 
 
‘No judgements better to breastfeed and smoke than not breastfeed because you 
smoke. I’ve got some strange funny looks myself but it’s my choice not theirs’ Meg (Dual 
User) 
 
Perceived acceptability of breastfeeding as a vaping mother was also a facilitator for 
breastfeeding, women discussed how by vaping and breastfeeding a mother was 
‘making healthier choices’ for her baby, and that a vaping mother who breastfed was 
doing the best by her infant: 
 
‘A mother is making a healthier choice by using an e-cigarette or vape as an alternative 
to smoking.’ Amy (Vaper) 
 
Acceptability would sometimes be context-dependent or conditional. Women would 
suggest breastfeeding as a smoker was not acceptable unless the mother was trying to 
quit or was experiencing stress/mental health difficulties. Some women would indicate 
that it was acceptable, but only if a mother took precautions: 
 
‘I think as long as precautions are taken so the baby is nowhere near the smoke, and 
the mother changes her clothes / covers her clothes whilst smoking and washes her 
hands afterwards it should not be a problem to breastfeed.’ Opal (Vaper) 
 
There were also examples of vaping and breastfeeding being acceptable conditionally. 
Some women suggested vaping should be treated like smoking (never around the 
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infant, washing hands, changing clothes). However, most centred on the nicotine 
content and strength; it was more acceptable for a vaping mother to breastfeed if she 
used zero or low nicotine liquids: 
 
‘If you vape nicotine I don't agree with it. If you're just vaping flavoured stuff carry on, 
who are we to judge?’ Sherry (Smoker) 
 
Women were more vocal about vaping and breastfeeding being acceptable. This was 
most often discussed in the context of smoking. The acceptability of breastfeeding as a 
vaping mother was often based on the unacceptability of smoking and breastfeeding: 
 
‘Vaping is a lot cleaner and smells a lot better than cigarettes but again I’d say 
handwashing and clothes changing is a must!’ Galadriel (Dual user)  
 
The acceptability of breastfeeding as a smoking or vaping mother varied; however, 
there were more expressions of acceptability amongst women for vaping than smoking. 
Overall opinions were often reduced to ‘what mothers should/shouldn’t do’, or ‘mother’s 
choice’: 
 
‘I think it's down to the Mother to decide to do it or not do it [smoking]. I know someone 
that smoked through pregnancy then quit when the baby was born to breastfeed and I 
know someone that quit once they found out they were pregnant to then start after the 
baby was born and breastfed.’ Rosalie (Smoker)  
 
The perceived safety of breastfeeding as a smoking or vaping mother  
Concerns about safety and risk were a significant barrier to breastfeeding as a 
smoking/vaping mother. Concerns about nicotine and other smoke constituents getting 




‘Breast is supposed to be best but I don’t think it counts if you smoke like when you're 
pregnant because if the smoke can go through the placenta then it can get in the milk. 
If you’re going to breastfeed you shouldn’t really smoke and I know friends who used 
bottles as it’s safer. I stopped breastfeeding when I started smoking even though it’s 
not much I still don’t want to do it’.  Belle (Dual user) 
 
However, safety wasn’t just limited to what may pass into breastmilk, but also from the 
skin to skin exposure and passive smoking due to the closeness needed to breastfeed: 
 
‘It is very dangerous to smoke whilst breastfeeding due to the toxins in your body and 
the skin to skin contact.’ Raya (Smoker) 
 
‘You are still passing on second-hand smoke from your skin and hair and things after 
having a cig even if you smoke outside away from the baby’ Skye (Dual user) 
 
Safety concerns were primarily related to smoking, although, for some women, the risk 
of nicotine entering breastmilk from vaping was cause for concern. Women also felt the 
lack of research and evidence for vaping created safety concerns: 
 
‘My personal choice was to stop bfing [breastfeeding] as there wasn’t much research 
as to what risks could be involved’ Lauren (Dual user) 
 
Women also compared the relative safety of vaping in comparison to smoking; this often 
involved discussion of ‘toxins’ and ‘chemicals.’ Predominantly, women discussed 
nicotine; this was a barrier for some women who felt that vaping with nicotine was as 
bad as smoking due to the nicotine content. However, many women discussed the 
lower levels of toxicants within vapour: 
 
‘They do not contain the chemical smoking does and if it's to aid in quitting smoking 




Safety beliefs could act as a facilitator for breastfeeding if women believed that ‘breast 
is best’ regardless of smoking/vaping status. This was often due to the belief that 
breastfeeding protected against some of the risks associated with smoking. This 
supported by the belief that breastmilk was nutritionally superior to formula milk: 
 
‘To add, for both I do believe that breastmilk will still always be the best option and more 
support should be out there so mothers will breastfeed. Regardless of the small nicotine 
content, it [breastmilk] will still always trump formula scientifically.’ Kyra (Smoker) 
 
Safety was often a facilitator specifically for vaping mothers to breastfeed. Mothers 
discussed how an e-cigarette was less harmful than a cigarette and therefore, safe for 
breastfeeding: 
 
‘I breastfeed and use an ecig right now. I feel that it can’t be half as harmful as smoking 
cigarettes. It also contains less harmful elements so I have no issue with this.’ Freya 
(Vaper) 
 
However, for some women, there was not yet enough research on vaping for them to 
feel safe with breastfeeding as a vaping mother, particularly the lack of long term 
research: 
 
‘It's a difficult one as we don't yet know enough about the long term effects and negative 
health risks associated with vaping. I would be hesitant to vape and breastfeed.’ 
Veronica (Smoker) 
 
As with acceptability, often safety was a facilitator for vaping and breastfeeding because 
of the perception that smoking and breastfeeding was not safe. This comparison of 
smoking and vaping was commonly used to form an argument for the safety of 
breastfeeding as a vaping mother. Although safety concerns primarily focused on 
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smoking, the knowledge that breastmilk could protect against some of the risks 
associated with smoking facilitated smoking mothers to breastfeed. 
 
Social Influences  
Social influences included support, advice and judgement. Perceived judgement was a 
barrier to breastfeeding for women who smoke/vape. When asked ‘what would make it 
easier for you as a smoking/vaping mother to breastfeed?’ many women highlighted 
that people not being judgemental would help. Some highlighted how many mothers 
suffer from low mood after giving birth and may smoke to cope, suggesting that the 
judgements she gets may contribute to her feeling worse. It was recommended that this 
fear of judgment might impact women’s choices when breastfeeding: 
 
‘You get a funny look if you do it [breastfeeding] outside anyway so you’d probably get 
more funny looks if you were doing it after a cig’ Belle (Dual user) 
 
‘I do think people shy away from breastfeeding as standard because of “what people 
will think” so being a smoker/vaper may add to the stigma’ Darcy (Vaper) 
 
Some women who did smoke and breastfeed held negative judgements about 
themselves; referring to themselves as ‘disgusting’ and ‘vile’. The fear of judgment was, 
for some women, more prominent than the fear of harm: 
 
‘I expressed my milk and still smoked didn’t want to but was 8 weeks early. Only thing 
I don’t like is mothers who are pregnant and smoke on the street. I did but only smoked 
in the back garden where no one could see me’ Blanche (Dual user) 
 
Although the perceived judgement was a barrier to breastfeeding for smoking/vaping 
mothers, women did feel there was a reduced stigma surrounding vaping, which may 




‘I feel vaping during breastfeeding is more acceptable because it’s not seen as such a 
bad thing, I'm also aware that the stigma around vaping is not as bad as smoking 
because of the fact that it's water vapour with nicotine and doesn't contain as many 
chemicals as tobacco and cigarettes.’ Ola (Smoker) 
 
As well as judgement, receiving no advice was also a barrier to breastfeeding. Women 
reported receiving little to no advice for both smoking and vaping in regards to 
breastfeeding, and this led to women being unsure: 
 
‘As a smoker nurses and midwives never suggested I should breastfeed and never 
brought it up. I’m not sure if this is because it is harmful or because they thought it was 
my choice.’ Hayley (Smoker) 
 
For some women, the fact they had quit smoking prior to, or during, pregnancy meant 
they received no advice on smoking/vaping during the postpartum period. Some women 
reported feeling guilty if they had smoked as a breastfeeding mother, others reported 
they had felt too guilty to ask for advice regarding breastfeeding: 
 
‘I also time my cigarettes between my feeds although I do admit I am somewhat ignorant 
to it because I feel guilty so don't want to ask, on the other hand, if more information 
was readily available I would have never resumed smoking’ Maya (Smoker) 
 
For many women, the only information they had received was related to pregnancy, not 
the postpartum period: 
 
‘I was told to quit whilst pregnant and advised there was a stop smoking clinic but no 
advice is given about smoking and breastfeeding  even though I could have started 
smoking after the birth’ Naya (Vaper) 
 
Women tended to seek/receive advice from midwives, health visitors, friends, stop 
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smoking services and online groups however women expressed a wish for more factual 
advice, often feeling most advice was based on opinions rather than facts, this was 
particularly true for vaping mothers; 
 
‘I received little to no actually, factual literature about e-cigarettes and vaping in 
pregnancy or when breastfeeding. Mostly opinions, but no proven evidence.’ Amy 
(Vaper) 
 
For women who did receive advice/information, it wasn’t always accurate or helpful. For 
some women, they were told to ‘just quit’ which they found to be dismissive. Other 
women received inaccurate advice that they found to be judgemental: 
 
‘I was told that if I smoked and breastfed that my health visitor would call social 
services.’ Kim (Smoker) 
 
Support and advice could also act as facilitators for smoking/vaping mothers to 
breastfeed if it was perceived as helpful and non-judgemental. Factual advice enabled 
women to make informed decisions about how to feed their infants, and being advised 
by a health care professional that it was safe to breastfeed if they smoked/vaped 
supported some women to breastfeed: 
 
‘When I had my baby I asked a Neonatal nurse about if it's okay to smoke and 
breastfeed (in my case pump) and she said it doesn't make a difference.’ Esmerelda 
(Smoker) 
 
Having these assurances from professionals helped women to feel they were doing the 
best for their babies, women were also told how breastfeeding would reduce risks to 






‘I was advised that because I smoke, breastfeeding was the best way forward as it 
would reduce the risk of my baby getting respiratory illnesses such as asthma’ Leah 
(Smoker) 
 
Women also found advice on how to reduce harm further to be beneficial; the advice 
was often centred on reducing the risk of second-hand smoke such as smoking outside, 
washing hands, or removing outdoor clothing before feeding the baby. Some women 
were advised to time smoking around their baby’s feeds. However, this was 
inconsistent; some women were told to smoke immediately after a feed and others, to 
smoke immediately before. The was always to reduce the amount of nicotine within the 
breastmilk: 
 
‘Midwives have told me it’s [breastfeeding as a smoker] safe as long as you wash your 
hand afterward and brush your teeth. Also advised to try wait 10 minutes before 
breastfeeding’ Cersei (Smoker) 
 
Social influences came from a variety of sources; judgement and inaccurate advice and 
support were barriers for breastfeeding amongst smoking/vaping women. However, 
non-judgemental support and accurate advice facilitated women to breastfeed. 
Unfortunately, many of the women reported receiving little to no information or advice 
during the postpartum period. 
 
5.4.3.3 Barriers and facilitators for switching to vaping and maintaining 
smoking abstinence postpartum 
Barriers and facilitators for women switching from smoking to vaping and remaining 
smoke-free included Experiences, Comparisons to smoking, and Motivations. 
 
Experiences  
Women discussed their experiences of vaping; experiences could act as a barrier or 
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facilitator for switching to vaping and remaining smoke-free. Women who previously 
tried vaping but were now smoking found their prior experiences of vaping to be a barrier 
to trying again. Women discussed how they had used a vape to quit smoking but had 
been unsuccessful and were therefore unwilling to try again. For some women, it was 
that a vape did not satisfy the cravings they had. Many of the women who shared their 
experiences of being unable to quit smoking with a vape did highlight that they 
attempted to vape with no nicotine liquid which may explain why some women found it 
difficult to remain smoke-free: 
 
‘I couldn't quit or give up so I thought if I switched to 0% nicotine e-cigarettes it would 
be better than smoking, but it didn't completely work out. Whenever I try giving up or 
cutting back smoking I'll use my e-cigarette, sometimes for a number of days sometimes 
for weeks but always end up full-time smoking again.’ Rosalie (Smoker)  
 
As well as finding vaping didn’t help them quit smoking, some women found overusing 
a vape to be a barrier. Women reported that during the time they did vape they realised 
they we less cautious than they were of smoking, so would regularly vape in the house. 
They also reported what they perceived to be overuse, finding that they would be vaping 
consistently throughout the day which they compared to the minimal time they spent 
going outside to smoke: 
 
‘I only smoke maybe 1-3 cigarettes per day. When I tried vaping, I found I was sucking 
on the thing all damn day.’ Gertrude (Smoker) 
 
Women also reported experiencing adverse events when vaping. These were mainly 
related to a sore/dry throat and a cough, although some women reported sickness as a 
side effect. Women who reported experiencing these events returned to smoking: 
 
‘I’ve tried e-cigarettes and find they are too harsh and cause me to have breathing 




Despite some adverse events, women also reported improvements socially, mentally, 
and physically when vaping, which acted as a facilitator. Some women reported vaping 
helped manage their stress levels while others talked about being able to still ‘smoke’ 
when out with friends or being able to use a vape around friends who didn’t smoke: 
 
‘We’re more sociable, energetic, less stressed in general and there’s no horrible smoke 
smell lingering on our clothes! Obviously, the main benefit being that our family is no 
longer subject to cigarette smoke.’ Darcy (Vaper) 
 
Positive experiences of vaping were facilitators to remain smoke-free. A lot of women 
talked about vaping being a pleasant experience; they found the range of flavours 
appealing. The most common positive experience was not smelling like smoke, and in 
particular, they didn’t want their infants to smell of smoke. Vaping was described as a 
‘cleaner’ or ‘fresher’ experience. This facilitated switching to vaping for some women: 
 
‘I had a random thought, would my children remember me by the smell of cigarette 
smoke If I was to die tomorrow!’ Maria (Vaper) 
 
Motivation for use 
Motivations for initially switching to vaping primarily wanted to quit smoking. For some 
women, this was to increase their chances of conceiving. For postpartum, this was due 
to not wanting their baby to smell of smoke. However, for the majority of women, this 
was explicitly related to quitting or cutting down on smoking during pregnancy. 
Successfully quitting during pregnancy was a facilitator for continuing to vape 
postpartum without returning to smoking: 
 
‘The hospital told me after examination that I had a threatened miscarriage and knew I 
needed to stop smoking immediately.   Fortunately, my baby was fine and no reason 
was found.   I felt quite unwell.  After advice from smoking cessation, I switched to a 
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vape instead going from a 20 a day habit to zero within a day.  I am now complete 
nicotine-free’ Daisy (Vaper) 
 
Switching to vaping during pregnancy was perceived as a way of reducing harm and 
‘doing what’s best for baby’. Previously smoking through pregnancy caused health 
concerns for some women that they attributed to smoking; such as threatened 
miscarriage and previous low birth weight, this was a protective factor against retuning 
to smoking postpartum: 
 
‘I personally smoked with my first child, she was born at full term but weighed 5lb14. 
My son I vaped all the way through my pregnancy and he was born a week early 
weighing 8lb15. I believe that smoking dramatically affects your child and birth weight, 
I also massively regretted it.’ Cordelia (Vaper) 
 
As well as pregnancy, health improvements in general motivated women to switch to 
vaping. For some women, it was seeing loved ones with smoking-related illnesses that 
prompted them to switch to vaping; for others, it was being diagnosed with a chronic 
condition or experiencing smoking-related health issues themselves: 
 
‘I stopped in 2014 when I was diagnosed with MS [Multiple Sclerosis], as cigarettes can 
exacerbate the disease. The nurse advised if I wanted to use nicotine replacement there 
were patients who used e-cigarettes to help quit smoking’ Lucy (Vaper) 
 
The cost of vaping was also attractive to women, although there were a few suggestions 
from women that help with the start-up cost (the device and liquids) would have enabled 
them to switch to vaping. Some women initially switched to vaping due to increased 
costs of cigarettes, and remaining on maternity pay or not returning to work motivated 
women to remain abstinent from smoking for economic reasons: 
 
‘I chose to quit smoking 5 years before I had my 1st child due to the prices of cigarettes 
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increasing. I bought a vape and since then have used my vape. I find it a much cheaper 
alternative and also I enjoy vaping.’ Violet (Vaper) 
 
Comparisons to smoking  
As well as the cost of vaping versus smoking, women compared smoking to vaping in 
other ways. A barrier to switching to vaping was the belief that smoking and vaping 
were inherently the same behaviours that carried the same risk, and in some cases 
(albeit very few) vaping was seen as more harmful: 
 
‘I think my views about e-cigarettes and vaping are pretty similar to smoking, to be 
honest. The only thing I would add is that we know all the risks with smoking, but we 
don't really know everything about e-cigarettes and vaping yet.’ Rosalie (Smoker) 
 
Some women felt that by switching to vaping, they were not quitting smoking, just 
changing ‘bad’ habits: 
 
‘I wouldn't swap one bad habit for another’ Viola (Smoker) 
 
Conversely, a belief that smoking and vaping were very different behaviours could act 
as a barrier. Some women felt vaping didn’t give them some of the perceived, positive 
benefits or experiences of smoking: 
 
‘I would [switch to vaping completely] if I felt like vaping had the same effects as 
smoking, I feel that smoking the actual cigarette isn't the only part of smoking that is 
satisfying compared to the vape, it’s hard to get used to not having to roll or light a vape, 
I think that's part of the satisfactory process of smoking’ Ola (Smoker) 
 
Despite this, the majority of women felt that differences between cigarettes and e-
cigarettes facilitated switching to e-cigarettes, as women perceived e-cigarettes 
sufficiently similar as an experience and way to reduce cravings, but at the same time 
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as a tool for harm reduction: 
 
‘Much better than smoking if unable to quit, much cleaner and healthier in the long run 
from personal experience’ Cordelia (vaper) 
 
Vape safety  
Women also discussed vaping in terms of safety without comparing it to smoking. 
Believing vaping to be ‘harmless’ was a facilitator for vaping; some women felt vaping 
posed no risk to health and felt comfortable vaping around their children. Women 
simplified the ingredients of e-liquids to back up their opinions: 
 
‘I don't see an issue ...the same things in a vape minus nicotine are in ice-cream ... 
There's nothing harmful in a vape just 3 ingredients’ Hermione (Vaper) 
 
Although some women felt vaping was harmless, other women were less sure and 
remained uncertain about vaping. This acted as a barrier to switching to vaping: 
 
‘Unsure as I only vaped a small amount and did not like this. I don’t think there are 
enough supportive evidence yet for this risk factor as vaping is fairly new.’ Raya 
(Smoker) 
 
Though this uncertainty was often due to the novelty of vapes; women felt there was 
not enough research of evidence to support their use which was a barrier to switching 
to vaping. Women discussed that no long term research on the effects of vaping was 
available: 
 
‘It's a difficult one as we don't yet know enough about the long term effects and negative 




When asked what would encourage them to try vaping, women who smoked often cited 
the need for further research and for the long term effects to be known. Some women 
felt that smoking was the better option as the risks were at least known: 
 
‘None tested no information I don’t trust it!!..... Nope, not tested, I know the risks with 




5.5.1 Key findings 
This study builds on the results in chapter 4 by directly asking women about their 
experiences and opinions of breastfeeding as a smoking or vaping mother. In a sample 
of 153 postpartum women who smoked (37.3%), vaped (30.7%) or smoked and vaped 
(32.0%), three main themes were observed; smoking, vaping and breastfeeding 
behaviour, barriers & facilitators toward breastfeeding as a smoking/vaping mother, and 
barriers & facilitators towards vaping postpartum.  
This study shows that smoking is a barrier to breastfeeding due to acceptability and 
safety concerns and that some women use vaping to overcome this. Vaping is 
perceived overall to be safer and more acceptable for breastfeeding mothers. However, 
there are distinct barriers to switching to vaping.  
Health care professionals have a pivotal role to play in increasing breastfeeding 
amongst smoking/vaping mothers. If mothers have access to relevant, clear, factual, 
and non-judgemental advice postpartum, they are better equipped and supported to 
breastfeed their infants, regardless of smoking/vaping status. 
 
5.5.2 Strengths & limitations 
There are limitations to this research; conducting online surveys means we cannot fully 
explore each woman’s experience as we might do using interviews. There were some 
quotes where it would have been beneficial to have been able to explore these 
narratives at greater length and with more detail. We are also unable to verify that each 
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participant was indeed a smoking or vaping mother. However the anonymity of an online 
survey can also act as a strength, women can disclose experiences, behaviours, and 
opinions without fearing judgement, which as evident in the results is a concern for 
women when discussing this subject. There were also limitations in some responses; 
for example, while many women gave at least some detail in their answers, others 
responded with single words and, in some cases, emojis. However, this had been pre-
empted, which was why a larger number of women were recruited than would typically 
be recruited for a qualitative study. A strength of this study is the recruitment strategy 
and flexibility of online surveys; while the aim was to recruit 80-120 participants over a 
6-8 week period, 153 mothers were recruited within four weeks. This may be due to the 
flexibility of online research; mothers primarily took part in this research during the 
evenings when face to face interviews would not typically be conducted. 
 
A limitation of this study was not conducting a priori power analysis for the Likert scale 
questions; these were added following PPI input, and as such, the study was not 
designed to include quantitative measures. The scales gave us some interesting data; 
however, this should be viewed with caution, and replication is needed to have 
confidence in the results.  
 
5.5.3 Quantitative results: relation to prior work 
In this sample, 69.3% of infants were breastfed at birth, similar to the national average 
of 74% [341]. However, by one month postpartum, only 44.4% of infants were receiving 
any breastmilk. This is similar to Public Health England’s breastfeeding prevalence 
rates of 46.2% at 6-8 weeks postpartum [121].  
Although we must be careful about what inferences we draw from the Likert scale 
results, they do suggest that more women view the safety of e-cigarettes while 
breastfeeding in a more positive light than they do smoking. This was also true for the 
social acceptability of vaping as a breastfeeding mother. Women viewed breastfeeding 
as a vaper more positively than did cigarettes. The acceptability of e-cigarettes in place 
of cigarettes is identified in previous research with the general population [195, 402]. 
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Overall, women mostly agreed mothers should be encouraged to breastfeed regardless 
of whether they smoke or vape. However, women expressed disagreement with this for 
smoking mothers than they did for vaping mothers. This would suggest that perhaps 
women view vaping when breastfeeding to be safer and more socially acceptable than 
smoking, which is similar to research on vaping during pregnancy; e-cigarettes are seen 
as the ‘lesser of two evils’ [269]. 
 
5.5.3 Qualitative results: relation to prior works 
Smoking, vaping and breastfeeding behaviours 
Smoking, vaping and breastfeeding behaviours centred on how women managed their 
smoking and vaping around their infants regarding breastfeeding, this included the 
behaviours they put in place to reduce any harm or risk posed to the infant; both 
documented and perceived risks. These behaviours were often following the outlined 
advice for postpartum smokers; smoke only outside of the house, wear a protective 
layer of clothing to be removed after smoking and observe good hand hygiene [56]. 
Women applied this advice to vaping as well; many mothers who vaped treated vaping 
similar to smoking, and those who didn’t vape highlighted that mothers who did should 
treat it the same as smoking. Some women were less cautious about vaping; they 
reported vaping meant they did not have to leave their baby. There were examples of 
women explaining that vaping helped them as new mothers because they could vape 
in the house, as opposed to going outside to smoke. This has been shown in prior 
research, where people hold the belief that e-cigarettes are safer in comparison to 
smoking, and therefore do not restrict their use in environments (such as homes or cars) 
as they would with cigarettes [403]. This was particularly evidenced in mothers who 
were dual users; they would talk about vaping during the day and only smoking when 
their partner returned from work to ‘watch the baby’. For some dual users, smoking and 
vaping was alternated around the infants needs to nurse from the breast. Some mothers 
talked about exclusively vaping until they had enough expressed breastmilk to be fed 
to the infant via a bottle, before allowing themselves a cigarette. This was done in the 
expectation that no nicotine would be transferred into the breastmilk. Currently 
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organisations such as La Leche League advise mothers who do smoke, to smoke 
directly after a feed. Nicotine has a half-life in breastmilk of two hours, therefore to 
reduce the amount of nicotine present in breastmilk, a mother should aim to smoke no 
less than two hours prior to feeding [404, 405]. Concerns about nicotine were evident 
in many women’s stories; women feared nicotine exposure to their infant via breast milk. 
Women who smoked or vaped nicotine talked about timing smoking/vaping around 
feeds, such as smoking/vaping directly after a feed to allow maximum time for the 
nicotine to leave their body before the next feed was due.  
 
Fear of nicotine transference is evident in other bodies of work; Bogen et al., (2008) 
found only 2% of 204 American women felt the use of Nicotine Replacement Therapy 
(NRT) was acceptable for breastfeeding mothers because of the transference of 
nicotine via breastmilk [406]. Goldade et al. (2008) also highlighted how, for some 
women, it was concerns regarding nicotine transference that lead to the early cessation 
of breastfeeding [162]. In chapter 4, nicotine transference was also a significant concern 
for mothers postpartum [394]. While nicotine is not a benign substance, it is not the 
primary health concern when smoking. Infant exposure to nicotine via breastmilk is 
roughly 50 times less than maternal exposure [407]. Although nicotine has some 
hemodynamic effects and is highly addictive, it is the multitude of other toxicants within 
cigarette smoke that pose a serious risk to health [408].  Women who felt vaping while 
breastfeeding was safe highlighted this. They would talk about the harmful toxins 
present in cigarette smoke, the risk of second/third-hand smoke, and the dermal 
transference of tobacco-related toxicants during breastfeeding. For these women, 
smoking was a barrier to breastfeeding for which vaping overcame. 
 
Barriers and facilitators for breastfeeding as a smoking/vaping mother 
Barriers and facilitators for breastfeeding as a smoking or vaping mother were how the 
specific behaviour of being a smoking/vaping could both hinder and support 
breastfeeding. Whether this was a barrier or a facilitator depended on the individual 
notion of acceptability, perceptions of safety and the social influences of others 
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(including health care professionals). 
Smoking and breastfeeding were sometimes discussed as being unacceptable, as 
reported in previous literature [406]. Women would talk about the rights of the infant; 
i.e. it’s the mother’s choice to smoke not the infants. This played into the notion that 
‘good mothers don’t smoke’ and ‘good mothers breastfeed’ [355-357, 409]; that a 
mother’s job was to protect her infant from harmful things, and breastfeeding as a 
smoker negated this. Although some women found vaping to also be unacceptable for 
breastfeeding mothers, the majority of discussions were positive with vaping viewed as 
acceptable behaviour, as found in previous research [195, 402]. This is sometimes due 
to the perception that when vaping, a person is making an effort to quit smoking [200]. 
Women suggested that a mother was making healthier choices for herself and her baby 
by vaping, and not smoking. This again ties in with the ‘good mother’ principle that is 
intrinsic with breastfeeding [355, 409]; good mothers breastfeed their infants, so to 
overcome a barrier (smoking) with an alternative (vaping) in order to breastfeed is 
evidence of ‘good mothering’. The acceptability of vaping may be very specific to the 
UK demographic, as the acceptability (overall) of vaping does vary by country [410, 
411]. 
 
Acceptability of smoking or vaping as a breastfeeding mother was sometimes 
conditional. Overall most women agreed that it was acceptable to breastfeed as a 
smoker or vaper on the condition that basic hygiene was followed, and distance/timings 
were observed. For women who vaped specifically, acceptability varied depending on 
whether women used nicotine. For smoking, conditional acceptability was more 
nuanced. It was acceptable for a mother to smoke if she breastfed as long as she was 
trying to quit, not smoking would be detrimental towards her mental health, or that not 
smoking would cause undue stress. The belief that smoking postpartum is a tool to 
reduce stress has been identified in previous work [61] and was identified in Chapter 4 
as a reason for the use of cigarettes and vapes [394] postpartum.  
 
Contrary to this, some women asserted quite firmly that acceptability was a moot point; 
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a woman’s decision to breastfeed, to smoke, or to vape was her choice and her choice 
alone. This ties in with feminist research that identifies infant feeding as a woman’s 
choice needed to overcome the guilt and shame that are associated with infant feeding, 
regardless of the preferred method [409]. This was expressed in terms of a woman’s 
right to choose what to do with her own body. Sometimes this was followed by the 
assertion that a mother intrinsically knows what is best for her baby with the phrase 
‘mother knows best.’ This works with the principle that a mother is able to make 
informed choices by contextualising risk to ensure she does the best by her baby, which 
may or may not go against the information and advice of public health bodies [356]. The 
idea of ‘mother knows best’ has previously been identified in other work that looks at 
how mothers manage nutrition or their infants [412]. 
 
The perceived safety of breastfeeding as a smoking/vaping mother could be a barrier 
to breastfeeding. As discussed above, the fear that smoking resulted in breastmilk that 
was ultimately unsafe led some women to stop breastfeeding; similar to prior research 
that suggests women may stop breastfeeding in order to resume smoking [150, 413]. 
Some women perceived vaping as safer than smoking, which facilitated breastfeeding. 
There were discussions about the ingredients of vape juice being similar to that of ice 
cream, or soup. However, not all women agreed, for some vaping was just too novel a 
concept to risk, women reported that until long term studies existed, they would be 
reluctant to breastfeed as a vaper. While women accepted smoking was harmful, for 
some women, there was a general belief that at least smoking was an informed risk, 
whereas vaping remained an unknown risk. 
 
The belief that ‘breast is best regardless’ was a facilitator to breastfeeding as a smoking 
or vaping mother. ‘Breast is best’ is a slogan that has been reported worldwide to 
women since the 1980s, as a way of increasing public awareness of the benefits of 
breastfeeding [414].  Women discussed how breastmilk was nutritionally superior to 
formula milk regardless of the mothers' smoking status and asserted that breastfeeding 
could negate some of the risks associated with smoking/vaping (such as the increased 
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risk of SIDs). This is in line with what the NHS state for new mothers [58], a stance 
support by breastfeeding charities ‘Laleche League’ and ‘breastfeeding network’.  Not 
all women agreed, some women felt that it was safer to formula feed an infant if you 
smoked/vaped, which was a barrier to breastfeeding. Some women stated that no one 
should judge them for formula feeding when other women smoked and breastfed (the 
insinuation that the latter was worthy of judgement). 
 
Judgement was a significant barrier for breastfeeding as a smoker/vaper. When asked 
what would make it easier for them to have breastfed, or have breastfed for longer, 
many women talked about judgement from others. Women discussed how 
breastfeeding in itself carried a lot of judgement; women felt judged if they didn’t 
breastfeed but also judged if they were seen to be breastfeeding in public, an issue 
identified in previous work [415]. With the added fear that mothers also get judged for 
smoking, some women felt they would be judged more harshly if they were seen to be 
a smoking/vaping mother who breastfed. Some women also harboured judgement 
towards themselves, describing their smoking (in particular) as ‘disgusting’ or feeling 
like they had failed their baby, this is similar to the findings in chapter 4 [394]. Some 
women found relief from this self-judgement through breastfeeding, talking about their 
shame of smoking but their pride in breastfeeding. For others, they felt they had to hide 
the fact they either smoked or breastfed. There were no examples of self-judgement 
amongst women who vaped. The judgement also came from false information, for 
example one participant was told by family or friends that if she breastfed as a smoker, 
her health visitor would call social services. Women did get some positive 
encouragement from others; some women mentioned online communities where they 
received advice to breastfeed regardless of smoking or vaping. Vaping was often a way 
of negotiating social judgements; i.e. if a mother vaped, she was therefore making 
healthier choices (by not smoking) and could therefore be afforded the identity of a 
‘good mother’. For mothers who smoked, or who did not breastfeed, passing judgement 
on other mothers was a way of mediating the judgements they felt towards themselves. 
For example, some women spoke about the fact that other mothers drank alcohol and 
142 
 
breastfed, those mothers were therefor irresponsible and by making the decision to 
bottle feed this mother was protecting her baby from harm. In this research, the morality 
of motherhood became more of a complex spectrum of behaviours. Women could 
identify themselves as being a ‘better’ mother, despite engaging in behaviours that fall 
outside of the ‘good mother’ principles. This was because there would always be other 
mothers engaging in perceived ‘less moral’ behaviours. 
 
Many social influences could be both a barrier and a facilitator for breastfeeding. For 
example, if a mother received encouragement and reassurance on safety from health 
care professionals, it could facilitate her to breastfeed. However, a large proportion of 
women did not receive any advice or information on breastfeeding as a smoker/vaper; 
this was particularly true for vaping. They found it challenging to find information about 
breastfeeding and vaping and often relied on advice about smoking to inform their 
behaviours. This was similar to the results in chapter 4 [394]; due to a lack of general 
consensus and advice women who vape adopt the advice given about smoking to 
inform their decisions regarding vaping. 
Often women reported that they were not asked about their smoking status (having quit 
during pregnancy), and were too embarrassed to ask health care professionals about 
breastfeeding as a smoker or vaper. For some women, the fact it wasn’t discussed with 
them led them to believe that they were not expected to breastfeed because of their 
smoking/vaping status. For vaping mothers, in particular, health care professional’s lack 
of guidance was a barrier to breastfeeding. This is similar to research that has explored 
barriers and facilitators to using NRT or e-cigarettes during pregnancy; women who 
have positive discussions about e-cigarettes as safer than smoking with health care 
professionals report more confidence in using e-cigarettes [416]. Health professionals’ 
influence, or lack of it, is an important factor to consider; many women mentioned that 
there was no advice being given on smoking and breastfeeding. This suggests that 
clinicians give little reassurance about smoking and breastfeeding, and thus women’s 




Barriers and facilitators for vaping (and not smoking) postpartum 
Although this study was primarily about the experiences and opinions surrounding 
vaping or smoking and breastfeeding, it’s also important to understand why some 
women vape, and why others continue to smoke, given vaping could be a safer 
alternative [417] for mothers who do not quit smoking. The majority of women who 
vaped in this study indicated that their motivation for switching to vaping (from smoking) 
was pregnancy; either in preparation for pregnancy or after finding out they were 
pregnant. Some women had switched prior to pregnancy because of health issues, and 
some women had switched to vaping as they could no longer afford cigarettes while on 
maternity pay, as identified in previous research [270].  
 
Experiences of using e-cigarettes could act as a barrier or facilitator depending on 
whether the experiences were positive or negative. Some women were reluctant to use 
e-cigarettes, having tried to quit smoking unsuccessfully with e-cigarettes in the past. 
Some women who had previously quit smoking with an e-cigarette reported over-using 
their device, such as spending a lot of the day vaping in comparison to what they 
perceived to be a relatively short time smoking cigarettes. Prior research has shown 
that vapers will regulate their nicotine levels regardless of the nicotine content in their 
e-liquid [211], so it may be that women were starting with a nicotine concentration too 
low to satisfy their cravings. One of the main barriers regarding experiences was 
adverse events. Women who had tried vaping and were reluctant to try again 
highlighted a sore throat or a cough. Some mentioned dizziness and nausea; these are 
all adverse events that have previously been associated with e-cigarette use [418]. 
Women reported that these adverse events disappeared once they resumed smoking. 
Positive experiences included feeling more energetic, no longer ‘smelling’ of cigarette 
smoke, feeling more sociable, saving money and successfully quitting smoking, this 
acted as a facilitator for women to continue to vape and not return to smoking.   
 
Comparing smoking and vaping could also act as a barrier or facilitator. For some 
women, vaping was simply trading one ‘bad’ behaviour for another. The majority of 
144 
 
women described smoking and vaping as being different, which could be either a barrier 
or facilitator. For some, vaping was not a similar enough experience to smoking, and 
they missed other aspects of smoking, such as the lighting or rolling of a cigarette, which 
acted as a barrier to switching. For others, vaping was perceived to be different to 
smoking in a positive way which facilitated switching to vaping; this could be in terms of 
safety and social stigma, where women discussed feeling less ’guilty’ when vaping. 
Overall the majority of women perceived vaping to be safer than smoking; some women 
felt they were safe to use, and a minority of women felt they were completely harmless. 
Despite the majority of women perceiving them to be safer than smoking, women still 
fell there is not enough research or evidence to be sure of the safety of vapes which 
was a barrier for switching to vaping from smoking. 
 
 
5.5.4 Implications for practice and future work 
While this research suggests that overall postpartum women see e-cigarettes as a safer 
alternative to smoking, and are more supportive of using e-cigarettes (than cigarettes) 
as breastfeeding mothers, there is a clear need for greater communication from health 
care professionals. Women are inundated with information on e-cigarettes from a 
variety of channels and are looking to health professionals to give them clear and 
concise guidance. Given the recent emergence of e-cigarettes, postnatal care should 
ensure that discussions around e-cigarette use are implemented within usual care, 
particularly in relation to breastfeeding. 
Given the relative safety of e-cigarettes compared to cigarettes, their efficacy as a quit 
aid, and the greater acceptability of e-cigarette use for breastfeeding mothers, there is 
potential for interventions to consider utilising e-cigarettes for reducing postpartum 
smoking and increasing breastfeeding. 
In order to trial e-cigarettes postpartum, the barriers to switching to vaping need to be 
considered. As women who had previously been unsuccessful in quitting smoking with 
an e-cigarette, smoking cessation services should consider providing information on 
regulating nicotine levels. For adverse events, it may be beneficial for new e-cigarette 
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users to be advised of the health impacts of smoking compared to these events, and 
be aware of alternative e-cigarette products for use.  
5.5.5 Conclusions 
In conclusion, there are various barriers and facilitators for breastfeeding as a smoking 
or vaping mother. However, women appear more favourable of breastfeeding as a 
vaper than a smoker. For some women, vaping was a way to overcome the barriers 
they faced as a smoking mother. There are still many misconceptions about smoking, 
vaping and breastfeeding, and a lack of information from health care professionals 
means women do not have the opportunity to discuss their worries. Clear and consistent 




















6. Chapter 6: Summary, implications, and directions for future 
research 
 
6.1 Summary of findings in relation to objectives: 
The overall aim of this thesis was to explore the use and acceptability e-cigarettes for 
breastfeeding mothers, and barriers and facilitators to their use postpartum: 
1. To understand whether there is a relationship between smoking and 
breastfeeding within a sample of smokers, ex-smokers, and vapers.  
2. Describe the characteristics of women who breastfeed, smoke and/or vape 
postpartum 
3. To explore women’s current usage, understanding and opinions of e-cigarettes 
in relation to breastfeeding 
4. To explore the barriers and motivators to breastfeeding as a smoking/vaping 
mother 
5. To explore the acceptability of using e-cigarettes as a breastfeeding mother 
6. To explore the motivators/barriers for using e-cigarettes, as an alternative to 
smoking, in the postpartum period 
This concluding chapter summarises the key findings of this research. It highlights the 
implications for future care and interventions that could use e-cigarettes to support 
those women who cannot, or do not wish to remain smoke-free postpartum, and 
consequently do not intend to initiate or continue breastfeeding. 
 
6.1.1 Chapter 3, Study 1 
 
The Pregnancy Lifestyle Survey (PLS) was a longitudinal survey of UK mothers, from 
early pregnancy to 3 months postpartum. The results showed that mothers who smoked 
were less likely to initiate breastfeeding at birth, and to continue breastfeeding at three 
months postpartum, compared to mothers who remained smoke-free.  
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Mothers who were older and had higher levels of education were also more likely to 
breastfeed, and a higher level of education was also associated with remaining smoke-
free. When adjusting for age and education, smoking was still negatively associated 
with breastfeeding at all time points. The characteristics of mothers who vaped were 
similar to those of mothers who smoked, however small sample sizes of exclusive 
vapers made analysis difficult. 
This study was limited by the sample size of exclusive vapers and the quantitative 
methodology. To explore the use of e-cigarettes postpartum, especially amongst 
breastfeeding mothers, qualitative research is needed that focuses explicitly on e-
cigarettes and not cigarette use. 
 
6.1.2 Chapter 4, Study 2 
 
Women’s views about e-cigarettes and breastfeeding were explored through infodemic 
methods. Infodemic research, as defined in Chapter 4, can be the analysis of how 
people search and navigate the internet for health-related information [358]. For this 
study, online forum discussions were analysed. Four main themes from ten discussion 
threads originating from two parenting forums were identified; use, perceived risk, social 
support, and evidence. Women appeared to be using e-cigarettes as an alternative to 
smoking; both to quit and prevent a return to smoking. Discussions suggested women 
generally believed that e-cigarettes were less harmful. However, opinions presented by 
forum contributors were divided; some believed that e-cigarettes were safe for 
breastfeeding mothers and others believed they were dangerous. This was sometimes 
due to concerns about the lack of long-term research about e-cigarettes or concerns 
about the trustworthiness of health bodies. Women reported accessing academic 
journals and other evidence from verified sources, as well as accessing non-verified 
sources (such as media articles) to form these opinions.  
Infodemic research does not give the opportunity to ask questions of participants or 
explore specific themes in depth. To explore women’s own experiences of vaping, 
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smoking, and breastfeeding, it was recommended that future work explore the themes 
identified in greater detail with participants. It was also recommended that postnatal 
care providers look to include discussions on e-cigarettes within usual postnatal care to 
ensure women’s concerns are addressed. 
 
6.1.3 Chapter 5, Study 3 
 
An online survey was conducted with smoking and/or vaping mothers who had given 
birth within the last 18 months. Three main themes were identified; smoking, vaping & 
breastfeeding behaviours, barriers & facilitators for breastfeeding as a smoker/vaper, 
and barriers and facilitators for switching to vaping. Women reported changing their 
behaviour to reduce harm; this included creating a smoke-free home and, for dual 
users, alternating between smoking and vaping around their infants' feed. For some 
women, the act of smoking itself was perceived to be a barrier to breastfeeding. This 
was overcome by using an e-cigarette. Social influences such as the judgment of others 
and advice form health care professionals could act as barriers or facilitators to 
breastfeeding.  
Mothers were more positive about the use of e-cigarettes when breastfeeding than they 
were about smoking. Generally, women were more likely to report that vaping as a 
breastfeeding mother was acceptable than smoking; although for some women, it was 
only acceptable if a woman vaped zero nicotine e-liquids. There were some concerns 
about the lack of long term research about vaping. 
Wanting to remain smoke-free, and not being able to afford to smoke cigarettes were 
key motivators for vaping, and not smoking, in the postpartum period. There were also 
other motivators such as health, not smelling of tobacco, and avoiding second-hand 
smoke. Barriers to vaping included previously trying e-cigarettes and being 
unsuccessful at quitting smoking, overuse of e-cigarettes, or experiencing adverse 
effects of vaping. A major barrier to using e-cigarettes postpartum was a lack of advice 
about vaping available to new mothers, particularly concerning breastfeeding. 
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Future recommendations are the inclusion of discussions about switching to e-
cigarettes during postnatal visits, and accessible information about their use and 
relative safety. Interventions should consider that e-cigarettes are, for the most part, 
more acceptable to breastfeeding mothers than smoking. However, barriers to 
switching to vaping should be minimised where possible. 
 
6.2 Main findings across all thesis studies 
The main findings of this thesis can be summarised as follows: 
 Women in the UK who smoke postpartum are less likely to initiate breastfeeding 
and continue breastfeeding than mothers who have quit smoking.  
 Women find smoking a barrier to breastfeeding because they are concerned 
the smoke will taint their milk, making it unsafe for their infant.  
 Some women view smoking and not breastfeeding as evidence of ‘bad 
mothering.’ 
 For some women, an e-cigarette can overcome these barriers, and women are 
more favourable about the use of e-cigarettes when breastfeeding than 
smoking.  
 The majority of mothers believe e-cigarettes to be safer than traditional 
cigarettes. 
 However, there are still barriers to switching to an e-cigarette; this is due to a 
lack of long term research and lack of (consistent) advice and support for 
breastfeeding mothers on using an e-cigarette.  
Study 1 showed a negative association between smoking and breastfeeding. The 
results of this thesis suggest this association is, at least in part, due to a fear of harm. 
In study 1, smoking mothers were less likely to intend to breastfeed, which suggests 
the association is not physiological (i.e., the effect of nicotine on lactation hormones), 
study 1 also showed an association persisted even when age and education were 
adjusted for. In study 3, women discussed their fears and beliefs that smoking 
contaminated breastmilk and made it unsafe for them to breastfeed. Some women 
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highlighted stopping breastfeeding due to this fear, and there was a belief that formula 
milk was a safer option for smoking mothers, something identified in previous work 
[406]. Much of this harm related to concerns about nicotine, in studies 2 and 3 women 
reported a fear that nicotine transfers via breastmilk and is therefore harmful to the 
infant, similar to previous work [162, 406]. In study 2 and study 3 women talked about 
not only the health concerns of transference through breastmilk but the morality of it. 
The valued self-identity of being a ‘good mother’ was present in studies 2 and 3; the 
expectation was that a ‘good mother’ does not smoke but does breastfeed [355, 356].  
In studies 2 and 3, the belief that a child could get addicted to nicotine via the mother’s 
milk was also evidence of ‘bad mothering’. The fear of harm from breastfeeding as a 
smoker was found to explain, at least in part, a negative association between smoking 
and breastfeeding; the very act of smoking was itself a barrier to breastfeeding. 
In study 3, some women overcame this barrier by vaping; across all three studies vaping 
was shown to be more acceptable than smoking. While acceptability did vary between 
participants within every study, overall, the majority of women across all studies were 
more positive about e-cigarettes. This was due to the belief that when using an e-
cigarette, a mother was making a concerted effort to quit/avoid smoking. This was a 
positive act, similar to findings in other research where e-cigarette use is seen a positive 
step towards being smoke-free [200].  
The acceptability of e-cigarettes was primarily due to a comparison between smoking 
and vaping. E-cigarettes were determined to be safer than cigarettes with far fewer 
harmful constituents; this is in line with PHE’s statements on vaping [417] and previous 
research examining e-vapour composition [196, 197, 216, 218, 276]. E-cigarettes were 
also generally seen as safer because they don’t produce second-hand smoke. In study 
2, women did raise some concerns about second-hand vapour. However, research 
suggests that second-hand vapour is only a source of nicotine exposure, not toxicant 
exposure [276]. One of the perceived benefits to vaping and breastfeeding was the 
ability to have skin to skin contact with the infant after vaping; women in studies 2 and 
3 discussed concerns about the dermal transference of toxins from smoking during the 
necessary skin to skin contact for breastfeeding.  
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While the majority of women perceived e-cigarettes to be safer and more acceptable 
than smoking, there were barriers to switching to vaping. In studies 2 and 3, women 
reported concerns there was a lack of long-term research on the effects of vaping and 
highlighted there was no research on breastfeeding as a vaping mother. Of the research 
that was available to them, some women reported scepticism that supporting bodies, 
such as PHE, were untrustworthy and overly favourable of e-cigarettes because of their 
targets to reduce smoking. This is not unique to e-cigarettes, such as the mistrust of 
recommendations for vaccinations [419].  
In studies 2 and 3, women highlighted the lack of information and advice for new 
mothers about e-cigarettes as a barrier. Some women felt the fact e-cigarettes were not 
discussed meant they were unsafe for use when breastfeeding. In contrast, others 
found they did not have the opportunity to discuss any fears and concerns about 
breastfeeding. A recent study has explored health care professionals’ beliefs, attitudes, 
knowledge, and behaviour around vaping in pregnancy and postpartum [420]. This 
study identified that generally, amongst healthcare professionals, vaping was perceived 
as safer than cigarettes. Still, a lack of evidence, health and safety risks and regulatory 
issues were a cause for concern. Greater information and guidance about vaping is 
needed for health care professionals [420].  This is vital, as previous research on NRT 
and e-cigarettes use in pregnancy has identified that consistent messages from health 
professionals based on high‐quality evidence, with clarity around safety concerning 
smoking, can improve the willingness to use harm reductive products [416]. In this 
thesis, women often managed their behaviours with e-cigarettes by relying on 
information given during pregnancy, or by applying information regarding smoking to 
their vaping. 
 
6.3 Strengths and limitations 
6.3.1 Quantitative work 
In chapter 3, study 1 was the only purely quantitative chapter in this thesis. This 
inclusion of a quantitative chapter allows the generalisation of results to a broader 
population of UK mothers. However, there are limitations as this study was designed 
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for other research purposes. Questions relating to breastfeeding were only included in 
the two follow-up surveys, not the baseline survey, so we were unable to measure how 
intentions may have changed throughout pregnancy alongside changes in smoking 
behaviour. There was also no data collected about any interactions with health care 
professionals about breastfeeding as a smoker or vaper, which following the findings in 
chapters 4 and 5, would have been useful. Drop-out rates are also a limitation of this 
methodology [421] and do impact the validity of research [422]. Even when using a 
mixed contact method for non-responses (such as telephone and SMS prompts), 
responses are still generally limited [423]. In this study of the original cohort, complete 
data sets (both smoking and vaping status recorded) were only available for 49.2% and 
53.9% at follow up 1 and 2, respectively. This may account for why age was not found 
to be associated with smoking status despite previous literature in Chapter 1 
highlighting age to be a significant factor in whether a woman breastfeeds. The PLS 
also did not specifically aim to recruit an equal sample of e-cigarette users, which 
resulted in a small sample of exclusive vapers. For analysis, dual users and exclusive 
vapers were combined however there may be key differences between dual and 
exclusive users which means results pertaining to e-cigarettes users should be viewed 
with caution. 
Chapter 5 also included some quantitative measures (Likert scales); however, as 
discussed within the chapter, this was ad hoc, and as such, no sample size or power 
analysis was conducted. These a priori tests are essential to minimise the risk of type I 
and type II errors [424]. This also meant that the results could not be separated to 
explore quantitatively any differences (or lack of) in opinions of those who smoked and 
those who vaped.  
6.3.2 Qualitative work 
Two methods of qualitative data collection, infodemic and surveys, were used for this 
thesis. The use of infodemic methodology allowed for the exploration of e-cigarettes 
and breastfeeding, a novel research question. The use of forum data permitted the 
analysis of naturalistic conversations, reducing research bias, and giving a voice within 
this research to women who may not have otherwise engaged in academic research. 
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This research method enabled the understanding of how and why women are using e-
cigarettes postpartum and what opinions they hold on their use in relation to 
breastfeeding. The limitations of this research also relate to the strengths. Data is 
naturalistic and driven by discussion, and the absence of clearly asking research 
questions means data can be overly saturated with themes not relevant to the proposed 
question. The use of a template analysis mitigated this; the inclusion of a priori codes 
focused the analysis on answering the research question only. However, the use of a 
priori codes can also be controversial; it begs the question of whether the findings are 
a true reflection of what is presented in the data or a reflection of what the researcher 
expected to see in the data. The use of a priori codes is an example of deductive coding, 
which is more consistent within the critical realism framework [425]. 
A further limitation of this work was the date of the threads included. E-cigarettes have 
grown in popularity in recent years, and with the PHE report in 2018 highlighting the 
harm reduction benefits of e-cigarettes, it stands to reason that there may be a shift in 
the opinions of women who engaged in discussions about e-cigarettes in 2015. The 
very nature of this research removes the possibility of following this up to identify any 
changes in opinions and beliefs. It also raises the question as to the usefulness of this 
research, given the data collected may be ‘out of date’ in such a rapidly evolving field 
of study as e-cigarettes. With this in mind, this research should be considered 
exploratory, and whilst limitations are clearly present, this work lays down the 
foundations for further study. The research conducted in study 3 did corroborate the 
findings of study 2, suggesting that whilst opinions may have changed they have done 
so in a significant way. 
Chapter 5, while not an infodemic piece of research, did rely on the distribution of 
surveys online. Therefore the sample of women within both qualitative chapters is 
confined purely to women who have access to the internet and are regular users of 
either parenting forums or social media platforms. An online approach was explicitly 
chosen to minimise the burden to participants who are in a transitional phase of life 
(new motherhood) and may struggle with alternative methods of research. It’s also 
worth noting that, according to the Office for National Statistics (ONS), 99% of UK adults 
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aged 16-44 are internet users [426]. However, it is important to note that inequalities in 
the quality and access of the internet persist in line with socio-economic disadvantages 
in the UK, which should be taken into consideration [427]. 
A further limitation of study 3 is due to the nature of surveys; as surveys are completed 
anonymously and in writing, there are no opportunities for the researcher to explore 
points of interest or ask for clarification on discourse. For example, one participant had 
used emoji’s to answer some questions which are open to varied interpretation. As a 
result, where some surveys were detailed and included lengthy sets of data, others 
were very brief, sometimes comprising of singular words. This was mediated by 
collecting data from a large group of women, ensuring there was adequate data to reach 
thematic saturation. Face to face interviews could further help obtain more in-depth data 
and allow for clarification of points raised; however, the loss of anonymity may prevent 
full disclosure. 
The anonymity of study 3 also raises concerns about whether participants did meet the 
study criteria. For example, not speaking or being in front of the researcher means it 
cannot be said with 100% certainty that each participant was indeed a new mother who 
smoked or vaped. However, given the nature of this research required commitment of 
time, and some understanding of the issues surrounding breastfeeding as a smoking 
or vaping mother, this is likely to have been a minor issue. This was potentially more of 
a concern in study 2 due to ‘internet trolls.’ Internet trolls are people who deliberately 
interrupt communications online with either fake stories or harsh opinions [428]. 
However, research has suggested that on parenting websites, trolls are generally more 
of a source of entertainment. They tend to post provocative and fake opinions rather 
than engage in serious discussions [429]. Nevertheless, only threads with several 
unique contributors were selected to minimise this risk.  
A limitation to both study 2 and 3 is the lack of awareness of the social and cultural 
contexts of the women involved in the study. For example, social norms relating to both 
smoking and breastfeeding are related to the environment a mother has lived in [136] 
[127], [62-64]. This is particularly important when considering e-cigarette acceptability 
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and use, as research suggests this too is influenced by the social and cultural 
environment a person lives in. For example, concerns about nicotine addiction amongst 
working-class smokers in the UK can act as a barrier to using e-cigarettes; smokers felt 
that switching to e-cigarettes using nicotine is similar to that of continuing to smoke due 
to the perception of addiction as a moral failure. There were also moral objections to 
spending money on e-cigarettes, and so choosing cheaper devices was a greater 
consideration than reducing health risks, as was choosing low nicotine juices [430]. This 
may have explained why some women involved in study 3 reported having previously 
used e-cigarettes and found them to be either unpleasant, or ineffective at satisfying 
their cravings. Thirlway (2016), identified differences in e-cigarette use and perceptions 
amongst working class areas in the UK. It was identified that e-cigarette use amongst 
working class families conflicted with hedonistic cultures. However an e-cigarette was 
often seen as functional in response to this, but only in male smokers [431]. In studies 
2 and 3 women talk about the pleasurable experience of vaping, such as the different 
flavours smells. In hindsight, it would have been useful to have gained information on 
participant’s areas of residence to explore any barriers that may have been socially and 
culturally specific. 
Both qualitative studies used thematic analysis, although Chapter 4 used a variation of 
this, template analysis. Thematic analysis allows for both inductive and deductive 
analysis [432], and thus, this flexible approach was crucial to the overall thesis. Due to 
the novelty of this research area, a deductive approach with a priori codes was 
necessary to narrow the scope of the study and inform the future direction of the thesis. 
An inductive approach, as taken in Chapter 5, then allowed the thesis to understand 
better women’s own experiences, barriers, and facilitators. 
 
6.3.3 Overall strengths and weaknesses 
This thesis utilised a mixed-methods approach, using quantitative and qualitative 
methodologies. Mixed methods approaches are comprehensive and can allow for 
research questions to be more efficiently answered [316]. This enables triangulation, 
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building a consensus through all findings, and can expand the scope and breadth of the 
questions posed [325]. Consideration of the findings across the methodologies 
described in section 6.2 of this thesis enabled a complete understanding of the 
acceptability of e-cigarette use as a breastfeeding mother, and how this may support 
maintaining a smoke-free status postpartum. 
Across all three studies, smoking and vaping status were self-reported. Research 
suggests smoking is often underestimated when self-report measures are used [433], 
particularly in pregnancy [434]. This may have impacted some responses; for example, 
in Chapters 3 and 5, women were given options including ‘I smoke, but less than before 
pregnancy’ or ‘I smoke, but less than when I was pregnant.’ This may have been subject 
to underestimation based on social desirability factors, and retrospective memory. The 
use of anonymous online surveys does, however, appear to increase the reliability of 
self-reported smoking status [340]. 
A further limitation of this thesis overall is the lack of perspectives from a wider 
stakeholder group. This thesis only reported the views, opinions and experiences of 
mothers, whereas research suggests that the wider family network is important in the 
decisions a woman makes regarding smoking, vaping and breastfeeding. For example, 
having a partner who smokes, or abstains from smoking is directly related to whether a 
mother quits smoking during pregnancy, and whether she remains smoke free 
postpartum [435]. Evidence is also emerging that whether a partner vapes, or is 
supportive of vaping, is also somewhat related to whether a mother makes the decision 
to vape [270]. Breastfeeding is also supported if the mother is around other women who 
have breastfed, or comes from a family who are supportive of breastfeeding [436]. 
Other stakeholders include health care professionals, and whilst the women involved in 
this thesis discuss in detail their perceptions of the support, or lack of support, afforded 
to them by healthcare professionals, this thesis is unable to represent those 
professionals own experiences and opinions. This thesis would have been 
strengthened by the inclusion of a wider range of perspectives. However, given the 
exploratory nature of this research, it was felt that fully representing mothers own 
157 
 
experiences was a higher priority, providing an evidence base for future studies to 
include a wider stakeholder groups.  
 
6.5 Triangulation of findings to inform future works/interventions 
A theoretical framework did not guide this thesis, this was due to the novelty of the 
research question. To reduce biases, this research was treated as exploratory, where 
themes were guided by the data, rather than a framework. If a theoretical framework 
had been used to guide this thesis, the data generated would have provided a more 
robust evidence base for the future development of behaviour change interventions. 
Whilst this is a limitation of the thesis, it is negated by the wealth of information 
generated by taking an exploratory approach. Applying a theoretical framework was 
considered early on in the thesis process, however it was decided that due to the novelty 
of the subject, an exploratory approach would produce the necessary evidence base 
for future, more theory driven, research.  
Throughout this thesis, a stance of critical realism was adopted. The research, being 
exploratory in nature, emerged to be more positivist; the assumption that there is an 
objective truth within the phenomena of smoking, vaping and breastfeeding. Critical 
realism is commonly known as the ‘answer’ to the epistemic fallacy; that our knowledge 
of the world cannot simply be reduced to our understanding of our knowledge of the 
world, and with this there is a flexibility in this approach. That positivism and 
constructivism are indeed a continuum, and although data may present as leaning more 
toward the positivist end of the spectrum, this ‘truth’ is presented within the context of 
motherhood throughout this thesis. For example, whilst the relationship between 
smoking and breastfeeding can be presented in an objective truth, this is within the 
context of the socially constructed ‘good mother’ principles. 
 Using this critical realism stance and a mixed-methods approach, the triangulation of 
the thesis chapters fits with the Theoretical Domains Framework (TDF) [437] and the 
Capability, Opportunity, and Motivation (COM-B) model [438]. The TDF and COM-B 
model provides a systematic and theoretical basis for changing, and better 
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understanding, behaviour [437]. The TDF includes 14 domains underpinned by 
psychological theory, which derive from 33 theories and 128 constructs. These domains 
include social factors (such as social support), individual factors (such as skills and 
knowledge), and environmental factors (such as access to resources) [437].  The TDF 
has been successfully used to identify the determinants of many health behaviours, 
including smoking cessation in pregnancy [439]. The COM-B model filters the TDF into 
three key domains that interact with one another to predict behaviour; a person’s 
capability, opportunity, and motivation to change [438]. Using this framework helps to 
identify relevant intervention functions, based on a wide range of influences, that may 
support behaviour change. Therefore to affect a behavioural change from smoking to 
vaping, and from not breastfeeding to breastfeeding, the TDF and COM-B model can 
be used to inform future interventions and directions for further research. 
To input the findings from this thesis into the COM-B/TDF domains, the findings across 
all three studies were entered into NVivo12©. From here, a simple coding template was 
formed based on the 14 TDF domains. Findings were coded depending on which 
domain they fitted, in the event a finding appeared to fit more than one domain, the 
finding was double coded. The coded findings were then filtered into the corresponding 
COM-B domain and noted as a barrier (B), a facilitator (F), or both (B/F). This is 
presented in Table 6.1, which was used to identify future research needs, implications 








TDF Domain Barrier (B) and facilitators (F) for 
breastfeeding as a smoker/vaper 
Barriers (B) and facilitators (F) for 



















Understanding that it is safer to 
breastfeed than formula feed regardless 
of smoking status (F) 
 
Holding the belief that smoking makes 
breastmilk unsafe for an infant (B)  
 
Being unsure of the safety of e-cigarettes 






Being able to time breastfeeding around 
smoking/vaping needs (F) 
Believing that e-cigarettes are safer 
than tobacco smoking (F) 
 
Concerns about a lack of long-term 
research on potential health effects of 
e-cigarettes (B) 
 
Finding e-cigarettes to be a similar 






Overusing e-cigarettes (B) 
 
Being less cautious with e-cigarettes 





Physical skills  
 
Being able to manage nicotine levels to 
suit their needs (F) 
 





Accessing information online through 
social media and parenting websites (B/F) 
 
Not having leaflets or advice available in 
healthcare settings (B) 
 
Having access to and understanding 
scientific journals (F) 
 




Social influences Feeling judged for breastfeeding as a 
smoker/vaper (B) 
 
Receiving positive support for 
breastfeeding as a smoker/vaper (F) 
 
Not receiving any advice on breastfeeding 
as a smoker/vaper (B) 
 
Getting inconsistent advice on vaping and 
breastfeeding (B) 
Seeing the health benefits of someone 
who has switched to vaping (F) 
 
Experiencing judgement of vaping being 


























Feeling proud of breastfeeding regardless 
of smoking/vaping status (F) 
 
 
Saving money through switching to 
vaping (F) 
 
Not smelling of tobacco smoke (F) 
 






















Feeling that breastfeeding, regardless of 
smoking/vaping status was evidence of 








Planning to breastfeed (F) 
 
Holding the identity of ‘smoker’ with a 
circle of friends (B) 
 
Feeling that vaping maintains their 






Wanting to quit smoking (F) 
 















Wanting to mitigate the harms of smoking 










Believing there may be health 
consequences of vaping and 
breastfeeding in the future (B) 
 
Believing smoking would make their milk 
unsafe, and make their infant ill (B) 
 
 
Wanting to improve fertility (F) 
 
Not wanting to (or wanting their infant 





Believing e-cigarettes are are as bad as 
(or worse than) smoking (B) 
 
Believing that e-cigarettes will improve 
health (F) 
 
Believing that future research will 







6.6 Recommendations  
 
Based on the triangulation of all findings within the COM-B/TDF (as outlined in Table 
6.1), the following recommendations are made for research, practice, and future 
interventions.  
 
6.6.1 Recommendations for research 
One of the key limitations of this thesis was the lack of representation of vaping mothers 
in Chapter 3. As this study did not specifically aim to recruit vaping mothers, a larger-
scale longitudinal survey recording smoking/vaping status at birth would provide a 
better picture of how popular vaping is amongst postpartum women. This would enable 
follow-up questions relating to feeding initiation and continuation, and allow exploration 
of similarities or differences between mothers who smoke, and mothers who switch to 
vaping. This could help inform future interventions, i.e., if mothers who switch to vaping 
are more likely to initiate and continue breastfeeding interventions should focus on 
helping smoking mothers to switch to vaping. However, if this research shows women 
initiate/continue breastfeeding similar to that of smoking mothers, interventions should 
focus more on education around the relative safety of e-cigarettes in the postpartum 
period. 
A longitudinal study of this nature would also enable long term follow up to measure 
childhood outcomes of infants who are breastfed by mothers who vape. This could 
identify any concerns and change the direction of interventions, or it could provide the 
necessary data to overcome fears of future implications of vaping and breastfeeding, a 
barrier identified in this thesis. Further ways to increase confidence in the relative safety 
of e-cigarettes use when breastfeeding could also come from trials measuring levels of 
tobacco-specific/vape-specific constituents within the breastmilk of smoking/vaping 
mothers. This could provide the scientific evidence some women reported needing to 
increase confidence in the safety of e-cigarettes, compared to cigarettes.   
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A key theme across Chapters 4 and 5 was the lack of consistent if any, advice from 
health professionals about vaping and breastfeeding. This is a barrier that needs to be 
addressed to give postpartum women the confidence to switch to vaping if they cannot 
or are unwilling to stop using nicotine. In the early stages of this thesis, a protocol was 
designed to explore health visitor’s beliefs and experiences around e-cigarettes and 
vaping (appendix 6.1). Semi-structured interviews with around 20 health visitors from 
across the UK were planned, and ethical approval was received. However, recruitment 
was a major obstacle to this study, with health visitors feeding back that they did not 
know enough about e-cigarettes and therefore did not wish to take part in research 
about e-cigarettes. While there were discussions about changing the recruitment 
strategy, the findings from chapter 4 indicated further work needed to explore 
postpartum women’s own experiences and opinions before work was conducted with 
health care professionals. Research has since explored health care professionals' 
beliefs, attitudes, knowledge, and behaviour around vaping in pregnancy and 
postpartum [420]; however, this was not specifically tailored to ask about breastfeeding. 
Future research should consider interviews with those specifically involved in 
postpartum health care to assess attitudes, beliefs, and knowledge about vaping in 
relation to breastfeeding. From this, research should also consider the development of 
resources, training and information for health care professionals to enable those 
discussions with new mothers about e-cigarettes and breastfeeding. Although 
recruitment difficulties were encountered when considering the inclusion of health 
visitors in this thesis, the popularity and public conversations about e-cigarettes have 
rapidly evolved over recent years, and this may no longer be a barrier to participation 
in research. It may also be worth focusing on the breastfeeding aspect of the study 
rather than e-cigarettes since health visitors are targeted on improving breastfeeding 
rates. It may also be worth widening recruitment to include other health care 
professionals involved in postnatal care, such as GP’s and midwives, due to success in 
another study [420]. 
Finally, research should seek to explore further the specific difficulties identified within 
this research for switching to vaping. Some women who had tried e-cigarettes reported 
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finding them ‘difficult to get on with’ and found a vape did not satisfy their nicotine 
cravings. Some of these barriers could be alleviated by having a better working 
knowledge of e-cigarettes and how to manage different nicotine strengths to achieve 
satisfaction. It may also help overcome the barrier of ‘overuse’ that women identified, 
as previous research has highlighted vapers will vape more to achieve their required 
nicotine levels, regardless of the strength they’re using [211]. Within this thesis, ex-
vapers were not specifically recruited or asked to expand on why they had returned to 
smoking; research should seek to explore this further. 
 
6.6.2 Recommendations for practice 
While further research is needed, some changes can be made to practice to facilitate 
mothers who smoke to switch to e-cigarettes and initiate/continue breastfeeding. 
Ensuring health care professionals are knowledgeable about the latest PHE guidance 
could lead to discussions with mothers who smoke about the relative safety of e-
cigarettes. Updating information on smoking and breastfeeding to include the use of e-
cigarettes, again highlighting the relative safety of them, could also facilitate switching 
to vaping and empower women to breastfeed. Health visitors and GP’s could also be 
encouraged to discuss smoking with every new mother as part of usual care. This would 
open up a dialogue for women to discuss smoking and have their concerns addressed, 
and also allow women who are at risk of relapse to have a source of non-judgemental 
advice and guidance. As part of these discussions, health care providers could also 
take the opportunity to discuss the relative safety of e-cigarettes and provide women 
with more information for them to be able to make informed decisions. 
 
6.6.3 Recommendations for interventions 
 
The Medical Research Council (MRC) gives guidance on developing and evaluating 
new healthcare interventions. The original guidance (2006) [440] and framework (2008) 
[441] are due to be updated in 2020. The framework acknowledges that due to the 
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complexity of health interventions, a mixed-methods approach is advisable [441]. The 
MRC recommends following the development-evaluation-implementation process, 
which includes: developing an intervention, piloting and feasibility, evaluating the 
intervention, reporting the intervention and implementation of the intervention [440]. 
Due to the novelty of this research, further research is needed before an intervention 
can be designed and piloted. This thesis identifies barriers and facilitators for 
breastfeeding as a smoking/vaping mother and for switching from smoking, to vaping 
as shown in Table 6.1, which could be used to inform future intervention designs. 
For example, health care professional’s attitudes, support, and ability to give consistent 
advice are key facilitators for both breastfeeding and switching to e-cigarettes. 
Interventions should first aim to address any concerns that health care professionals 
have and address any training needs identified during further research. Future trials 
with postpartum women should include health care professional-led interventions.  
Further barriers and facilitators in the COM-B also suggest that empowering women to 
manage breastfeeding around their smoking/vaping needs is important. Ensuring 
women are knowledgeable about how to time smoking around their infants’ feeds could 
mitigate some of the risks to the infant. This may encourage more women to breastfeed; 
while this information has been available on NHS websites, women in these studies 
were still unaware or unsure of the recommendations. 
To support women who smoke to switch to an e-cigarettes, education on how to use a 
vape and manage nicotine needs is important. Interventions should ensure women 
know how to correctly and safely use devices, and begin vaping with the right level of 
nicotine for their needs. 
As myths about vaping are a barrier to their use, but positive experiences are 
facilitators, interventions could also consider highlighting positive stories of women who 
have quit smoking using e-cigarettes. Counteracting the negative media that e-
cigarettes receive with positive stories that highlight facilitators such as ‘not smelling of 
tobacco,’ ‘feeling healthier,’ ‘having more money,’ and ‘having more energy’ could 
facilitate women who smoke to switch to e-cigarettes. 
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6.7 Closing remarks 
This thesis presents data on e-cigarettes and breastfeeding for the first time. This data 
is triangulated from three studies that explored the use of e-cigarettes, the acceptability 
of e-cigarettes, and the barriers and facilitators for their use postpartum. From this, we 
are able to understand that women are using e-cigarettes postpartum in place of 
smoking and that the use of e-cigarettes can overcome some barriers that smoking 
mothers face when considering breastfeeding. While there are still barriers for switching 
to vaping that need to be addressed, e-cigarettes could potentially reduce the number 
of women who smoke postpartum and enable women to breastfeed who otherwise 
wouldn’t have. Negative beliefs about e-cigarettes do persist, and are more evident 
within study 1, where the majority of participants were smokers. As any interventions 
will aim to support women who smoke to switch to e-cigarettes, this is a major barrier 
to overcome. Clear messages on reducing risk and dispelling myths about e-cigarettes 
are needed. This relates to a need to have clear and consistent messages on e-
cigarette use within health care settings. 
This area of research is in its infancy, and there is still more work to be done to address 
the feasibility and effectiveness of e-cigarettes postpartum. However, we now have 
evidence to show that e-cigarettes are acceptable to many postpartum women and are 
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Appendix 6.1: Health Visitor study protocol 
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